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“If we had a pill that conferred all the confirmed health benefits of exercise, would we not do everything humanly 
possible to see to it that everyone had access to this wonder drug? Would it not be the most prescribed pill in the 
history of mankind?” (Sallis, 2009). 
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intensidad de ejercicio adaptada a esta población para hacer ejercicio físico de una forma 
eficaz y segura, que fue presentada en el congreso “Europrevent” en Amsterdam (2014). Por 
otro lado, en otro estudio recién publicado en el J Strength Cond Res, analizamos la respuesta 
cardiovascular de 50 pacientes durante sus sesiones de ejercicio físico aeróbico y de fuerza 
con el fin de entender las dificultades de los propios pacientes para adherirse a las intensidades 
programadas. De Fernando y de Koro me quedo con la perseverancia, empatía, compasión y 
cercanía que transmiten en su trabajo diario, involucrando a todo el pueblo por un fin común 
y solidario. 
 
 
 
 
 
 
 
 
 
 
 
 
 
“El sol, que ilumina y da calor” 
“Paciencia, vas a conseguir todo lo que te propongas” 
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conocimientos y la experiencia adquirida en Miranda de Ebro en la mochila, cambiamos de 
rumbo, esta vez a mi tierra natal, a Pamplona. En el Centro de Estudios, Investigación y 
Medicina del Deporte (CEIMD) del Gobierno de Navarra fue donde pude desarrollar mi 
actividad investigadora principal durante esta tesis doctoral. La gran formación como fisiólogo 
del ejercicio se la debo en especial a Esteban Gorostiaga, doctor en Medicina Deportiva y 
director del CEIMD, un apasionado e incansable Investigador que me ha trasmitido su pasión 
por la evaluación de la capacidad aeróbica mediante umbrales de lactato, me ha hecho 
reflexionar, desmontar ideas, incluso leer artículos de principios del siglo pasado para 
comprender el origen, la trayectoria y la interpretación de conceptos de fisiología del ejercicio 
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de todos los integrantes del CEIMD, y tras tropezar y aprender de las adversidades del camino, 
conseguimos fusionar mis inquietudes en el área de la medición de la actividad física 
generadas por la experiencia de Miranda de Ebro y tras la lectura en profundidad sobre el 
tema, con los conocimientos, experiencia y los intereses de investigación del CEIMD. Del 
mismo modo que se utilizaba la intensidad relativa medida a través de umbrales metabólicos 
o en base a la máxima capacidad cardiorrespiratoria en atletas y pacientes como referencia 
para guiar la programación y las sesiones de entrenamiento/ejercicio, ¿por qué a la hora de 
medir los niveles de actividad física mediante cuestionarios o monitores de actividad no se 
aplicaba este principio? Con el fin de dar una solución a este problema que abarca todo el 
ámbito de la epidemiología, investigación clínica, incluso el ámbito comercial y del fitness 
donde el uso de monitores de actividad está en auge, comenzábamos un nuevo proyecto. 
Tras año y medio de recogida de datos, perdí la cuenta del número de orejas 
perforadas, pero sigo recordando la felicidad de las más de 100 mujeres que participaron en 
este estudio y que continúan correteando por la Vuelta del Castillo tras los consejos recibidos. 
 
 
Este estudio da un paso más en la medición objetiva de la actividad física mediante monitores 
de actividad, aplicando conceptos de fisiología del ejercicio para individualizar las diferentes 
categorías de intensidad en las que se desglosa la actividad registrada por el acelerómetro. Es 
a partir de estos valores por los cuales los estudios epidemiológicos evalúan la proporción de 
personas inactivas en la población de estudio, por lo que una evaluación precisa resulta 
trascendental para la interpretación de los resultados. 
 
“Vísteme despacio que tengo prisa” 
“To be effective, exercise has to be daily and moderate in intensity and never excessive or to exceed 
the half-maximum limit for exhaustion, because disease or even death can ensue” Sushruta, India (600 
B.C) 
 
Y qué decir de la experiencia de los congresos… el equipo LAKET de Sara Maldonado-
Martín al completo por tierras andaluzas, con gente acogedora que desprende alegría. Mi 
primera exposición en inglés que se vería mejorada tras las tres estancias de investigación 
posteriores realizadas en el extranjero. La primera de ellas fue en la Unidad de Investigación 
Musculo Esquelética de la Universidad de Bristol, Reino Unido. Intrigado por su experiencia 
clínica e investigadora sobre el impacto de la actividad física medida a través de acelerómetros 
en el hueso, contactamos con el Profesor Jon Tobias, y tras un par de conversaciones por 
Skype, en un abrir y cerrar de ojos me encontraba en Bristol, con Jon, su mujer Isabelle y su 
hijo Zak con los que compartí muy buenos momentos. En ese mes y medio profundicé en la 
medición de la actividad física mediante acelerometría y su relación osteogénica en el proyecto 
VIBE. 
 
 
“Exercise to be osteogenic have to exceed a minimum 
stress threshold, which can vary among individuals and 
across the lifespan. Individually tailored impact-training can 
be an effective strategy to prevent osteoporosis” 
 
 
 
 Recomendado por Jon Tobias, y tras finalizar la parte experimental del Proyecto del 
CEIMD, me mude de nuevo al Reino Unido, a Bath, una localidad encantadora a tan solo 40 
minutos de Bristol por el “cycle path”. De nuevo, el grupo del estudio de investigación 
multicéntrico REACT (REtirement in ACTion) liderado por la Doctora Afroditi Stathi me acogió 
con los brazos abiertos. El objetivo del ensayo clínico aleatorizado REACT era evaluar la 
efectividad clínica y el coste-efectividad de una intervención de ejercicio físico comunitario 
para reducir las limitaciones funcionales a causa de problemas de movilidad de personas 
mayores con alto riesgo de dependencia. Aún recuerdo esos desplazamientos en bici a Bristol 
con Max Western, más vale que salíamos con tiempo de Bath, ya que el compañero pinchó la 
rueda dos días en el mismo sitio. Aquellas sesiones de ejercicio físico a cargo de Jolanthe De 
Koning, donde los ancianos tomaban su cafecito entre un ejercicio y otro, o las sesiones de 
medición de la batería SPPB y los interminables cuestionarios que agotaban la memoria de los 
encantadores ancianos, que tenían que echar mano a las pastas y los racimos de uvas para 
poder seguir concentrados. 
 Durante ese tiempo aproveché también para avanzar en el análisis de datos y redacción 
de artículos del estudio principal del CEIMD. No podían faltar los monitores de actividad en la 
Universidad de Bath, por lo que indagamos en el análisis de los acelerómetros Geneactive 
mediante procedimientos en el programa estadístico “R”. Conocí, aprendí y ayudé en 
diferentes proyectos de investigación en Cáncer, Ejercicio e Inmunología, en la estimación del 
gasto energético con diferentes marcas comerciales de monitores de actividad utilizando las 
famosas “Douglas Bags”, e incluso me presté voluntario para un estudio de biopsias 
musculares, tejido graso y muestras sanguíneas, aunque después de ver el procedimiento con 
dos participantes se me quitaron las ganas de prestar mi muslo. Gracias al grupo de postdoc 
en Química, al equipo de triatlón de “Bath Amphibians” y las largas tiradas en bici de los 
domingos con Adrián y el club ciclista de Bath, los cinco meses trascurridos dejaron un poso 
de felicidad a pesar de las noches oscuras y lluviosas. 
“Just coming to the session and having a nice chat with their peers, makes the exercise enjoyable”  
 
 
Pero ahí no terminaba la historia, incluso antes de marchar a Bath, en uno de los cursos 
impartidos en la Diputación de Bizkaia sobre el ejercicio físico terapéutico en enfermedades 
crónicas conocí a Marisol Arietaleanizbeaskoa y a Gontzal Grandes, jefes de la Unidad de 
Investigación en Atención Primaria de Osakidetza. Ahí comenzó una nueva amistad y una 
nueva etapa investigadora ambiciosa en el ámbito sanitario. Con sus más de 10 años de 
experiencia en investigación en implementación en atención primaria y con diversas 
enfermedades crónicas y mi granito de arena como fisiólogo del ejercicio, aplicamos las 
técnicas y protocolos de medición de la capacidad aeróbica mediante umbrales de lactato y la 
actividad física con acelerómetros en el proyecto EFIKRONIK, financiado por el Ministerio de 
Investigación y Cultura, y el Instituto de salud Carlos III. EFIKRONIK es un estudio de 
investigación híbrido, un ensayo clínico aleatorizado de dos grupos paralelos en una primera 
fase, donde se compara el efecto común que tiene un programa de ejercicio físico de tres 
meses de duración, individualizado y supervisado por enfermería en una red de centros de 
salud de Bilbao, en la capacidad funcional, sintomatología, calidad de vida y en biomarcadores 
de inflamación específica en pacientes con diversas enfermedades crónicas, desde cánceres 
sólidos metastásicos o hematológicos, hasta pacientes con esquizofrenia. En una segunda fase, 
EFIKRONIK evalúa la dosis-respuesta entre la actividad realizada a los 3, 6 y 12 meses y las 
principales medidas de resultado, además de investigar cualitativamente el proceso de 
implementación, describir la percepción de los pacientes sobre el programa e identificar 
barreras y facilitadores para que EFIKRONIK se implemente de manera generalizada, sostenible 
y continuada. 
No me pude resistir ante un proyecto tan tentador, así que cogí las maletas y me 
marché a Bilbao, donde continúo aprendiendo cada día de la piel de los pacientes y rodeado 
de un equipo multidisciplinar que abarca los retos que supone la implementación real de este 
tipo de proyectos de investigación. Todos y cada uno de los pacientes sois los que dan color 
y sentido a ese trayecto diario en bicicleta por la ría desde Algorta a Deusto. Ayudaros en esa 
lucha ante ese contratiempo, es sin duda lo más gratificante. 
 
 
 
 
“Cambiar los hábitos de vida de los pacientes 
comienza por investigar el proceso de 
implementación, identificar barreras y 
facilitadores para una práctica sostenida y 
desarrollar múltiples estrategias que 
involucran a diferentes agestes del ámbito 
sanitario y comunitario”  
 
 
 
 
 Y para ponerle la guinda al pastel, recomendado por Marisol y Gontzal, y con el 
inmensurable apoyo de la UPV/EHU, cogí un largo vuelo que me llevaría a uno de los centros 
de investigación más conocidos a nivel mundial en cáncer y ejercicio físico, el “Exercise 
Medicine Research Institute, EMRI”, en Perth, Australia Occidental. Entre canguros y koalas y 
largas playas se encontraba este centro, liderado por Robert Newton y Daniel Galvao, dos de 
las personas que redactan las guías de ejercicio físico para pacientes con cáncer a nivel 
mundial, junto a otros expertos que se reúnen en el ACSM. A través de la Investigación han 
conseguido implementar programas de ejercicio físico comunitarios para pacientes con cáncer 
con el apoyo del “Cancer Council Western Australia”. Tan solo en la clínica de ejercicio físico 
del EMRI, reciben más de 30.000 visitas de pacientes anuales bajo la supervisión continua de 
un grupo compacto de fisiólogos del ejercicio físico con formación en oncología, 
investigadores y estudiantes universitarios. En el congreso “Sports Medicine Australia” 
celebrado en Perth, tuve la oportunidad de compartir ideas y presentar dos de los trabajos de 
la presente tesis doctoral, despidiéndome de esta etapa predoctoral. 
 
“To promote exercise you should persuade clinicians and patients to feel what you say with the heart” 
Nigel Spry, Oncologist. 
 
 Este largo recorrido no hubiera sido posible sin el constante apoyo, comprensión, 
consejos y la educación recibida por parte de mi aita Ioxeba, mi ama Lurdes, y mi hermano Lur, 
así como de toda la cuadrilla de amigos de la Txantrea, compañeros y compañeras de 
Licenciatura, Máster y Doctorado, y como no, de personas maravillosas que han pintado de 
colores mi vida, Iraia y Maialen. 
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Resumen  
 
 
Antecedentes: La capacidad cardiorrespiratoria (CCR) y el nivel de actividad física (AF) son 
dos robustos predictores de la mortalidad. Las recomendaciones actuales, basadas en 
evidencia científica, abogan por acumular un mínimo de 150 min·sem-1 en actividades de 
intensidad moderada y/o vigorosa (AFMV), debido a la estrecha relación existente entre la 
dosis de AF medida a través de cuestionarios y la reducción en las tasas de mortalidad. Sin 
embargo, el término de “intensidad del ejercicio físico” (EF) es ambiguo. Con el fin de 
simplificar y agrupar las actividades físicas en relación a su intensidad, las autoridades 
internacionales han establecido unas categorías genéricas, basadas en equivalentes 
metabólicos de gasto energético (METs). No obstante, la intensidad del EF expresada en 
términos relativos es la que presenta una mayor asociación con el riesgo de mortalidad y 
proporciona beneficios en diferentes marcadores de salud.  
Esta tesis doctoral Internacional que tiene entre manos se ha realizado en forma 
de compendio de 4 artículos científicos que abordan la temática de la intensidad del EF 
en dos poblaciones diferentes. El primer estudio evalúa la factibilidad de prescribir/diseñar 
un programa de EF en pacientes diagnosticados de diferentes tipos de cánceres en base a las 
guías genéricas disponibles, y ofrece una guía de prescripción de la intensidad del EF adaptada 
a la respuesta cardiopulmonar de pacientes y supervivientes de cáncer (SC). Los dos siguientes 
estudios tratan de dar solución a la utilización de categorías de intensidad de EF en términos 
absolutos mediante la medición de la AF con acelerómetros en un grupo de mujeres 
postmenopáusicas, comparándola frente a categorías de intensidades relativas, 
individualizadas en función de sus umbrales de lactato. El último estudio, utilizando la misma 
muestra que en los dos estudios anteriores, ofrece un método sencillo y preciso para estimar 
el máximo estadio estable de lactato, comúnmente conocido como “umbral anaeróbico”, y 
diseñar un programa de EF individualizado, a través de un único test de ejercicio incremental 
y submáximo, con el fin de evitar el largo proceso necesario para una correcta determinación 
del máximo estado estable de lactato o para evitar las desventajas derivadas de realizar una 
prueba de esfuerzo cardiopulmonar hasta el agotamiento. 
Capítulo 4: La diversidad de tipos de cáncer, tratamientos y los efectos adversos asociados 
dificultan el establecimiento de unas guías de EF apropiadas para todos los SC. La Asociación 
Americana en Cáncer y el Colegio Americano de Medicina del Deporte (ACSM) recomiendan 
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evitar la inactividad y progresar hacia la dosis de AF recomendada para la población general. 
Sin embargo, la reducción significativa en la CCR, en la masa y fuerza muscular, sumado a los 
efectos adversos de los tratamientos como fatiga, dolor o afectaciones cardiovasculares que 
presentan los SC, hacen de estas recomendaciones de AF todo un reto para esta población. El 
objetivo principal de este estudio fue adaptar las intensidades recomendadas para la población 
adulta a la capacidad cardiopulmonar de SC. Para ello, se recolectaron y analizaron datos de 
las pruebas de esfuerzo cardiopulmonares realizadas a 152 SC durante 10 años. El primer 
umbral ventilatorio (VT1) y el umbral de compensación respiratoria (UCR) de cada participante 
sirvieron de referencia para categorizar tres zonas de intensidad relativa de ejercicio; suave (< 
VT1), moderada (VT1-UCR), y vigorosa (>UCR), que se compararon con la clasificación de 
intensidad basada en términos absolutos y relativos recomendada para la población general. 
Tanto el consumo de oxígeno pico (V̇O2pico) (5.3 ± 1.3 METs), como la frecuencia cardíaca 
máxima (FCmax) (145 ±18 ppm) de los SC se situaron muy por debajo de los valores estimados 
en función de su edad. La zona de intensidad moderada se situó por debajo de las intensidades 
recomendadas para la población general. El rango de intensidad moderada se situó entre 2.4-
4 METs en términos absolutos, y en términos relativos entre 8-14 puntos en la escala de 
percepción del esfuerzo de Borg (6-20), el 41-64%V̇O2max  y el 55-70%FCmax sobre los valores 
máximos estimados. Este estudio demuestra que las recomendaciones de intensidad de EF 
actuales para programar una intervención de EF a la población general, pueden generar 
un sobreesfuerzo a personas diagnosticadas de un cáncer, debido a su reducida CCR en 
relación a la estimada por las ecuaciones disponibles. Por lo tanto, se recomienda utilizar la 
guía de intensidad de EF propuesta y adaptada a la CCR de los SC con objeto de garantizar 
seguridad y proporcionar el éstimulo adecuado que provoque adaptaciones cardiopulmonares 
y metabólicas, aspecto de gran relevancia debido a la baja CCR de los SC, y a su estrecha 
asociación con la mortalidad. 
Capítulos 5 & 6: Los acelerómetros proporcionan información objetiva acerca del 
movimiento humano y, como consecuencia, reducen el riesgo derivado de la interpretación y 
de la AF medida a través de cuestionarios. Sin embargo, este resultado final depende en gran 
medida de los puntos de corte seleccionados para demarcar las diferentes categorías de 
intensidad de la AF (actividad sedentaria, suave, moderada y vigorosa). Por ello, los dos 
siguientes estudios investigan en qué medida la selección de estos puntos de corte afecta al 
resultado final. Para ello, se comparó el método tradicional que utiliza puntos de corte de 
conteos de actividad por minuto (ct·min-1) fijos que representan la categoría de intensidad 
moderada en términos absolutos (3-6 METs) establecida en el Compendio Internacional de 
Actividades Físicas, y utilizada en estudios epidemiológicos para analizar la relación entre la 
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dosis de AF y la mortalidad, así como por las grandes Instituciones Internacionales como el 
ACSM para ofrecer unas recomendaciones basadas en evidencia científica a la población, con 
un método basado en intensidades relativas, a través de la medición de umbrales de lactato 
para determinar los ct·min-1 que delimitan las diferentes zonas de intensidad. Para ello, 75 
mujeres postmenopáusicas se sometieron en días diferentes a un test de marcha-correr 
incremental y a sucesivos test a velocidad constante mientras portaban un acelerómetro 
triaxial en la cadera, para identificar los ct·min-1 asociados a los umbrales de lactato (LT1 y LT2). 
Por medio de regresiones lineales se establecieron las siguientes categorías de actividad: 1) 
sedentaria (<200 ct·min-1), 2) suave (desde 200 ct·min-1 hasta ct·min-1al LT1), 3) moderada 
(ct·min-1 entre LT1 y LT2), y 4) vigorosa (ct·min-1 >LT2). Posteriormente, se registró su AF 
semanal mediante acelerometría para comparar el tiempo trascurrido en cada categoría de 
intensidad en términos absolutos y relativos. Un sub-grupo de 30 participantes realizó dos 
pruebas de esfuerzo adicionales con medición de intercambio de gases y así comparar los 
ct·min-1 producidos en los límites asignados a la intensidad moderada tanto en términos 
absolutos (3-6 METs) como relativos (46-63%V̇O2max) y en relación a los umbrales de lactato 
submáximos (LT1-LT2). Los conteos de actividad producidos al umbral de 3 METs, (2026 ± 808 
ct·min-1), fueron significativamente menores que los conteos de actividad producidos a 
intensidades relativas, tanto al 46%V̇O2max (p <0.01, ES: 1.95), como al LT1 (p <0.01, ES: 2.27), 
que se situaron a una intensidad de 4.6 ± 0.7 METs en mujeres postmenopáusicas con una CCR 
de 10.0 ± 4.2 METs. Los ct·min-1 medidos a la intensidad del LT2 (7249 ± 2499 ct·min-1) (situado 
al 73%V̇O2max) fueron significativamente mayores que los registrados al límite superior de 
intensidades moderadas absolutas de 6 METs (p <0.01, ES: 0.72) y al límite de intensidades 
relativas de 63%V̇O2max (p <0.01, ES: 0.55). La CCR explicó en un ~50% la amplia variabilidad 
en los ct·min-1 (CV = 30-34%) producidos en los límites de intensidad relativa. Como 
consecuencia, y conforme a lo esperado, al seleccionar los ct·min-1 individualizados, el tiempo 
promedio trascurrido en AFMV se redujo a la mitad (p <0.01) en comparación a los puntos de 
corte estándares basados en intensidades absolutas (3-6 METs). Sorprendentemente, a pesar 
de que las mujeres con mayor CCR estuvieron ~1 h·día-1 menos en actividades sedentarias (p 
<0.01), registraron ~3000 pasos diarios más (p <0.01) y estuvieron el doble de tiempo en AFMV 
en términos absolutos (p <0.01) en comparación al grupo de menor CCR, estas diferencias 
desaparecieron (p = 0.62) al utilizar unos puntos de corte individualizados, ya que ambos 
grupos estuvieron ~20 min·día-1 en AFMV en términos relativos. En conclusión, en este estudio 
se demuestra que individualizar los puntos de corte acorde a los umbrales de lactato es 
una manera más precisa y significativa de medir la AF con acelerómetros, reduciendo el 
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riesgo de subestimar o sobreestimar los niveles de AF y el porcentaje de personas inactivas, 
en comparación al método de intensidad absoluta ampliamente aceptado y utilizado. 
Capítulo 7: La programación de la intensidad del EF en base a los umbrales de lactato 
proporciona un estímulo cardiometabólico más homogéneo entre individuos sujetos a una 
intervención de EF, en comparación a ejercitarse a un determinado nivel de intensidad tanto 
en términos absolutos (e.j. 6 METs), como en términos relativos (e.j. 70%V̇O2max). El primer 
incremento en la concentración de lactato durante un ejercicio incremental, denominado 
como “Lactate Threshold” o LT1, ha sido postulado como la mínima intensidad requerida para 
provocar mejoras en la CCR y en marcadores de salud en personas sedentarias. En el otro 
extremo, la máxima carga sostenible en el tiempo sin incrementos continuos de lactato 
durante un ejercicio a carga constante, conocido como máximo estado-estable de lactato, 
también denominado MLSS o LT2, es el indicador gold-estándar del rendimiento deportivo en 
deportes de resistencia, y podría reflejar el límite superior de intensidad del ejercicio en 
términos de seguridad cardiovascular en la población general. En la práctica diaria, estos dos 
umbrales de lactato (LT1 y MLSS) se utilizan para individualizar la intensidad de intervenciones 
de EF/entrenamiento y evaluar su efectividad. Sin embargo, la determinación del MLSS es 
costosa debido a que requiere realizar entre 2-5 pruebas de al menos 20min de duración a 
una intensidad constante en días diferentes. Para evitar dicho proceso, en este estudio 
tratamos de estimar el MLSS en el mismo grupo de mujeres que en los capítulos 5 y 6 a través 
de la determinación de variables relacionadas con la acumulación del ácido láctico y otras 
variables no-invasivas (frecuencia cardíaca y percepción del esfuerzo) durante un único test 
incremental submáximo. Los resultados de este estudio muestran que la velocidad 
correspondiente al MLSS puede estimarse con precisión (R2 = 0.85, p <0.001; SEE = 0.38 km·h-
1) a través de una combinación de variables relacionadas con la acumulación de ácido láctico 
y marcadores no-invasivos durante una sola prueba incremental submáxima. Si además se 
realiza una prueba adicional a velocidad constante durante 20min, se puede explicar en un 
90% la variación del MLSS con un error estándar de estimación estrecho (0.32 km·h-1). En 
definitiva, se recomienda incluir el test incremental submáximo dentro de la práctica 
clínica/deportiva diaria como una alternativa segura, fácil de administrar y altamente 
eficiente a la clásica determinación del MLSS o a pruebas de esfuerzo máximas, al menos 
para el tipo de población estudiado. 
Conclusiones: En la presente tesis doctoral se demuestra que, cuando realizar una prueba 
de esfuerzo no es factible y la programación del EF se basa en intensidades relativas respecto 
a los valores de V̇O2max or FCmax estimados, las guías de intensidad del EF recomendadas para 
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la población adulta pueden provocar sobreesfuerzos en SC que presentan una CCR y una 
respuesta cardíaca reducida con respecto a la población sana de la misma edad. Este 
inconveniente se puede solventar midiendo la CCR a través de umbrales metabólicos 
submáximos, que también pueden ser utilizados para prescribir o diseñar una intervención EF 
individualizada. Este procedimiento garantiza la seguridad y la idoneidad de la dosis de EF 
administrada a cada paciente, maximizando los beneficios terapéuticos. En ausencia del 
equipamiento adecuado para ello, se ofrece una guía de intensidad de EF adaptada a SC como 
herramienta útil y sencilla para clínicos, profesionales del EF y para los propios pacientes, con 
la que monitorizar la intensidad de las sesiones de ejercicio. 
Los estudios epidemiológicos deberían, al menos, ajustar la relación entre la AF y la 
mortalidad por la CCR de los individuos, ya que, tal y como se demuestra, es más fácil realizar 
mayores niveles de AF en términos absolutos para los individuos con mayor CCR, aunque no 
necesariamente significa que esa actividad la estén realizando a mayor intensidad relativa. Por 
esta razón, la reducción en el riesgo de mortalidad asociada a mayores niveles de AF 
probablemente esté sobreestimada debido a la mayor influencia de la CCR en la mortalidad. 
En esta tesis doctoral se presenta una manera más precisa de cuantificar la AF en 
términos relativos, la cual podría aplicarse en futuros ensayos clínicos o incluso en consultas 
clínicas individuales. Su aplicación reduciría el riesgo de subestimar o sobreestimar los niveles 
de AF en comparación a la utilización de categorías de AF basadas en intensidades absolutas. 
La medición de los umbrales de lactato a través de una prueba incremental y 
submáxima caminando y/o corriendo es una manera eficaz de; 1) evaluar la CCR y la efectividad 
de una intervención de EF, 2) Diseñar una intervención de EF por medio de categorías de 
intensidad relativa apropiadas, y 3) medir con mayor precisión los niveles de AF habitual a 
través de acelerómetros, para comprobar su adherencia a las recomendaciones actuales, 
modificar hábitos de vida y/o evaluar la efectividad de una intervención en el cambio en los 
niveles de AF, sin tener que someter a las personas a pruebas de esfuerzo hasta el agotamiento. 
Palabras clave: Actividad física, intensidad relativa, umbrales de lactato, acelerómetro, 
supervivientes de cáncer, mujeres postmenopáusicas. 
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Summary 
Background: Cardiorespiratory fitness (CRF) and physical activity (PA) levels are strong 
predictors of all-cause mortality. Current PA guidelines recommend to engage in a minimum 
of 150 min·wk-1 of moderate to vigorous physical activity (MVPA) based on the accumulated 
evidence from questionnaire-based reported PA levels and its association with chronic disease 
and mortality. However, the “exercise intensity” concept is ambiguous. While, most of 
epidemiological studies have categorized reported physical activities according to their energy 
cost in absolute rates of energy expenditure (METs), it is widely recognized that relative exercise 
intensity plays a major role in the association with CRF and health benefits, and avoids the 
underestimation or overestimation of PA levels in people differing in age or CRF, compared to 
absolute exercise intensity.  
The present International doctoral thesis is composed of four scientific articles 
that address the issue of exercise intensity in two different populations. The first study of 
this doctoral thesis looks at whether current guidelines for exercise intensity prescription for 
healthy adults could be safely applied in cancer patients and survivors (CS). The next two 
studies try to overcome the drawbacks of using absolute exercise intensity categories to 
objectively measure PA with accelerometers. The last study, using the same sample as the last 
two studies, offers an easy-to-administer and accurate method to estimate the maximal lactate 
steady-state or the so-called “anaerobic threshold”, and therefore, to design a tailored exercise 
program, using blood lactate-related thresholds (BLRTs) from a single, submaximal incremental 
exercise test, as opposed to the widely used maximal cardiopulmonary testing. 
Chapter 4: The large number of cancer types, treatments and related toxicities make difficult 
to state general guidelines that fit all CS. Whenever possible CS should avoid inactivity and 
progressively build the amounts and intensities of PA recommended for healthy population. 
However, the significant reductions in CRF, muscle mass and strength, as well as common side 
effects related to treatments, such as, fatigue, pain and cardiovascular impairments, could 
hinder the adherence to recommended PA guidelines, as well as the compliance of prescribed 
exercise intensities. Therefore, the purpose of this study was to adapt the general guidelines 
for exercise intensity prescription to the CRF of CS. Data from 152 CS who performed a maximal 
cardiopulmonary test (CPET) was collected during a ten-years period, and analysed thereafter. 
The exercise intensities corresponding to the first and second ventilatory thresholds (VT and 
8 
 
RCP, respectively) of each participant defined the “moderate” intensity category, which was 
compared to that recommended by current guidelines. Peak oxygen uptake (V̇O2peak) (5.3 ± 1.3 
METs) and maximum heart rate (HRmax) (145 ±18 bpm) of CS were well below from the age and 
maximum workload-adjusted estimated values (p <0.01). Thus, the “moderate intensity” 
category was placed at 2.4-4 METs in absolute intensity, 8-14 points of perceived effort (6-20 
Borg´s scale) and at 41-64%V̇O2max or 55-70%HRmax from the maximum estimated values in 
relative intensity. When CPET is not feasible, it is accepted to prescribe exercise intensity 
according to maximum estimated values. However, due to the lower peak values of CS 
compared to those estimated by validated equations, CS could be overstressed when 
exercise is programmed according to generic guidelines. Therefore, it is recommended 
using the proposed exercise intensity guideline for CS to guarantee the safety during exercise, 
and to induce training adaptations through adequate exercise intensity programming, which 
is of paramount importance due to the low CRF values of CS and its strong association with 
mortality. 
Chapter 5 & 6: Accelerometers can objectively measure human movement and reduce the 
shortcomings of subjective questionnaires to report the number of individuals meeting the 
current recommended target of 150 min·wk-1 of MVPA. However, the final outcome largely 
depends on the selection of accelerometer activity cut-points to demarcate different PA 
intensity categories (i.e., sedentary, light, moderate and vigorous). Therefore, we aimed to 
investigate how objectively measured PA levels (i.e., time spent in each PA intensity category) 
using standard absolute intensity cut-points based on recommended moderate intensity 
targets (3-6 METs) for adults by international agencies, such as, the American College of Sports 
Medicine (ACSM), differed from an individualized relative intensity cut-points approach, using 
the gold-standard lactate thresholds to categorize PA intensity. Seventy-five postmenopausal 
women performed an incremental exercise test and several constant-velocity tests wearing an 
accelerometer to identify the activity counts (ct·min-1) corresponding to the lactate thresholds 
(LT1 and LT2). Individual linear regression determined activity counts cut-points for each 
intensity: 1) sedentary (<200 ct·min-1), 2) light (from 200 ct·min-1 to ct·min-1at LT1), 3) moderate 
(ct·min-1 between LT1 and LT2) and 4) vigorous (ct·min-1 >LT2). Participants then wore an 
accelerometer during a week to measure the time spent at each PA intensity level, which was 
compared to previously validated cut-points from recommended moderate absolute intensity 
target (3-6 METs). A sub-group of 30 postmenopausal women conducted two additional 
submaximal and maximal CPETs to compare the activity counts cut-points for moderate 
intensity category in absolute rates of energy expenditure (3-6 METs), with relative intensity 
cut-points according to CRF (46-63% V̇O2max) and to individual lactate thresholds (LT1-LT2). The 
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activity counts measured at the widely used 3 METs threshold (2026 ± 808 ct·min-1) were well 
below than its relative intensity counterparts either at 46%V̇O2max intensity threshold (p <0.01, 
ES: 1.95) or at LT1 (p <0.01, ES: 2.27), which corresponded to 4.6 ± 0.7 METs in these women 
with CRF values of 10.0 ± 4.2 METs. The activity counts measured at LT2 (7249 ± 2499 ct·min-
1) were higher compared to the absolute 6-METs threshold (p <0.01, ES: 0.72) and to the relative 
63% V̇O2max intensity threshold (p <0.01, ES: 0.55). There was a large interindividual variability 
in the activity counts measured at relative intensity cut-points (CV = 30-34%), which was largely 
explained by CRF level (R2 = ~50%). Therefore, as expected, when individualized activity cut-
points were selected, recorded MVPA was reduced by half (p <0.01) in comparison to the 
widely used cut-points derived from absolute intensities (3-6 METs). The high-fit women were 
~1 h·day-1 less sedentary (p <0.01), recorded ~3000 more daily steps (p <0.01), and they 
engaged in twice as much time (p <0.01) at absolute MVPA compared to low-fit women. 
However, these differences disappeared (p = 0.62) when appropriate relative intensity cut-
points (LT1 and LT2) were applied to each participant, with the two groups recording ~20 
min·day-1 of MVPA on average. In this study it was demonstrated that individually-tailored 
accelerometer cut-points demarcated through lactate thresholds could reduce the risk 
of under- or over estimating PA levels and may provide a more representative PA profile 
of individuals differing in CRF, in comparison to the widely-used and accepted method 
of fixed absolute intensity.  
Chapter 7: Programming exercise intensity through lactate thresholds can provide a more 
homogenous cardiometabolic stimulus to individuals undergoing an exercise intervention, 
rather than exercising at a certain absolute or even relative intensity level (expressed as a 
%V̇O2max). The first increase in lactate concentrations during an incremental test (i.e., LT1) has 
been suggested as the lower boundary of moderate exercise intensity and the minimum 
exercise intensity to improve CRF and health. On the other hand, the highest workload that 
can be sustained over-time without continual blood lactate accumulation (i.e., maximal lactate 
steady-state or MLSS) is nowadays considered the gold-standard marker of endurance 
performance in athletes, and can be used as the upper boundary of moderate exercise intensity 
(LT2), or the highest point from a safety perspective in non-athlete population. These two 
lactate thresholds are used in practice to individualize the intensity of exercise 
interventions/training and to assess its efficacy. To avoid the extensive procedure needed to 
accurately measure the MLSS, we aimed to elucidate whether it could be accurately estimated 
from blood lactate-related thresholds (BLRTs) and or bloodless variables (heart rate and 
perceived effort) measured during a single, incremental submaximal exercise test in the same 
group of postmenopausal women. The results of this study showed that a combination of BLRTs 
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and bloodless variables from a single incremental and submaximal exercise test can accurately 
estimate MLSS velocity (R2 = 0.85, p <0.001; SEE = 0.38 km·h-1). The addition of a constant 
velocity test of 20 min carried out a few days later can still improve the estimation of the 
velocity associated with MLSS, explaining up to a 90% of its variation, with a lower standard 
error of the estimate (0.32 km·h-1). It is, therefore, recommended to include the incremental 
submaximal shuttle test as a simple non-exhaustive and time-efficient alternative to the 
classical determination of MLSS or maximal exercise tests for non-athletic population. 
Conclusions: This doctoral thesis shows that when exercise testing is not feasible and 
intensity prescription is based on estimated V̇O2max or HRmax values, applying currently 
recommended absolute and relative exercise intensity targets for adults by the ACSM, could 
overstress CS, who present a much lower CRF and maximum cardiac response compared to 
healthy adults. This drawback could be solved by prescribing exercise intensity or 
designing/delivering exercise interventions according to submaximal physiologic breakpoints 
such as, ventilatory or lactate thresholds from submaximal exercise tests. This procedure 
guarantees the safety and the adequacy of the exercise dose administered to each patient and 
might maximize the therapeutic benefits. In the absence of exercise testing equipment, we 
offer an adapted exercise intensity guideline for CS that can guide clinicians, exercise 
physiologists and the patients themselves during exercise training.  
Epidemiology studies should at least consider adjusting the association between PA 
and mortality risk by CRF, because as it has been demonstrated, it is easier for high-fit 
individuals engaging in higher levels of PA, but it does not necessarily mean that they are 
having higher relative intensities. Thus, the aforementioned association might have been 
inflated by the higher CRF in those reporting higher PA dose. Another, more accurate way of 
quantifying PA levels that suits better to small clinical trials or to one-on-one consultations, 
that overcomes with the risk of under-or overestimating PA when using fixed absolute intensity 
cut-points to define the PA intensity categories, is, to individualize this intensity cut-points 
according to relative intensities. Measuring the lactate thresholds through an incremental and 
submaximal walking exercise test is a feasible way of; 1) evaluating the CRF and assessing the 
efficacy of an exercise intervention, 2) Designing a tailored exercise intervention, and 3) 
measuring PA levels with accelerometers to provide behaviour change feedback and evaluate 
its efficacy, without the need to expose the individual to exhaustion. 
Key words: Physical activity, relative intensity, lactate thresholds, accelerometer, cancer 
survivors, postmenopausal women. 
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1 
 
Theoretical 
Framework 
 
1.1. Dose-response relationship between 
physical activity, cardiorespiratory fitness and 
mortality 
Every steps counts 
Physical activity (PA) (a behavior) and cardiorespiratory fitness (CRF) (an attribute) are inversely 
associated with all-cause mortality rates, as well as with lower incidence and mortality from 
several chronic diseases, such as cardiovascular diseases (CVD) and cancers 1,2. The findings are 
consistent for men and women and hold after adjustment for age, serum cholesterol level, 
blood pressure, smoking habit, fasting blood glucose level, family history of coronary heart 
disease (CHD), and length of follow-up 2. The apparently protective effect of a more active life 
was first seen for occupational activity and death from CVD by the mid '50s by Morris and 
colleagues 3. They demonstrated that men in physically active jobs had a lower incidence of 
CHD. Bus conductors (double-decker vehicles) were found to have less incidence and severity 
of CHD than bus drivers, and postmen less than telephonists, executive officers and clerks. In 
another experiment conducted by the same group, they examined the role of the physical work 
involved in different jobs by social classes and they concluded with that statement: “In brief, 
the coronary mortality of the groups doing physically heavy work is rather less than half that 
of light groups. More important, the disease is not so severe in physically active workers, 
tending to present first in them as angina pectoris and other relatively benign forms and to 
have a smaller early case-fatality and a lower early-mortality rate” 3. 
Since then, it has been an enormous interest in quantifying the physical demand 
(energy expenditure by indirect calorimetry) of different tasks and jobs 4. Brown and Crowden 
5 obtained metabolic data from 381 factory and industrial workers to establish an objective 
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classification of work grades according to energy expenditure (EE) and nutritional 
requirements. The intensity of occupational work can be summarized in the following ranges; 
Sedentary (<1.9 metabolic equivalents of EE or METs), Light (1.9-3.3 METs), Moderate (3.4-4.7 
METs), Heavy (4.8-7.1 METs), and Very Heavy (>7.1 METs) 6. 
A few years later, British and German researchers started to develop and validate PA 
questionnaires against personal interviews to record the whole daily activity, which essentially 
consisted of follow-up questions relative to the intensity of effort and frequency of 
participation in the physical activities which the respondent had indicated in the self-
administered form 7. A decision classifying each individual into one of four PA groups (very 
active, active, moderate, light) on each component (occupation, leisure, and home) was made 
by consideration of the questionnaire and interview responses by three judges. Next, each 
activity was weighted relative to EE (light; 0.5-1 Kcal·min-1, moderately active; 1-1.5 Kcal·min-1, 
active; 1.5-2 Kcal·min-1, and very active; 2-5 Kcal·min-1) using previously reported tables 4 and 
was checked against previous decision, resulting in a high discrepancy between the two 
methods.  
The study conducted on 10.269 Harvard Alumni by Paffenbarger and colleagues 8 is 
another classic work assessing changes in personal and lifestyle characteristics recorded in 
questionnaires from 1977 through 1985 and their relationship with all-cause mortality. Those 
individuals with an EE <2000 kcal·week-1, walked less than 14 km·week-1 or men who did not 
engage in moderate-to-vigorous intensity sports activity had a 25, 16 and 44% higher risk of 
all-cause mortality than more active individuals, respectively. Overweighed, smokers and 
hypertensive people had also a 31, 87 and 69% higher risk of all-cause mortality after 
controlling for other factors. They also showed that favorable changes in lifestyle, such as 
taking up moderate-to-vigorous sports activities had a substantial reduction in mortality for 
all causes (23%) and from CHD (41%) compared to the most sedentary classmates, resulting in 
0.72 years of life gained. This association was higher than the change to higher total EE per 
week. The women´s health study 9 also showed a strong inverse association between PA and 
CHD in a large sample of women aged 45 years or older with little activity. Women who spent 
600 to 1500 Kcal·wk-1 were at significantly lower risk (45%) of developing CHD after adjustment 
for smoking status, diet, and other confounders. Particularly the energy spent in vigorous-
intensity activities contributed to such benefits. However, among women who did not perform 
vigorous intensity activities, walking at least 1 hour per week resulted in about half the CHD 
risk of women who did not walk regularly. All these findings are evidence that among people 
with little activity, engaging in even light-to-moderate activity is associated with health 
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benefits. Among people who are more active and fit, however, vigorous activity is required to 
obtain such benefits 8,9. 
Overall, large prospective cohort studies show that EE in the range of 500-1000 Kcal·wk-
1 of moderate-intensity PA (an equivalent minimum of 150 min·wk-1) is associated with ~30% 
lower rates of CVD and premature mortality. Compared to inactive individuals, at age 30 years, 
life expectancy for individuals achieving this target is 4.21 years longer for men and 3.67 years 
longer for women, and significant all-cause mortality reductions are evident with only 15 
minutes per day of moderate intensity activities 10. As shown in ¡Error! No se encuentra el 
origen de la referencia., the mortality risk appears to continue to decrease (up to 40%) with 
increased exposure up to five times the recommended amount of PA 8,9,11,12.  
 
 
 
 
 
 
 
 
 
Figure 1. Risk of all-cause mortality and self-reported physical activity, by minutes of moderate-to-
vigorous physical activity per week 12. 
 
Determining the amount of PA that is adequate for maintenance of health and that is 
in accordance with our biological makeup is possible by analyzing the habits of traditional 
populations that still follow a preindustrial lifestyle. To standardize PA levels, researchers have 
used the so-called PA ratio (PAR), calculated as the daily total EE of an individual divided by 
the daily basal metabolic rate. A PAR value of 1.40–1.69 represents the inactive to lightly active 
lifestyle that is characteristic of Western societies, whereas values of 1.70–1.99 and ≥2.00 
represent moderately active and vigorously active lifestyles, respectively. Among hunter-
gatherers, the Hadza people of Tanzania, who show an absence of CVD risk factors, have an 
average PAR of 1.78 in women and 2.26 in men. Moreover, Hadza people spend on average 
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950min each week performing moderate-to-vigorous physical activity (MVPA), which is 
approximately sixfold greater than the minimum 150min per week recommended for adults 
by the World Health Organization (WHO). A high PAR is also characteristic of forager–
horticulturalist, pastoralist, and traditional farming populations. The Tsimané people of Bolivia, 
who still follow a forager–horticulturalist lifestyle and have a low incidence of coronary 
atherosclerosis and a near-absence of CVD risk factors, have a PAR of 2.02–2.15 in men and 
1.73–1.85 in women. Moreover, the estimated PAR is 1.70 in non-Westernized horticulturalists 
from Kitava, Papua New Guinea, who reportedly have a very low incidence of stroke, ischaemic 
heart disease, diabetes mellitus, and metabolic syndrome. These examples illustrate that a very 
active lifestyle that is well above the minimum WHO recommendations has been a normal 
characteristic throughout human evolution. Nonetheless, technological improvements over 
the past ~350 generations (that is, during the agricultural, industrial, and, most recently, digital 
revolutions) have led to substantial decreases in human PA levels. Indeed, physical inactivity is 
now the fourth leading cause of death worldwide. Approximately one-third of adults 
worldwide (~50% of adults in the United States) do not meet the minimum WHO 
recommendations for MVPA; the trend towards inactivity starts in adolescence (age 13–15 
years), leading to a suboptimal cardiovascular phenotype and an increased risk of 
cardiometabolic disorders 13. Inactivity has been estimated to be comparable to smoking one 
packet of cigarettes a day, it is responsible for 12% of the deaths in the United States, and it is 
estimated to be the main cause for approximately 21-25% of breast and colon cancers, 27% of 
diabetes and approximately 30% of ischemic heart disease worldwide 14.  
In contrast, higher levels of PA, and regular moderate-to-vigorous exercise induces 
myriad physiological adaptations that benefit human health either directly or indirectly.  Many 
of these benefits seem to be independent of traditional CVD risk factors, blood lipid and 
glucose levels, obesity, and high blood pressure and cholesterol levels. Skeletal muscle is an 
endocrine organ that can produce and release myokines into the bloodstream (particularly 
during muscle contraction in a dose-dependent manner), where they function locally and/or 
systematically to elicit myriad beneficial effects, including decreased inflammation and insulin 
resistance 13,15 Of particular relevance to older adults and postmenopausal women, exercise 
preserves bone mass and reduces the risk of falling 16,17. Prevention of and improvement in 
mild to moderate depressive disorders and anxiety can occur with exercise 18. A physically 
active lifestyle enhances feelings of ‘‘energy’’, well-being, quality of life, and cognitive function 
and is associated with a lower risk of cognitive decline and dementia 19. Vigorous-intensity 
exercise is associated with even greater reductions of CVD and all-cause mortality, as well as 
with greater adaptations in CRF, blood pressure, lipid profile, oxidative stress and inflammation, 
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insulin sensitivity and cardiac function compared with moderate-intensity activity of similar 
energy expended 15,19,20. 
A higher level of cardiorespiratory fitness protects against death 
The most widely accepted index of CRF is maximum oxygen uptake (V̇O2max), expressed in ml 
O2·kg-1·min-1or in metabolic equivalents of EE (1 MET = 3.5 ml·kg-1·min-1) 2. The minimum level 
of CRF that is associated with significantly lower event rates for men and women is 
approximately 9 and 7 METs (at 40 years old), 8 and 6 METs (at 50 years), and 7 and 5 METs (at 
60 years), respectively (corresponding to the ability of continuous walking speed of 6.4 km·h-1 
and 4.8 km·h-1 for men and women around 50 years of age, respectively) 1. Epidemiology 
studies show that 1 MET higher level of CRF (corresponding to 1 km·h-1 higher running/jogging 
speed) is associated with 13% and 15% decrements in all-cause mortality and cardiovascular 
disease risk, and is comparable to the risk reduction associated to a 7 cm, 5 mmHg, 1 mmol·l-
1 and 1 mmol·l-1 decrement in waist circumference, systolic blood pressure, triglyceride level 
and fasting plasma glucose, respectively 1,21,22. A meta-analysis conducted by Williams 23 
reported higher potential to reduce the risk of developing CVD in favour of CRF compared to 
the amount of PA. Although PA increases CRF and may be an appropriate therapy mostly for 
the unfit, only 35% of the variance in CRF is explained by PA, probably because of the low 
correlation of CRF with the amounts of light or moderate intensity activity. The reductions in 
relative risk are nearly twice as great for CRF than PA. Individuals below the 25th percentile of 
the fitness distribution are at substantially higher risk than those at higher percentiles. 
Although V̇O2max testing has become the gold standard method for measuring CRF in 
healthy adults and in people with chronic diseases, it requires to perform a maximal stress test, 
which is very often not posible nor advisable in middle-aged people due to motivational, safety 
or financial reasons 22. Failure of participants to reach maximal exertion would result in V̇O2max 
or maximum heart rate (HRmax) being underestimated. It is common to apply certain checks to 
evaluate wheter the measurement was trully maximal. For example criteria such as respiratory 
exchange ratio (RER) >1.1 or 1.15, a “plateau” in V̇O2max with an increased workload, an 
absolute heart rate >85% of the predicted HRmax, and blood lactate concentration (BLC) >8 
mmol·L-1 are often used to verify a true V̇O2max 24. CRF is usually determined by a maximal 
incremental treadmill or cycling test with slow increments in work-rate and/or grade (in 
treadmill) until individual’s volitional fatigue. The test protocol should be individualized 
according to the characteristics and experience of the individual to achieve exercise durations 
of 8 to 12 minutes. For a non-athlete population, the use of smaller, more frequent increments 
in work-rate is preferable to larger, less frequent increases, both physiologically and 
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psychologically. For cycle ergometry, the initial power output is usually 10 or 25W, followed 
by increases of 25W every 2 or 3 minutes until end points are reached. Ramp protocols that 
increase in small steps have many advantages, including a more accurate estimate of 
submaximal MET level and V̇O2max, in contrast to the more widely used stepwise Bruce 
protocol, which requires more gait changes that can hinder a true V̇O2max achievement as a 
consequence of a premature neuromuscular fatigue or discomfort, or inability to tolerate the 
high workload increments 22. However, in the types of protocols that the work-rate increase 
continuously or in short increments, complete steady states are not reached 22,24. Hence, the 
exercise training prescription based on an incremental protocol by setting workload or HR 
targets should be taken with caution when exercising for longer periods at constant work-
rates. A given V̇O2max or %HRmax value would thus be reached at a lower workload during 
constant work-rate exercise due to an increased oxygen uptake (V̇O2) slow component above 
the first ventilatory (VT1) or lactate threshold (LT1), where the abrupt accumulation of 
metabolites occurs, leading to an accelerated fatigue. 
 
Key points 
 An EE of 500-1000 Kcal·wk-1 of moderate-intensity PA (an equivalent minimum of 
150 min·wk-1) is associated with ~30% lower risk of all-cause mortality and is even 
lower in more active individuals (up to 5 times recommended levels). 
 
 Vigorous intensity PA is associated with even greater reductions in health 
biomarkers, CVD and all-cause mortality. 
 
 1 MET higher level of CRF is associated with 13% and 15% decrements in all-cause 
mortality and cardiovascular disease risk. The minimum CRF level associated with 
lower event rates for middle age (~50 years) men is ~8METs and ~6METs for women. 
Research Gaps 
 The associations established between the dose of PA and all-cause mortality is 
derived from questionnaires. Accurate measurement of PA is, therefore, essential to 
evaluate its effects with health biomarkers and all-cause mortality. 
 
 Performing a “true” maximal exercise test to measure and prescribe exercise based 
on V̇O2max or HRmax values is problematic, not free of risks, costly and within the reach 
of very few people. Alternatively, the measurement of submaximal lactate thresholds 
is a single, cost-effective and accurate method to evaluate CRF and to design 
individually tailored exercise programs. 
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1.2. Physical activity guidelines for adults. Is 
exercise intensity the key? 
In the past, exercise recommendations were based on scientific studies that investigated dose-
response improvements in performance capacity after exercise training and they usually 
involved 20 to 60 min of moderate-to-high intensity endurance exercise (60-90%HRmax) 
performed three or more times per week 25. The classification of exercise intensity and its 
standardization for exercise prescription based on a 20- to-60-min training session has been 
confusing, misinterpreted, and often taken out of context. The origin of these exercise 
classification systems 6,25  was based on EE values of industrial tasks for an 8-h workday. The 
classification of industrial and leisure-time tasks by using absolute values of EE has been 
valuable for use in the occupational and nutritional setting, but it has no meaning to 
extrapolate these values for preventive and rehabilitation exercise training programs unless 
adapted for age and regimens lasting up to 60 min. In 1993 and in the following updates 
Ainsworth et al. 26 collected EE data of multiple daily occupational, recreational, transportation 
and home activities for use in epidemiologic studies to standardize the assignment of MET 
intensities in PA questionnaires. 
Given the low prevalence of adults performing the above-mentioned target and the 
high prevalence of sedentary behaviour, the following recommendations of the Centers for 
Disease Control and Prevention and the American College of Sports Medicine (ACSM) 27 by the 
90ties extended the traditional exercise-fitness model to a broader PA-health paradigm and 
claimed that every adult should accumulate about 30 minutes (enough to expend 
approximately 200 Kcal·day-1) of moderate intensity activities (definition of light, moderate and 
vigorous activities is displayed on Table 1) on most, preferably all days of the week. This is 
equivalent of activities of absolute EE of 3-6 METs (for people weighting ~68-91 kg) and ~7.5-
10 MET·h·wk-1 19.  
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Table 1. Examples of common physical activities for healthy US adults by intensity off effort required in 
MET scores and Kilocalories per minute. 
Light 
(<3 METs or < 4 kcal·min-1) 
Moderate 
(3-6 METs or 4-7 kcal·min-1) 
Hard/Vigorous 
(>6 METs or < 7 kcal·min-1) 
Walking, slowly (strolling) (1.6-
3.2 km·h-1) 
Walking, briskly (strolling) (4.8-
6.4 km·h-1) 
Walking, briskly uphill or with a 
load 
Cycling, stationary (<50W) Cycling for pleasure or 
transportation (≤16 km·h-1) 
Cycling, fast or racing (≥16 
km·h-1) 
Swimming, slow treading Swimming, moderate effort Swimming, fast treading or 
crawl 
Conditioning exercise, light 
stretching 
Conditioning exercise, general 
calisthenics 
Conditioning exercise, stair 
ergometer, ski machine 
… Racket sports, table tennis Racket sports, singles tennis, 
racketball 
Golf, power cart Golf, pulling cart or carrying 
clubs 
… 
Bowling … … 
Fishing, sitting Fishing, standing/casting Fishing in stream 
Boating, power Canoeing, leisurely (3.2-6.4 
km·h-1) 
Canoeing, rapidly (≥6.4 km·h-1) 
Home care, carpet sweeping Home care, general cleaning Moving furniture 
Mowing lawn, riding mower Mowing lawn, power mower Mowing lawn, hand mower 
Home repair, carpentry Home repair, painting … 
*Adapted from 27.  The METs (work metabolic rate/resting metabolic rate) are multiples of the resting rate of oxygen 
consumption during physical activity. One MET represents the approximate rate of oxygen consumption of a seated 
adult at rest, or about 3.5 ml·kg-1·min-1. The equivalent energy cost of 1 MET in kilocalories·min-1 is about 1.2 for a 
70-kg person, or approximately 1 kcal·kg-1·hr-1. 
 
However, the energy cost of PA from compendium-derived values do not account for 
individual differences in body mass, age, sex, adiposity, the efficiency of movement, or 
geographic and environmental conditions in which the activities are performed. Besides, 
people differing in CRF respond in markedly different ways to an exercise challenge (i.e., 
relative intensity). For example, Figure 2 shows why one must use caution when interpreting 
an absolute intensity of exercise being “moderate” when it is applied to individuals differing in 
CRF. On average, V̇O2max decreases with age, and is lower in women, compared to men, across 
age. Therefore, the 3.8 MET activity identified in Figure 2 represents a range of relative 
intensities of 32-76%V̇O2max for different fitness groups.  
Therefore, for individual exercise prescription, a relative measure of intensity (i.e., 
relative to the individual’s maximal capacity) is more appropriate, especially for older and 
deconditioned persons. The minimum training intensity threshold for improvement of V̇O2max 
and the lactate threshold is aproximately 40-50%V̇O2 reserve (i.e., the difference between the 
V̇O2max and the V̇O2 at rest, also known as V̇O2R) or an equivalent of 55-65% of the maximum 
heart rate (HRmax), although it is greatly influenced by initial CRF level. The person who has a 
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very low level of fitness can achieve a significant effect with a training heart rate (HR) as low as 
~55%HRmax, whereas people with higher fitness levels require a higher training stimulus 25. 
Exercising at the appropriate intensity is especially important for the improvement of CRF and 
plays a significant role to control the altered lipidic and hormonal profile, insuline sensitivity 
and inflamatory biomarkers, as well as for the prevention of sarcopenia and osteoporosis 
associated with ageing, particularly in post-menopausal women 28-31. 
 
Figure 2. Changes in the relative intensity of exercise (%V̇O2max) 
when the same absolute intensity of exercise is performed by 
groups differing in V̇O2max 34. 
 
In fact, a large-scale surveillance study showed that relative intensity (the level of 
exertion perceived when individuals exercise on their usual fashion) presented a stronger 
association with CHD rates in healthy men compared to the energy expended on all physical 
activities or to the absolute intensity of sports and recreational activities. Compared to men 
rating their exercise as “weak” or less intense (0 to 2 on the Borg scale), those rating their 
relative intensity as “moderate” (3 on the Borg scale), “somewhat strong” (4 on the Borg scale), 
and “strong” or more intense (≥5 on the Borg scale) had 19%, 38%, and 40% lower CHD rates, 
respectively. Of note, the inverse association between relative intensity of exercise and CHD 
risk persisted among men who did not satisfy current recommendations for PA 32. This study 
goes hand in hand with the results obtained in another large British study 33, where walking at 
self-rated average or brisk/fast pace was associated with a 24% reduction in all-cause mortality 
after adjusting for total duration of MVPA and light-intensity PA. The authors suggest that this 
association may be explained by the increased relative exercise intensity elicited by a faster 
pace providing a greater stimulus for physiologic adaptations in functions known to influence 
CVD mortality. Walking is a cornerstone of PA promotion for public health, but volume of 
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walking (steps per day) has often been emphasized. Given the perceived time barrier cited by 
those who fail to meet current PA guidelines, a pace change may be more feasible than the 
increased volume of walking 33. 
As a reference international agency in the science behind PA, the ACSM develops 
evidence-based position stands and guidelines in the use of physical exercise for the 
development of cardiorespiratory, musculoskeletal and neuromotor fitness in healthy adults 
19. These exercise intensity classifications are based in %V̇O2R and %HRR as a reference for the 
other expressions of exercise intensity (%HRmax is based on V̇O2max values of the 10-MET fitness 
group), and absolute MET values for groups differning in V̇O2max. Direct measurements of HR 
and V̇O2 are recommended for individualized exercise prescription for greater accuracy, but 
when it is not feasible, estimation of exercise intensity is acceptable. In brief, “moderate” 
intensity is defined as 40-59%V̇O2R or HRR, 46-63%V̇O2max, 64-76%HRmax, 3-6 METs, or an 
equivalent walking pace of 4.8-6.4 km·h-1 (brisk walking). Recommended PA target by public 
guidelines 19,35 is to engage in MVPA for ≥30 min·day-1 on ≥5 d·wk-1 for a total of ≥150 min·wk-
1. On 2-3 d·wk-1 adults should also perform muscle strengthening exercises.  
However, PA recommendations and exercise intensity classifications from position 
stands of the ACSM 19,25,35, the American Heart Association 22,36 or the European Heart 
Association 24, as well as reports of the U.S. Department of Health and Human Services 12 have 
been continuously updating, leading to confusion among exercise professionals to prescribe 
exercise intensity in healthy adults and people with chronic diseases. Figure 3 shows how the 
usual intensity target for adults, ie., moderate intensity, can range from 50% to 65% HRmax at 
the lower boundary and from 70 to 80% at the upper boundary depending on the reference 
used. 
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Figure 3. A representative summary of exercise intensity categories defined by different 
position stands.  
 
More than half of the population has at least 1 chronic condition. 
What are the physical activity guidelines for people with chronic 
diseases?  
Reports from the WHO manifest that CVD and cancers are the leading causes of death 
worldwide, accounting for 17.7 and 8.8 million deaths in 2014, respectively 37. Unfortunately 
the incidence of chronic diseases increases with advancing age and unhealthy lifestyles. 
Accordingly, more than 80% of older adults (>65 years) in the Basque Country suffer from a 
minimum of one chronic disease, and more than 65% suffers from two or more chronic 
conditions, generating up to 70% of public health costs 38.  
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Evidence for prescribing exercise as a therapy in chronic diseases is gaining. It is 
acknowledged that exercise has a role as medicine in at least 26 diseases, from psychiatric 
diseases to cancers or CVD 39. The secretion of muscle-derived peptides and myokines through 
muscle contraction during exercise favors muscle hypertrophy, adipose tissue oxidation, insulin 
sensitivity, osteogenesis, anti-inflammation, antitumor defense, improves pancreas and 
endothelial function and revascularization of ischemic vessels 28. The evidence suggests that in 
selected cases exercise therapy is just as effective as medical treatment and in special situations 
more effective or adds to its effect. The accumulative knowledge is now so extensive that it has 
to be implemented. 
While extensive research has postulated exercise to be safe and effective in cardiac 
patients, leading to specific guidelines for exercise prescription 24 and cardiac rehabilitation 
programs as part of the standard care of cardiac patients, little has been advanced in terms of 
exercise implementation in oncology. Early post-hospitalization exercise training in cardiac 
patients usually involves a minimum of 20-30 minutes per session, three to four days per week 
24. Aerobic exercise training intensities as low as 40% V̇O2peak have proven to be effective in 
cardiac patients with reduced exercise capacity and thus, light to moderate intensity training 
(up to the first ventilatory or lactate threshold) is possibly the most indicated for 
hemodynamically decompensated patients, those at high exercise-related risk, and those in 
need for weight loss. During the last years, high-intensity interval training (HIIT) (85-95%HRpeak) 
has gained popularity, since its significantly greater cardiovascular effects when compared with 
isocaloric moderate to high-intensity continuous training, both in coronary artery disease and 
CHD patients. High-intensity interval training also favors the improvement of endothelial 
function, reduction in atherosclerosis, better calcium regulation and left ventricular systolic and 
diastolic properties, and greater V̇O2peak improvements 24.  
Cancer is one of the diseases that causes major public health problems in Spain. The 
probability of developing any type of cancer in Spain during the lifetime is of 50% in men and 
30% in women 40. The Basque Country is the autonomous community that records the highest 
incidence rates in men (550 per 100.000 European age-adjusted rates) and the second in 
women (287 per 100.000) 40. Currently increasing incidence rates and decreasing mortality rates 
due to advances in earlier detection and treatments have translated to a higher number of 
people living with cancer (i.e., cancer survivors or CS). This leads to increased costs of cancer 
care and a growing burden on health care systems in terms of medical management, cancer 
surveillance and supportive care. 
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Both, the disease itself and the treatments lead to an increase in psychosocial distress, 
depression and to an impaired cognitive function, increased levels of pain and fatigue. 
Consequently, CS experience a decrease in their quality of life (QoL) and a greater risk of 
developing comorbidities. Cancer patients have lower CRF and strength levels 41 as a 
consequence of several factors; 1) direct results of cancer such as anaemia, resulting in a 
decreased oxygen carrying capacity of the blood, 2) cardiac and pulmonary limitations caused 
by systematic therapy, 3) a reduction of PA after cancer diagnosis, 4) loss of muscle and bone 
mass as a consequence of accelerated thermogenesis and catabolic state 42. The oxygen uptake 
at the first lactate/ventilatory threshold in CS and people diagnosed with many other similar 
chronic diseases is really low, indicating that any light stimulus could induce a relatively high 
metabolic effort. Therefore, the first lactate/ventilatory threshold can be considered a valid 
indicator of the functional capacity of CS. Besides, it is closely associated with the intensities 
of daily activities (walking, gardening, climbing stairs, household activities…) which are closely 
associated with QoL 43.  
It has been estimated that approximately one-third of cancer deaths are related to 
obesity, lack of PA and poor nutrition, and therefore may have been prevented 44. A growing 
body of evidence has demonstrated that CS who achieve a minimum of 150 min·wk-1 of MVPA 
recommended by the ACSM 45 and the Australian Association for Exercise and Sport Science 46 
have ~27-50% lower cancer deaths and recurrences 47-51. Unfortunately, only ~4-20% of CS 
meet international PA guidelines according to objectively measured PA with accelerometers 
and they show a high sedentary behavior (~7-9.5 h·day-1) 52-55. 
Current evidence from experimental studies indicates that exercise reduces tumour 
growth and cancer-specific mortality, in a dose-dependent manner. Moderate to high-intensity 
endurance exercise (at intensities associated with increases in catecholamine levels) is superior 
to light exercise when aiming to target tumour intrinsic factors 56. During exercise, the release 
of several systemic factors (i.e., catecholamines, myokines, etc.), sympathetic activation, 
increased blood flow, shear stress, and increased temperature exert immediate stress on 
tumour metabolism and homeostasis. Following long-term training, these acute effects lead 
to a reduction of a systemic inflammation and oxidative stress, hormone-receptor and 
circulating factors modulation adaptations (i.e., insulin, growth factors, sex-steroid hormones 
etc.), intratumoral adaptations of improved blood perfusion, enhanced immunogenicity, and 
gene expression, and metabolism adjustments, which contribute to slower tumour progression 
and can reduce the ability of cancer cells to form tumours in distant tissues 56-59. Thus, cancer 
patients should not just exercise because it improves their overall health, but exercise training 
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should be implemented in standard healthcare systems as a targeted approach in order to 
regulate cancer progression and formation, ameliorate cancer-associated adverse events and 
improve anti-cancer treatment efficacy 56.  
The ACSM 45 generally recommends to avoid inactivity, returning to normal daily 
activities as quickly as possible after surgery, and to continue normal daily activities and 
exercise as much as possible during and after non-surgical treatments. Recommendations for 
aerobic and resistance/strength exercise training are the same as PA guidelines for the general 
population 19, with several alterations for patients with and at risk of lymphedema, and care 
about fracture risk among some cancer populations (e.g., those treated with hormone 
therapies, diagnosed osteoporosis or bony metastases) and infection risk among those who 
are immune-compromised because of treatment (e.g., care is needed to avoid the spread of 
infection through the use of equipment at public gyms). Exercise tolerance of patients currently 
undergoing treatment and immediately after treatment may vary from exercise session-to-
session. Patients who have received hematopoietic stem cell transplantation should exercise 
at the lighter intensity and lower progression to avoid overtraining given the immune effects 
of vigorous exercise. Resistance training might be more important than aerobic exercise in 
bone marrow transplant patients. If peripheral neuropathy is present, a stationary bike might 
be preferable over weight bearing exercise. Morbidly obese patients would require additional 
supervision and altered programming. In addition, several contraindications for exercise are 
identified, including arm and shoulder problems secondary to breast cancer treatment, having 
an ostomy after colon cancer, or swelling or inflammation in the abdomen, groin, or lower 
extremity following gynecologic cancer.  
The Exercise and Sport Science Australia (ESSA) published a position statement in 2009 
46 indicating that the optimal exercise prescription for CS remains unknown, and may depend 
on the type of cancer, treatments, and characteristics of the patient. It was recommended to 
avoid certain types of aerobic or strength exercises (e.g., high impact activities) during periods 
of increased risk of infection, ataxia, dizziness, peripheral sensory neuropathy, low platelet 
counts, bone pain, or in patients with primary or metastatic bone cancer. The ESSA highlights 
that exercise programs need to be flexible, particularly during periods of cancer treatment. 
Programs need to be adjusted according to changes in treatment, the presence of side effects, 
functional and physical status of the patient, and presence of contraindications and clinical 
concerns. At least 3-5 times per week of 20-30 minutes of moderate intensity aerobic exercise 
is recommended (50-75%V̇O2max or 60-80%HRmax, or an RPE of 11-14). Daily exercise at a 
shorter duration and lower intensity may be preferable for deconditioned patients. Guidance 
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for strength training is to perform dynamic resistance exercises (6-10 involving the largest 
muscle groups), 1-3 times/week at intensities ranging from 50 to 80%1RM, along with exercises 
that replicate daily tasks causing problems for patients (e.g., getting up from a chair, breast 
cancer patients finding hanging clothes on the line troublesome). Resistance exercise is 
particularly important for CS experiencing loss of muscle mass (sarcopenia or cachexia) during 
and following treatment 48,60. This type of training is associated with a 33% lower risk of all-
cause mortality after adjusting for potential confounders, including PA 61.  
Definitely, exercise prescription in this population should be considered a vital adjuvant 
therapy aimed at maintaining or improving structure and function, alleviating symptoms, and 
assisting the recovery of survivors or slowing the decline of palliative patients. Current PA 
guidelines for CS are generic and more research is needed to develop specific exercise 
prescription guidelines (e.g., mode, frequency, intensity, duration), for a given cancer site at a 
particular phase of cancer trajectory, disease impact and treatment side effects 48. 
Key points 
 Current PA guidelines for adults recommend to engage in MVPA for ≥30 min·day-1 
on ≥5 d·wk-1 for a total of ≥150 min·wk-1, and 2-3 d·wk-1 of muscle strengthening 
exercises. 
 
 There are high discrepancies in the classification of exercise intensity categories by 
different expert panels and position stands, leading to confusion with regards to 
exercise intensity terminology. 
 
 Cancer is one of the chronic diseases that causes major public burden is Spain. 
Exercise training has a therapeutic role in the disease, improves physical function and 
QoL of patients, reduces the secondary effects associated with cancer treatments and 
extends their survival. However, most CS are inactive. 
Research Gaps 
 There is a high prevalence of CS worldwide, who could decrease their cancer 
progression and improve their physical function, QoL and survival engaging in 
recommended amounts of PA. However, unlike with cardiac patients, there is not 
uniformity in the optimal exercise type, frequency, duration and intensity to be 
prescribed, and this exercise dose should be likely adapted to each type of cancer, 
stage, treatments and adverse effects, and participant’s characteristics. 
 
 An exercise intensity classification based on individual metabolic thresholds could 
overcome with the over- or underestimation of exercise intensity prescribed to each 
patient, and thus; 1) ensure that a sufficient therapeutic dose is provided, and 2) 
avoid an overdose of exercise given the immune effects of vigorous exercise.  
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1.3. Individualization of exercise intensity 
categories through lactate thresholds 
A criticism to the use of %V̇O2max or %HRmax for exercise intensity prescription is that this 
methods fail to account for differences in metabolic stress between individuals 24,62,63. Authors 
highlighting this discrepancy have advocated the use of metabolic thresholds as preferable 
“anchors” for relative exercise intensity prescription. For example, Katch and colleagues 
showed that at an intensity corresponding to 80%HRmax (~62%V̇O2max) half of the athletes were 
training below their anaerobic threshold (AnT), but the other half were training at higher 
intensities than their AnT 62 (Figure 4). Dwyer and Bybee observed that for an intensity between 
58 and 75%V̇O2max, some of their participants were below, and others above their AnT. 
Conversely, Meyer and colleagues 63 showed that the workload associated with 75%V̇O2max 
corresponded to 86-118% of the individual AnT and blood lactate concentrations (BLC) of 1.4-
4.6 mmol·l-1 in different individuals following an incremental exercise test. In contrast, exercise 
intensity prescribed relative to metabolic thresholds would be expected to produce less 
individual variation in metabolic responses and less individual variation in time to exhaustion 
at constant exercise intensity, providing a more homogenous training stimulus than training 
prescribed as a given %V̇O2max or %HRmax 64. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Plot of individual subject´s percent of anaerobic 
threshold (AT) at the different percent HRmax. On the left axis 
is labeled the corresponding oxygen uptake for the 
respective percent AT 62. 
29 
 
Besides, the European Heart association 24 acknowledges that beyond the first 
lactate/ventilatory threshold, a given relative exercise intensity expressed either as %V̇O2max or 
as %HRmax  measured during an incremental exercise protocol would result in an EE higher than 
expected when performing a constant-work-rate exercise. In other words, for a given V̇O2 
value, the workloads are not the same when performing incremental versus constant work-rate 
exercise. Consequently, when prescribing constant workload training (i.e, 10 min cycing at 
100W) based on incremental exercise data, it is necessary to reduce the work-rate prescription. 
An easier, safer, non-dependent on motivation and widely accepted approach to 
evaluate CRF is, therefore, the analysis of variables related to the accumulation of blood lactate 
concentration (BLC) plotted against exercise intensity or duration during submaximal exercise. 
It has been recognized since early independent experiments published in the 1920s that lactate 
increases in blood from resting values only above a certain exercise level or threshold 65,66. 
When the oxygen supply is inadequate to meet the oxygen requirement of the contracting 
muscles, it increases anaerobic glycolysis for energy generation, converting pyruvate to lactate. 
This mechanism helps to sustain the total energy needed when O2 transport to the 
metabolically active muscles becomes inadequate to meet the total oxidative requirement for 
energy generation 67.  
 The physiologic breakpoint representing the first abrupt rise in BLC above resting levels 
during incremental exercise (Figure 5) was proposed by Hollmann and thereafter by 
Wasserman and Mcllroy by the 1960ties as an exercise intensity that provided a substantial, 
yet safe, amount of physical stress for patients suffering from CVD, and was considered a valid 
indicator of exercise capacity in cardiac patients 68,69. In these patients, this first lactate 
threshold (LT1) might be evident at less than twice the resting metabolic rate, whereas in 
sedentary healthy subjects this threshold might be surpassed at about four times the resting 
metabolic rate. In trained individuals, the LT1 may not be observed until the subject exercises 
to a level that is 10 to 20 times the resting metabolic rate (see differences between participant 
A, B, and C on Figure 5). The first exponential increase in BLC (i.e., LT1) has been suggested as 
the minimum exercise intensity required by inactive individuals to improve CRF 70-72, and 
presents a high association with V̇O2max and sport performance 72-75.  
 Due to the time-consuming and invasive procedures related to blood lactate 
measurements in the mid 50ties, non-invasive methods that relied on respiratory gas exchange 
measurements were introduced for physiological detection of this threshold 76. These methods 
are supported by the concomitant increase in H+ above the intensity of LT1, which is buffered 
by bicarbonate (HCO3-) resulting in increased production in CO2 and to a steeper increase in 
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ventilation (VE), whereas the increase of V̇O2 remains linear with increasing workload. Although 
there is a high correlation between gas-measurements and blood lactate methods for the 
detection of this threshold, they do not always occur together 68. The beginning of arterial or 
venous lactate increase is the standard against which indirect methods must be evaluated 77. 
 
Figure 5. Lactate-workload plot during incremental exercise in three different representative 
participants of the current study. 
    
 With increasing exercise intensity above LT1 during constant workload exercise, the 
lactate production rate is higher than the metabolizing capacity of the cell, and intensities only 
slightly above LT1 result in elevated but constant BLC (an equilibrium between BLC appearance 
and elimination) during steady-state exercise that can be maintained for prolonged periods of 
time. The highest constant workload which can be maintained over time without a systematic 
increase in BLC is called the “maximal lactate steady-state” (MLSS) and reflects the gold 
standard for the determination of the second (i.e., LT2) or the so-called “anaerobic threshold” 
68,74,78,79. With further increase in the workload above the MLSS, the muscular lactate production 
rate exceeds the systemic elimination rate. This leads to an exponential increase in BLC and 
catecholamine levels 80 during incremental exercise and to non-steady increase (>0.05 mmol·l-
1·min-1) of BLC during constant work-rate exercise 74 (Figure 6). A further nonlinear increase 
in V̇CO2, and more pronounced in VE, is observed.  
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These blood markers are closely related to metabolic activity in the muscle through 
significant correlations with muscle capillarization (r = 0.59-0.77), percentage of slow twitch 
fibers (r = 0.74-0.77), oxidative capacity (r = 0.94), and muscle enzyme activity (r = 0.54-0.68) 
and it is not surprising that blood lactate markers have been shown to explain more variation 
in sport performance than V̇O2max (r = 0.51-0.83 vs 0.61-0.91) 75. 
Figure 6. Blood lactate response to several constant walking (W) and running (R) velocities in one 
representative participant included in this study. The highest velocity with steady-state blood lactate 
concentration as a function of time (an increase <0.5mmol·l-1 during the last 10min of the trial) is defined 
as the maximal lactate steady-state (MLSS) 74,75. 
 
 In the 1960s, the enzymatic method for measuring BLC from capillary blood samples 
was developed. This led to the increasing popularity of using blood lactate as a parameter to 
assess endurance capacity as well as for exercise intensity prescription. In the following years, 
numerous blood lactate-related thresholds (BLRTs) concepts were developed, leading to 
considerable confusion and misinterpretation 64,75, but the aforementioned two physiologic 
breakpoints of energy supply are considered the gold standard lactate thresholds. The intensity 
range between LT1 and LT2 is called the aerobic-anaerobic transition and clearly demarcates 
three intensity levels according to energy supply: light (<LT1), moderate (LT1-LT2) and 
vigorous (>LT2) 68,75, allowing an accurate prescription of exercise intensity for endurance 
training, as well as an objective evaluation of training adaptations 81-83.  
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 While LT1 can be determined in a single graded submaximal test, the assessment of 
MLSS is, however, cumbersome since it requires several (3-6) constant workload tests on 
separate days, lengthening aerobic conditioning evaluation to a minimum of 1-3 week period 
84. To avoid such an extensive procedure, simpler methods have been proposed to estimate 
MLSS intensity from a single incremental test, involving the use of either blood lactate 71,74,75,85-
88 respiratory 67,89 or the maximum workload achieved during an exercise test to exhaustion 
72,90, showing a wide range of correlations (r = 0.63-0.95) with MLSS. However, all existing single 
session MLSS-estimating tests are variably handicapped by compromised validity, accuracy, 
resolution and reliability due to methodological differences and a suboptimal statistical 
approach (i.e. correlation analysis) leading to incomparable and inconclusive results 75,77,85,91. 
Most of these studies have been conducted in small groups of athletes using exercise tests to 
volitional fatigue, but little is known about the prediction of MLSS from BLRTs using 
submaximal tests in adults. This might reduce the premature fatigue, dyspnea and symptoms 
of discomfort associated with maximal exercise testing in sedentary adults, as well as the 
economic cost associated with it 22. From a practical and statistical point of view, it would be 
of interest to know the variability of individual differences between respective BLRTs and the 
MLSS, which is rarely reported 75. Low individual differences between BLRTs and MLSS in large 
heterogeneous samples would guarantee an accurate estimation of MLSS intensity from a 
single exercise test and its usefulness for individualized exercise intensity prescription 78. 
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Key points 
 Exercising at the same relative intensity (i.e., %V̇O2max or %HRmax) produces a large 
variability in the metabolic stress among individuals. 
 
 The first exponential increase in BLC during an incremental exercise (ie., lactate 
threshold or LT1), and the highest work-load sustained over time with steady-state 
BLC during continuous exercise (i.e, MLSS or LT2) are the two gold-standard 
physiologic thresholds to demarcate individualized exercise intensity categories. 
 
 The determination of MLSS is handicapped due to the extensive exercise testing 
required. Simpler single-session MLSS-estimating exercise protocols have been 
proposed, involving either, the use of blood lactate, ventilatory thresholds, or the 
maximum workload or time attained at exhaustion. 
Research Gaps 
 Most studies aiming to estimate MLSS intensity from single exercise tests have been 
conducted in small groups of athletes. Besides, they do not reflect accurately the 
individual responses on this association. More research in the non-athlete population 
is needed to implement simple and accurate exercise tests for a proper exercise 
intensity prescription. 
 
 Compared to relative intensity categories defined by PA authorities (e.g., ACSM), 
exercise intensities corresponding to the gold-standard lactate thresholds are not 
well studied. 
 
  
34 
 
1.4. Measurement of Physical Activity. From 
questionnaires to activity monitors.  
How do activity monitors work? Principles and data processing 
Physical activity has been studied for the purposes of understating the basic characteristics of 
human movement and its association with chronic diseases and mortality. The accurate and 
detailed measurement is, therefore, a crucial prerequisite. In an attempt to overcome the 
shortcomings of subjective reports and questionnaires, portable PA monitors gained 
popularity since their initial designs by the 1970s as modified wristwatches that showed an 
accumulated count of movements 92. In the following years, different kind of activity monitors 
were developed with integrated circuitry and memory to provide internal control and timing 
as well as off-line data retrieval. In the beginning, these activity monitors were used to study 
rest/activity cycles and other behavioral variables of soldiers involved in sustained operations 
and other conditions that adversely affect sleep and performance, as well as to evaluate 
hyperactivity and related disorders in children 93. These devices use one or multiple 
piezoelectric accelerometers that measure body movements in terms of acceleration (both 
amplitude and frequency), which can then be used to estimate the intensity of PA over time. A 
piezoelectric acceleration sensor consists of a piezoelectric element and a seismic mass, 
housed in an enclosure (Figure 7).  
 
 
 
 
Figure 7. Schematic of the two common piezoelectric accelerometer 
configurations. 
 
When the sensor undergoes acceleration (change in speed with respect to time; 1 g = 
gravitational acceleration or 9.8 m·s-1), the seismic mass causes the piezoelectric element to 
experience deformation in the form of bending or direct tension or compression. These 
conformational changes cause displaced charge to build up on one side of the sensor, which 
can generate a variable output voltage signal that is proportional to the applied acceleration. 
This signal which is recorded in different frequencies is filtered to overcome with non-human 
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movement. Most of human PA is below the frequency of 5 Hz, although the accelerations 
during certain vigorous movements such as running (< 8 Hz) or specific movements of the 
arms can be as high as 25 Hz 93,94. The limits of the band pass filter are also determined by the 
type of movement the device is intending to capture and is generally in the range of 0.1-10g. 
This voltage signal, after being filtered and amplified, is then sampled at a prefixed frequency 
by the device to convert the analog voltage signal to a digital series of numbers (raw 
accelerations). These accelerations can then be simplified applying different analytical 
approaches to report the final output for a selected time window (epoch) (Figure 8). The most 
commonly applied method is to use the area under the curve algorithm (integration or 
average) above a certain acceleration threshold, which favours movements in low frequencies 
in contrast to peak counting that favours the higher frequency component (counting the 
number of times per epoch that the signal level exceeds and then recedes below the reference 
threshold. The final output can be further incremented in proportion to the magnitude of 
displacement from baseline reference). This final output is known as “activity counts” which are 
summed for each given time window or epoch (Figure 8). The advantages of using integrated 
signals include the simplicity for general understanding, the ease of processing for both 
hardware and software needs, and statistical robustness (integrated algorithm). However, the 
use of such processing techniques to extract PA measurements has significant limitations. First, 
the integration process diminishes the details of the signals within each time window. The 
common duration for such time windows, at least in adults, is 1 min. However, it should be 
recognized that the time period over which accelerometer counts are averaged (termed an 
epoch) can affect the interpretation of data. Choosing a short epoch yields a higher resolution 
of bout durations, which may be important if PA is accumulated in multiple short bouts. On 
the other hand, a disadvantage of short epochs is that the EE associated with 10- to 30-s 
epochs has little physiological value. Choosing a longer epoch has the normal data-smoothing 
advantage of time averaging. The main drawback is that if a long epoch contains a mixture of 
two activities of different intensity, then the data will be averaged to reflect an intermediate 
intensity. If the bout of a higher intensity PA within a particular epoch is shorter than the width 
of the epoch, the averaged PA count for the epoch will be lower than the actual PA intensity. 
This can lead to misclassifying higher intensity PA, which is usually intermittent, into moderate 
or light categories 94.  
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Figure 8. Analytical processing of the acceleration 
data. 1. Raw: a 60-s window of a digitized raw signal 
collected at 32Hz and using a 8-bit A/D conversion. 2. 
Rectification: all negative signal from (1) was tuned 
into positive. 3. Integration in 15-s epochs 94. 
 
From early steps to the present 
Since the early works of Montoye and colleagues validating uniaxial accelerometers against 
movement counters to measure daily EE 95, its use rapidly spread in behavioural and 
epidemiology studies replacing PA questionnaires to objectively measure PA behaviour and 
adherence to recommended PA targets 96. Montoye and colleagues 95 used one of the first 
portable accelerometers to measure human movement integrating and summing the absolute 
values of acceleration-deceleration curves during different daily activities and found that the 
two activity monitors (i.e., the accelerometer and the mercury switch activity monitor) 
underestimated EE of either graded walking or running activities and static exercise, or when 
the body mass is partially supported, as in cycling or rowing. In the following years numerous 
accelerometers with higher storage capacity and advanced software features (e.g., Caltrac, 
Actical, CSA, Actigraph, Geneactive…), worn either, on the hip or on the wrist, were developed. 
Melanson and Freedson 97 tested the accuracy of both the Caltrac and the Computer Sceince 
and Applications (CSA) with estimates (r) of EE ranging from 0.66 to 0.82 from single-location 
accelerometers. The best model included body mass and a combination of activity counts from 
different locations (hip, wrist, and ankle) and explained 92% of the variance in EE, and predicted 
mean EE to within 1%, but had relatively large standard error of the estimate (SEE) of 0.85 
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kcal·min-1 (11.4%). A few years later Freedson, Melanson and Sirard 98 using the same uniaxial 
accelerometer model on the hip were the first authors defining activity counts cut-points for 
adults that corresponded to different activity intensity levels operationally defined as light 
(<3METs), moderate (3-6 METs), hard/vigorous (6-9 METs) and very hard/vigorous (>9 METs) 
categories. Fifty young adults (25 males and 25 females) performed 6 min on different exercise 
conditions on a motorized treadmill wearing the accelerometer on the right hip (slow walking 
at 4.8 km·h-1, fast walking at 6.4 km·h-1 and jogging at 9.7 km·h-1 ranging from 3.7 to 9.7 METs) 
while oxygen consumption was recorded. They used linear regression analysis (R2 = 0.82, SEE 
= 1.12 METs) to establish count ranges corresponding to previously mentioned MET-level 
categories (e.g. 1952-5724 ct·min-1 for moderate intensity) and to estimate EE.  
Crouter, Churilla and Basset Jr 99 compared one of the most widely used accelerometers 
that was being utilized in the US National Health and Examination Survey, the Actigraph model 
7164 (formerly known as CSA), to the Actical counterpart to estimate EE from previously 
validated equations. In general, they showed that EE estimating equations through activity 
counts work quite well for walking and running activities, but underestimated lifestyle activities 
from not accounting for the additional EE of arm activity, uphill walking, stair climbing, lifting 
and carrying objects. Regarding the classification accuracy in light, moderate and vigorous 
intensity activities, several equations gave close estimates of time spent in moderate PA, but 
failed to give close estimates of light and vigorous PA 99. 
Accurate measurement of PA is essential in evaluating the efficacy of interventions and 
understanding the relationship between PA and health. During the last years, accelerometers 
have replaced PA questionnaires to capture objective human activity, and different techniques 
have developed to summarize population-level PA patterns and the prevalence of individuals 
meeting PA guidelines 100. Currently, on the one hand, novel machine-learned algorithms are 
applied to the raw acceleration data to predict specific behaviors (PA type) and EE estimation 
models from acceleration and HR data (e.g., sitting, standing, walking, running and lifestyle 
activities), rather than measuring intensity levels 101. On the other hand, epidemiology studies 
interested in the adherence of certain populations to recommended amounts of MVPA use 
standard or population-specific intensity cut-points. 
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Categorization of physical activity intensity levels with 
accelerometers 
Both, the traditional count-based Actigraph approach 98,102,103 and the new method analysing 
data in “R software” called “GGIR” 104 use raw vector magnitude (a combination of three axis 
or VM3) accelerations to quantify the time spent in different PA intensity levels applying 
accelerometer cut-points derived from the traditional absolute intensity recommendations for 
moderate intensity (3‒6 METs) activities. The use of a wide range of activity types (treadmill 
walking, running and overground activities) and intensities in these studies has produced a 
great deal of variation in the resulting prediction equations and cut points (Table 2), even 
when using the same monitor 99,105,106. For example, Gorman and colleagues 107 identified eight 
Actigraph uniaxial accelerometer cut-points used for classifying MVPA in adults. This wide 
range of cut-points resulted in a correspondingly large range in minutes of MVPA (4 to 80 
min·day-1). Ideally, individualized cut-points would allow the most accurate assessment of an 
individual´s activity level and reduce the risk of overestimating or underestimating PA. 
 
Table 2. Description of existing Actigraph prediction equations and cut points 106. 
 
 
 
 
 
 
 
 
 
 
 
As such, with increasing age or decreasing CRF, an activity at a given absolute intensity 
(MET) requires a greater percentage of relative intensity 19,108 and thus, using the absolute 
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intensity approach may not be the most accurate option for assessing PA outcomes in samples 
varying in age or CRF 109,110. If the cut-points are too high when evaluating accelerometry data, 
then participants will not be credited for engaging in MVPA even when being adherent to their 
prescriptions; conversely, using cut-points that are too low would falsely elevate levels of MVPA 
111. In an attempt to individualize intensity cut-points relative to V̇O2max (45-60%), both Miller 
et al. 109 and Ozemek et al. 110 reported large interindividual variability in the activity counts at 
these cut-points. CRF level (V̇O2max) explained 26% and 32% of the variability in activity counts 
at these thresholds. However, less than 1% of the variability in activity counts was explained 
by individuals´ age and BMI 110. These results indicated that younger and most fit individuals 
had higher activity counts at relative intensity cut-points (4573-6786 cpm in the vertical axis) 
compared to older individuals (2847-5376cpm in the vertical axis). This suggest that the 
standard 3-6 METs absolute intensity approach will underestimate PA intensity particularly for 
older and less fit groups, while overestimating PA intensity in younger and most fit groups.  
Large epidemiology studies using self-reported PA questionnaires 11 have commonly 
grouped recreational PA into three intensity categories according to their energy 
requirements, supported by evidence-informed guideline recommendations 12,19,26,27,35,112: light 
(<3 metabolic equivalents [MET]), moderate (3-6 METs, or an equivalent of brisk walking at 4.8-
6.4 km·h-1) and vigorous (>6 METs). Contrary to self-reported estimates, results of 
accelerometer-based objective assessments of PA report much lower volumes of MVPA 11,113 
indicating that only a small proportion of adults (7-15%) meet current PA recommendations 
113-116. Reported objective weekly volumes of MVPA are significantly lower in women and vary 
from as low as seven min·day-1 to 57 min·day-1 113-116. However, interestingly, Kujala and 
colleagues (2017) using HR-based PA assessment reported that although the time spent at 
MVPA applying fixed absolute intensity cut-points was higher in men compared to women, 
and decreased with age, when intensity levels were calculated relative to individual´s CRF, these 
differences disappeared.  
The inactivity, along with the lower CRF observed in women 6 and the increased risk of 
CVD 117 and osteoporosis 16,118 after menopause and with advancing age requiere well-
designed and adequately powered PA programs.  
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Key points 
 Accelerometer-based PA quantification shows that a small proportion of adults (7-
15%) meet current PA recommendations, and women are less physically active. 
 
 All existing accelerometer activity cut-points used to classify PA in different intensity 
categories are derived from the widely used absolute intensity (METs) ranges (i.e., 3-
6 METs for moderate intensity activities). 
 
 Activity counts measured at moderate relative intensity recommendations (relative 
to V̇O2max) show high variability among participants. CRF is the strongest predictor of 
activity counts at these relative intensity thresholds. Thus, individualizing 
accelerometer activity counts relative to CRF might overcome with the under or 
overestimation of the time spent in different PA categories in people varying in CRF. 
Research Gaps 
 It is unknown whether accelerometer activity cut-points based on relative intensities 
differ from the widely used fixed absolute intensity cut-points on the time spent in 
different PA intensity categories. 
 
 Although absolute intensity MVPA is higher in men and decreases with advancing 
age, does still follow the same tendency when activity counts cut-points are 
individualized relative to CRF values? 
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2 
Objectives and 
Hypothesis 
 
ESTUDIO 1 
Exercise intensity guidelines for cancer survivors: a comparison with 
reference values 
Objetivos 
1. Evaluar los parámetros cardiorespiratorios (pico y umbrales submáximos) de 
pacientes diagnosticados de un cáncer para establecer una guía de prescripción de 
intensidad del ejercicio físico adaptada a esta población, que permita la 
comparación con las guías estándares actuales. 
Hipótesis 
1. Se espera que los pacientes con cáncer presenten una capacidad cardiorrespiratoria 
un ~30% menor que la población sana, y por lo tanto las guías de clasificación de 
intensidad para la población sana no se ajustarán a las características fisiológicas de 
estos pacientes. 
ESTUDIO 2 
Individualized accelerometer activity cut-points for the measurement of 
relative physical activity intensity levels 
Objetivos 
1. Comparar los conteos de actividad de acelerometría derivados de los 3 y 6 METs que 
delimitan la categoría de intensidad moderada en términos absolutos, 
recomendados de forma habitual, con los conteos de actividad medidos en base a 
la capacidad cardiorrespiratoria en términos relativos (46-63%V̇O2max) y en los 
umbrales de lactato individuales (LT1 y LT2). 
Hipótesis 
1. Se espera que los conteos de actividad medidos en el límite inferior de la categoría 
de intensidad moderada (3 METs) establecida por las guías de actividad física de 
referencia sean un ~45% menores que los medidos al límite inferior de intensidades 
relativas o LT1.  
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ESTUDIO 3 
Objectively measured absolute and relative physical activity intensity levels 
in postmenopausal women 
Objetivos 
1. Comparar los niveles de actividad física medidos con acelerómetros entre el método 
existente basado en umbrales de conteos de actividad fijos a intensidades absolutas 
(3-6 METs), y un método que individualiza los umbrales de conteos de actividad en 
base a los umbrales de lactato (LT1 y LT2). 
2. Verificar si mujeres postmenopáusicas con mayor capacidad cardiorrespiratoria 
presentan mayores niveles de actividad física tanto en términos absolutos (3-6 METs) 
como en relativos (LT1-LT2) que aquellas con una capacidad cardiorrespiratoria 
menor. 
Hipótesis 
1. Se prevé que las mujeres con mayor capacidad cardiorrespiratoria presenten un nivel 
de conteos de actividad en torno a un 25% mayor al LT1 y se incremente al LT2. 
2. Las mujeres con mayor capacidad cardiorrespiratoria presentarán mayores niveles 
de actividad física tanto en términos absolutos como en términos relativos.  
ESTUDIO 4 
Estimation of the maximal lactate steady state in postmenopausal women 
Objetivos 
1. Estimar la velocidad del máximo estado estable de lactato (LT2) desde variables no 
invasivas y/o umbrales de lactato a través de un solo test incremental submáximo, y 
verificar si hacer una prueba submáxima adicional a velocidad constante puede 
mejorar la estimación del máximo estado estable de lactato. 
Hipótesis 
1. Los umbrales de lactato extraídos de las curvas individuales (lactato-velocidad) de 
un solo test progresivo incremental serán las variables individuales que estimen el 
máximo estado estable de lactato con mayor precisión. El añadir una prueba 
adicional a velocidad constante mejorará la estimación. 
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3 
Methods 
 
 
 
 
3.1. Design of the doctoral dissertation 
La presente tesis doctoral engloba cuatro estudios observacionales llevados a cabo entre los 
años 2013 y 2017 en dos centros de medicina deportiva de dos localidades diferentes. El 
primero de ellos se llevó a cabo en el Gabinete de Medicina Deportiva del Ayuntamiento de 
Miranda de Ebro (Burgos) en 2013, bajo la tutela del Dr. Fernando Herrero Román. Los tres 
restantes se realizaron en Pamplona, en el Centro de Estudios, Investigación y Medicina del 
Deporte (CEIMD) del Gobierno de Navarra desde el 2015 hasta el 2017, bajo la tutela del Dr. 
Esteban Gorostiaga Ayestarán. Todo ello coordinado y supervisado por la Dra. Sara Maldonado 
Martín, profesora agregada de la Facultad de Educación y Deporte-Sección Ciencias de la 
Actividad Física y del Deporte (Vitoria-Gasteiz) de la Universidad del País Vasco/Euskal Herriko 
Unibertsitatea (UPV/EHU).  
 1st STUDY: Exercise intensity guidelines for cancer survivors: a comparison with 
reference values 
Este estudio recoge la información de las pruebas de esfuerzo iniciales de 152 
pacientes/supervivientes (78% mujeres y 34% hombres) con diversos tipos de cáncer (SC) (57% 
cáncer de mama), asintomáticos para realizar sus actividades habituales de la vida diaria ( 
escala ECOG 0) y con bajos niveles de actividad física (AF) (≤90 minutos de AF moderada a la 
semana) que acudieron por primera vez al Gabinete de Medicina del Deporte del 
Ayuntamiento de Miranda de Ebro (Burgos) tras recibir el consentimiento de su oncólogo del 
hospital Santiago Apóstol de Miranda de Ebro (32.7 ± 42.7 meses post-diagnóstico). El 
protocolo del estudio ha sido aprobado por el Comité Ético de Investigación Clínica de Burgos 
y Soria. 
Esta prueba de esfuerzo inicial se realizó con el objetivo de evaluar la capacidad 
cardiorespiratoria (CCR) inicial del paciente y su evolución, así como de diseñar un programa 
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de ejercicio físico (EF) individualizado a partir de los datos obtenidos en dicha prueba. La 
Figure 9 representa esquemáticamente el proceso metodológico del estudio. 
 
 2nd, 3rd, and 4th STUDIES:  
(2) Individualized accelerometer activity cut-points for the measurement of 
relative physical activity intensity levels 
(3) Objectively measured absolute and relative physical activity intensity 
levels in postmenopausal women 
(4) Estimation of the maximal lactate steady state in postmenopausal women 
 
Estos estudios responden a diferentes preguntas dentro del mismo proyecto de investigación 
que aborda la problemática de la prescripción-diseño de la intensidad del EF y la medición de 
la AF mediante acelerómetros desde un enfoque individualizado (Figure 10). 
 Las participantes del estudio fueron reclutadas a través de anuncios y gracias a la 
colaboración de enfermeras y médicos de atención primaria de tres centros de salud situados 
en los alrededores del CEIMD. Para poder participar en el estudio debían cumplir los siguientes 
criterios de inclusión; 1) edad entre 50 y 75 años, 2) encontrarse en periodo post-menopausia 
(al menos 12 meses sin periodo menstrual). Aquellas con limitaciones funcionales, 
cardiovasculares y/o músculo esqueléticas que pudieran ser agravadas durante la evaluación 
por medio de un test de ejercicio incremental, o no fueran capaces de caminar durante 20 
minutos seguidos (duración de la prueba a velocidad constante) fueron excluidas del estudio.  
Un total de 104 mujeres expresaron su interés en participar en el estudio, de las cuales 
12 no cumplían los criterios de elegibilidad y dos no aceptaron participar. De las 88 
participantes elegibles, 13 quedaron excluidas del análisis de datos debido a inhabilidad, dolor 
musculoesquelético o molestias al correr (n = 6), detección imprecisa del segundo umbral de 
lactato (LT2) (n = 3), registro de AF semanal con acelerómetro inválido (n = 1), enfermedad 
cardiovascular o pulmonar (n = 2), e incapacidad de seguir asistiendo a las mediciones (n = 1). 
Setenta y cinco participantes completaron con éxito todas las mediciones y fueron incluidas 
en el análisis de datos final. 
Una vez revisados los criterios de elegibilidad y la historia clínica de cada participante, 
se procedió a realizar una prueba incremental progresiva submáxima con medición de 
frecuencia cardiaca (FC), lactato y percepción del esfuerzo (RPE), caminando en una pista de 
20 metros (ida y vuelta girando alrededor de un cono) con un acelerómetro situado a la altura 
de la cadera derecha, para determinar la velocidad, FC y conteos de actividad al primer umbral 
de lactato (LT1). Una vez terminada la prueba, se suministró un acelerómetro triaxial a cada 
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participante junto a un diario de actividad, para registrar su AF habitual durante una semana. 
A la vuelta, una vez recogido el acelerómetro y revisado su diario de actividad, se realizaron 
dos test de fuerza máxima (press banca y press de piernas) con medición de la velocidad de 
ejecución en cada repetición. Tras 10 minutos de descanso, la participante realizó un test a 
velocidad constante durante dos bloques de 10 minutos, separados por dos minutos de 
descanso para tomar una muestra de sangre para la determinación de su concentración de 
lactato, con el objetivo de determinar la velocidad, FC y conteos de actividad al máximo estado 
estable de lactato (MLSS) o LT2. Esta misma prueba se repitió semanalmente aumentando o 
reduciendo la velocidad de la prueba hasta determinar el MLSS con una precisión de ≤0.30 
km·h-1. Al finalizar las mediciones y una vez analizados los datos, cada participante recibió un 
informe sobre su nivel de capacidad aeróbica, fuerza y sus niveles de AF, junto a 
recomendaciones y un programa de EF adaptado. 
Un sub-grupo de 30 participantes del estudio, realizaron dos pruebas adicionales en 
tapiz rodante (una submáxima replicando la prueba incremental realizada en pista y otra 
máxima aumentando progresivamente la pendiente) con medición de oxígeno, dióxido de 
carbono y flujo de inspiración, para; 1) determinar el consumo máximo de oxígeno (V̇O2max), 
y 2) para conocer el consumo de oxígeno (V̇O2) correspondiente al LT1 y LT2 y compararlo con 
los puntos de corte utilizados en estudios epidemiológicos que miden la AF con acelerómetros 
basados en intensidades absolutas de 3 y 6 METs que limitan la categoría de intensidad 
moderada definida por las autoridades científicas que crean las guías de AF reconocidas a nivel 
internacional. 
 
3.2. Overview and main characteristics of the 
studies 
La Table 3 resume las características metodológicas principales de los cuatro estudios incluidos 
en esta tesis doctoral, siguiendo las guías STROBE para estudios observacionales. No es objeto 
del presente apartado dar detalles concretos acerca de cada uno de los estudios, sino ofrecer 
una visión global sobre cada uno de los proyectos de investigación que permita compararlos 
entre ellos. En los siguientes capítulos se profundiza sobre los procedimientos metodológicos, 
protocolos de los test de ejercicio, las principales variables medidas en cada uno de los 
estudios, así como una detallada discusión acerca de los resultados obtenidos y su implicación. 
 
46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Diagrama de flujo del estudio 1: Exercise intensity guidelines for cancer survivors: a 
comparison with reference values. 
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Figure 10. Diagrama de flujo de los estudios 2, 3 y 4 llevados a cabo en el centro de Estudios, 
Investigación y Medicina del Deporte con mujeres postmenopáusicas. 
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Table 3. Características metodológicas de los estudios incluidos en la tesis doctoral. 
Estudio 
(1) Exercise intensity 
guidelines for cancer 
survivors: a comparison with 
reference values 
(2)  Individualized accelerometer 
activity cut-points for the 
measurement of relative physical 
activity intensity levels 
 
(3) Objectively measured absolute 
and relative physical activity 
intensity levels in postmenopausal 
women 
(4) Estimation of the maximal 
lactate steady state in 
postmenopausal women 
Diseño del estudio Observacional retrospectivo Observacional cross-sectional Observacional cross-sectional Observacional cross-sectional 
Comité ético Comité Ético de Investigación 
Clínica Burgos y Soria 
Comité Ético de Investigación Clínica de 
Navarra 
Comité Ético de Investigación Clínica de 
Navarra 
Comité Ético de Investigación Clínica de 
Navarra 
Entorno del estudio Miranda de Ebro Pamplona Pamplona Pamplona 
Captación Hospital Santiago Apostol  Centros de salud Centros de salud Centros de salud 
Ubicación  Gabinete Medicina Deportiva  CEIMD  CEIMD  CEIMD  
Fechas 2004 – 2013 03/17 – 06/17 11/15 – 06/17 11/15 – 06/17 
Participantes analizados 
y características 
N =152 
Edad = 55.1 ± 12.3 años 
IMC = 26.5 ± 4.1 kg·m-2 
METpico = 5.3 ± 1.3 
MET VT1 = 2.5 ± 0.6 
MET VT2 = 4.0 ± 1.1 
N = 30 
Edad = 57.2 ± 5.0 años 
IMC = 26.5 ± 4.1 kg·m-2 
METmax = 10.0 ± 2.0 
LT1 = 4.6 ± 0.7 METs o 5.5 ± 0.6 km·h-1 
LT2 = 7.3 ± 1.9 METs o 7.3 ± 1.1 km·h-1 
N = 75 
Edad = 59.0 ± 5.5 años 
IMC = 26.0 ± 3.9 kg·m-2 
LT1 = 5.1 ± 0.7 km·h-1 
LT2 = 7.1 ± 1.0 km·h-1 
N = 75 
Edad = 59.0 ± 5.5 años 
IMC = 26.0 ± 3.9 kg·m-2 
LT1 = 5.1 ± 0.7 km·h-1 
LT2 = 7.1 ± 1.0 km·h-1 
Criterios de 
Inclusión 
Diagnóstico de cáncer 
ECOG = 0 
AF<90min/sem 
Mujer postmenopáusica (>12 meses) 
<75 años 
Mujer postmenopáusica (>12 meses) 
<75 años 
Mujer postmenopáusica (>12 meses) 
<75 años 
Criterios de 
exclusión 
Enfermedad CV 
TA no controlada 
Dolor no controlado 
Contraindicaciones específicas al 
ejercicio (anemia severa, 
plaquetas, riesgo fracturas) 
Artrosis severa, o fracturas 
Limitación funcional para caminar 
20min 
Enfermedad crónica con alto riesgo CV 
Artrosis severa, o fracturas 
Limitación funcional para caminar 20min 
Enfermedad crónica con alto riesgo CV 
Artrosis severa, o fracturas 
Limitación funcional para caminar 20min 
Enfermedad crónica con alto riesgo CV 
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Protocolo del test de 
ejercicio 
Cardiopulmonar máximo (1) Cardiopulmonar submáximo a 
(2) Cardiopulmonar máximo b 
(1) Incremental submáximo a 
(2) Velocidad constante b 
(1) Incremental submáximo a 
(2) Velocidad constante b 
Modo Cicloergómetro Tapiz rodante Pista Pista 
Carga Inicial 
20W 2.4 km·h-1 a  
4.9 km·h-1  b 
2.4 km·h-1 a  
5.5 – 10.0 km·h-1  b 
2.4 km·h-1 a  
5.5 – 10.0 km·h-1  b 
Duración (nº 
estadíos) 
8-12 min 24 – 42 min a (8-14) 
9 – 20 min b  
21 – 42 min a (7-14) 
22 min  b (2) 
21 – 42 min (7-14) 
22 min  b (2) 
Duración del 
estadio 
1 min 2 min a 
1 min b 
2 min a 
10 min b  
2 min a 
10 min b 
Intervalos de 
descanso 
- 1 min a 
Sin Descanso b 
1 min a 
2 min b 
1 min a 
2 min b 
Incrementos de 
carga 
8-10W 0.6 km·h-1 a – 0.6 km·h-1 + 0.5% 2º 
estadío y + 1.3% restantes  b 
0.6 km·h-1 a 
Velocidad constante b 
0.6 km·h-1 a 
Velocidad constante b 
Criterios 
finalización 
No incremento de V̇O2  y/o FC 
con aumento de carga 
FC >85%FCmax  
RER ≥ 1.10 
RPE = 20 (20) 
≥3 mmol·l-1 a 
Agotamiento a, b 
Incapacidad de seguir con el ritmo 
marcado a, b 
No incremento de V̇O2  y/o FC con 
aumento de carga b 
RPE ≥ 8 (10) b 
FC >85%FCmax b 
RER ≥ 1.10 b 
BLCmax >8 mmol·L-1 b 
≥3 mmol·l-1 a 
Agotamiento a, b 
Incapacidad de seguir con el ritmo 
marcado a, b 
 
≥3 mmol·l-1 a 
Agotamiento a, b 
Incapacidad de seguir con el ritmo 
marcado a, b 
 
Mediciones 
V̇O2 - V̇CO2 y variables 
ventilatorias 
FC 
RPE 
TA 
V̇O2  - V̇CO2 y variables ventilatorias 
Conteos de actividad 
FC 
Lactato 
RPE 
Conteos de actividad 
FC 
Lactato 
RPE 
Actividad física seminal (acelerómetro 
triaxial) 
Conteos de actividad 
FC 
Lactato 
RPE 
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CEIMD, Centro de Estudios, Investigación y Medicina del Deporte; IMC, índice de masa corporal; MET, equivalente metabólico del gasto energético de las actividades, VT1; primer umbral ventilatorio 
durante una prueba incremental; VT2, segundo umbral ventilatorio durante una prueba incremental, conocido como umbral de compensación respiratoria o RCP; LT1, primer umbral de lactato durante 
una prueba incremental; LT2, segundo umbral de lactato o máximo estado estable de lactato durante una prueba a carga constante; ECOG, Eastern Cooperative Oncology Gorup; AF, actividad física; CV, 
cardiovascular; W, vatios; V̇O2, consumo de oxígeno; V̇O2max, consumo de oxígeno máximo; FC, frecuencia cardíaca; RER, coeficiente respiratorio; RPE, percepción del esfuerzo; V̇CO2, producción de 
dióxido de carbono; BLC, concentración de ácido láctico; TA, tensión arterial; BLRTs, umbrales relacionados con la concentración de ácido láctico en sangre; MVPA, actividad física moderada y vigorosa; 
MLSS, máximo estado estable de lactato. 
 
 
Principales medidas de 
resultado 
V̇O2pico 
Umbrales ventilatorios (VT y RCP) 
Conteos de actividad en los límites de 
la categoría de intensidad moderada 
(absolutos a 3-6 METs, relativos a 46-
63%VO2max y en los umbrales de lactato 
LT1-LT2) 
Tiempo (promedio diario) transcurrido en 
cada una de las categorías de intensidad 
en términos absolutos y relativos 
MVPA 
Pasos 
Tiempo sedentario 
Predicción de vMLSS (R2, SEE y 95%LoA) 
Variables independientes 
Edad 
V̇O2pico 
 
V̇O2max 
IMC 
Edad 
Capacidad aeróbica (LT2) 
Conteos de actividad  
Velocidad 
BLRTs 
Edad 
Variables antropométricas 
FC, RPE 
Cambio en el lactato del min10 al 20 en 
la prueba a velocidad constante 
Variables confusoras 
Tiempo post-diagnóstico 
Tipo de cáncer 
 IMC 
Edad 
 
Subgrupos 
METs 
Tiempo post-diagnóstico 
Edad 
Tipo de intensidad (absoluta, relativa, 
umbrales de lactato) 
Capacidad aeróbica (LT2) 
Tipo de intensidad (absoluta, umbrales de 
lactato) 
 
Análisis de datos 
principal 
Comparación de medias por 
subgrupo  
(ANOVA de un factor) 
Regresiones individuales polinómicas 
ANOVA de medidas repetidas 
Comparación por pares (variables intra 
grupo y entre grupos) 
Regresión lineal múltiple y validez 
individual de las ecuaciones predictivas 
de cada modelo 
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4 
Results 
1st Study  
 
Exercise intensity guidelines for 
cancer survivors: a comparison 
with reference values 
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Abstract 
 
The optimal dose of PA in CS is unknown due to the large variety of types of cancer, illness 
stages and treatments, low C, and physical inactivity. It is recommended that CS follow current 
PA guidelines for healthy population. There are no specific exercise prescription guidelines for 
CS. Purpose: To know the cardiorespiratory parameters of CS in order to create exercise 
prescription guidelines for this population, 152 inactive CS were recruited to perform a 
cardiopulmonary exercise test. Methods: Peak oxygen uptake (V̇O2peak), ventilatory threshold 
(VT) and respiratory compensation point (RCP), determined three exercise intensity zones to 
create exercise intensity classification guidelines for CS. Results:  V̇O2peak (18.7  4.6 mLkg-
1min-1) and peak heart rate (HRpeak) (145.117.9 bpm) were lower than the estimated values (p 
<0.001). Moderate intensity zone for CS was different from the current PA guidelines for 
healthy population: 41-64% V̇O2max, 55-70% HRmax, 23-48% HRres, 2.5-4 METs and 8-14 points 
in RPE scale. Conclusion: Intensities in PA guidelines for healthy population are not adapted 
to the characteristics of CS. For individual exercise prescription in CS specific PA guidelines 
should be used in order to maximize the benefits obtained by the use of aerobic exercise 
training.  
 
Key words: Exercise prescription; Survivorship; Physical activity; Quality of life. 
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Introduction  
 
There were around 12.7 million cancer cases all over the world in 2008. This number is expected 
to increase, reaching 21 million by 2030. One out of three people will develop cancer before 
the age of 75 years 119. Currently increasing incidence rates and decreasing mortality rates due 
to the advances in earlier detection and in therapeutic modalities have translated to a higher 
number of CS 120. 
Both the disease itself, the treatments and the lack of PA lead to an increase of pain 
and fatigue thresholds, a significant reduction of the muscle mass and strength, a higher level 
of adipose tissue, and decreased CRF. All of the factors mentioned negatively impact daily 
activities and reduce the QoL of CS 120-123. Related to this topic, PA offers important 
psychological and physiologic benefits in CS 122,124,125, and plays an important role on 
preventing or delaying other chronic diseases (e.g. cardiovascular diseases, hypertension, 
diabetes, osteoporosis, obesity, depression), thereby contributing positively to their survival 
120,126. 
However, there are no specific guidelines for exercise prescription for CS. Current PA 
guidelines for CS are generic. Whenever possible, CS should avoid inactivity and maintain an 
active and healthy lifestyle 35,45. PA guidelines for CS are based on guidelines for healthy 
population; i.e., for aerobic activity 150 minutes per week of moderate PA (30 min 5 days a 
week) or 75 min per week of vigorous PA (20 min 3 days a week) or any combination thereof. 
Furthermore, strength training guidelines recommend 2-3 weekly sessions that include 
exercises for major muscle groups 35,45,127. In this regard, it has been shown that CS meet 
international recommendations for moderate PA, but very few complete those for vigorous PA 
128. The optimal dose of PA in this population is unknown 129, possibly affecting each CS 
differently due to the large variety of types of cancer, illness stages and treatments, low CRF, 
physical inactivity and co-morbidities. Thus, it is crucial to create individualized exercise 
programs, starting from specific PA guidelines for CS. 
Compared to healthy individuals of the same sex and age, CS usually exhibit ~30% 
lower V̇O2peak 35. It has recently shown that many of the CS present poor CRF 130. In addition to 
V̇O2peak, gas exchange thresholds (i.e., ventilatory threshold, VT, and respiratory compensation 
point, RCP) are currently the gold standard references for the evaluation of aerobic metabolism 
function and, consequently, for aerobic exercise intensity assessment and prescription 24,131. VT 
could be considered as a valid indicator of functional capacity of CS and it is closely associated 
with the intensities of daily activities (e.g., walking, gardening, climbing stairs, household 
activities) 132. It has been previously observed that the V̇O2 at VT in CS  is very low 132, indicating 
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that any light stimulation could induce moderate intensities in this population 131. It was 
investigated whether submaximal indices of CRF such as VT and RCP were related to QoL in 
women survivors of breast cancer and they concluded that the improvement of these indices 
could have a beneficial effect on QoL 132. Therefore, exercising at those intensities to improve 
submaximal thresholds (i.e., VT and RCP) could be an effective strategy 132. In practice, these 
submaximal thresholds are used to define individualized intensity zones and prescribe exercise. 
Generally, 3 intensity zones are defined: intensity below VT, intensity between VT and RCP and 
intensity above RCP. This exercise-prescribing method has been used with athletes 133, healthy 
sedentary individuals 134 and with chronic heart failure patients or chronic obstructive 
pulmonary disease patients 131. Regarding the optimum PA level, CS should exercise at a higher 
level than the minimum recommended whenever possible to achieve more benefits 45,128. 
Nevertheless, exercise intensity is more complicated to prescribe, measure and control. 
Whereas with high intensity activities there is still high controversy, moderate intensity has 
proven to be safe and provide health benefits 128.  
But what is considered to be light, moderate and high intensity? Where are the limits 
of each? Light intensity is defined as 6–11 points on the RPE scale, <63%HRmax, and 20–
39%HRres. Moderate intensity is defined as 12–13 points on the RPE scale, 3–6 METs, 64–
76%HRmax and 40–59%HRres. High intensity is defined as 14–19 points on the RPE scale, 77–
93%HRmax and 60–84%HRres 19,35,123. There are slight differences in exercise intensity reference 
guidelines. Absolute intensities like METs, cannot be generalized due to the high variability in 
CRF among subjects. What is considered to be a light walk for some people could be 
considered to be moderate or vigorous for others. For this reason, relative intensity was 
introduced 135. However, the same relative intensity for 2 subjects could result in different 
metabolic responses (above or below anaerobic threshold) 136. It seems that an individualized 
prescription based on ventilatory thresholds (VT and RCP), could be less variable among 
individuals. Those thresholds show the metabolic adaptations and the evolution induced by 
exercise training 64,137. 
The main purpose of this study was to assess the cardiorespiratory parameters of CS 
(peak and submaximal thresholds) for the purpose of creating an adapted exercise intensity 
prescription guideline for this population that allows the comparison with current standard 
guidelines. The secondary purposes were: 1) to analyse the CRF of CS, classifying them by age 
ranges; to compare it to that of the healthy population; and 2) to evaluate the association 
between the HRmax and V̇O2max estimated by equations to prescribe exercise and the real peak 
values obtained in the cardiopulmonary exercise test (CPET). 
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Methods 
 
Participants 
One hundred and fifty-two CS were recruited from the oncology department of the “Santiago 
Apóstol” Hospital of Miranda de Ebro, Burgos, Spain. Inclusion criteria: 1) cancer survivor, 2) 
Eastern Cooperative Oncology Group (ECOG) scale = 0, 3) physical activity ≤ 90 min/week. 
Exclusion criteria: 1) heart disease (≥New York Heart Association II), 2) uncontrolled 
hypertension (blood pressure >160/90 mmHg), 3) uncontrolled pain or 4) any other 
contraindication for participation in a physical exercise program such as high risk of bone 
fractures, severe anemia (<8g/dL), or <50·109/μL of platelet count 138. Participants were 
informed about the study. Each participant obtained the consent of the oncologist and gave 
their written informed consent before participating in the study. The study received ethical 
approval from The Clinical Research Ethics Board of Burgos and Soria and meets the ethical 
standards in sport and exercise sciences research 139. After obtaining peak and submaximal 
cardiorespiratory variables in the CPET, participants were offered an individualized exercise 
program (3 sessions per week of 90 min each combining aerobic and resistance exercise). With 
the data obtained in the CPET, the exercise intensity classification guideline was created. 
 
Measurements 
Each participant performed a CPET in the same center of sport medicine (Gabinete Médico 
Deportivo, Miranda de Ebro, Burgos, Spain) at the same time (10 a.m. – 2 p.m.) and in similar 
environmental conditions (temperature, ~20ºC; relative humidity, 45-55%; barometric 
pressure, ~720 mmHg). The test was performed on an electric braking cycle-ergometer 
(Variobike 600, Marquette Hellige, Freiburg, Germany). Participants were not involved in any 
exercise during the previous 24h before the test. After an unloaded 5-min warm-up, the load 
was increased 8-10W per minute starting with an initial load of 20W. Participants were 
informed to maintain cadence between 60-70 rpm, cadence being displayed on a monitor 
placed in front of them. Gas exchange data were measured breath by breath using an open 
spirometer circuit (MasterScreen CPX, Jaeger, Viasys Healthcare, Hoechberg, Germany). The 
test was performed until volitional fatigue or when the cadence could not be maintained above 
60 rpm. Confirmation of a maximal effort was determined by meeting three out of four of the 
following criteria: 1) no increases in V̇O2 with increased workload, 2) HR values ≥85% estimated 
maximum HR (HRmaxT), 3) RER ≥1.10, and 4) RPE = 20 (Borg 6-20) 35. Regardless of achieving 
maximal criteria, the maximal values achieved during the CPET are referenced as “peak” 124,127. 
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V̇O2peak was defined as the highest 20-s value of V̇O2 elicited during the CPET. Peak V̇O2 is 
expressed in terms relative to body mass (mL·kg-1·min-1). 
Ratings of perceived exertion (RPE) and blood pressure were evaluated at the end of 
each stage (1 min). HR was monitored during the test using a 12-lead ECG. V̇O2, ventilation, 
ventilatory equivalents (for oxygen and carbon dioxide) and respiratory quotient for peak and 
submaximal values (VT and RCP) were also measured. To detect the VT the first exponential 
increase in the O2 ventilatory equivalent (VE/ V̇O2) without a concomitant increase in the CO2 
ventilatory equivalent was considered. The RCP was determined using the ventilatory 
equivalent method (the first exponential increase in CO2 ventilator equivalent alongside an 
increase in the ventilatory equivalent for O2) 123. Two experienced researchers detected those 
points individually and in case of disagreement, a third researcher´s opinon was obtained. CS 
were classified by age to compare their CRF against the age and sex-matched ACSM 50th 
percentile 35. 
To estimate HRmax  the equation (206.9 – (0.67 * age)) was used given its higher accuracy 
compared to other equations 140. To estimate the maximum V̇O2 (V̇O2maxT), we used the ACSM´s 
metabolic equation for bike ergometer (1.8 * (W * 6.1183) / (body mass + 7)) 35. Absolute and 
relative values below VT determined the light intensity zone (zone 1). Values between VT and 
RCP were considered as moderate intensity (zone 2) and values above the RCP determined the 
high intensity zone (zone 3) 131,133. 
Cancer survivors were categorized into 3 groups according to their CRF. The first group 
corresponded to the most deconditioned individuals and was considered <4.5 METs (<15.75 
mL·kg-1·min-1 of V̇O2peak). In the second group CS were between 4.5 and 6 METs (15.75-21 mL·kg-
1·min-1 of V̇O2peak. The third group corresponded to CS with >6 METs (>21 mL·kg-1·min-1 of 
V̇O2peak. 
 
Statistical analysis 
Descriptive statistics were calculated for continuous variables (mean, standard deviations or 
SD) and for non-continuous variables (frequencies). To determine the statistical analysis type, 
normality criteria was verified for each variable (Kolmogorov-Smirnov test) and for the groups 
which they would be compared with different variables (Kolmogorov-Smirnov or Shapiro-
Wilk). To verify the variance homogeneity, Levene´s test of homogeneity of variances was 
performed. To examine the validity of the equations estimating HRmaxT and V̇O2maxT a linear 
regression was used, while to examine the differences between the real and estimated values, 
a paired samples t-test was performed. Pearson´s correlation coefficient was used to examine 
the association between the estimated and real values, as well as to determine whether there 
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was any relationship between post-diagnosis time and cardiorespiratory variables. Correlations 
were categorized as follows: 0.26 to 0.49 is a low correlation, 0.50 to 0.69 is a moderate 
correlation, 0.70-0.89 is high correlation, and 0.90 to 1.00 is very high correlation. One-way 
ANOVA for parametric samples and Kruskal Wallis H test for non-parametric samples, were 
used to compare the cardiorespiratory values in submaximal point among CRF groups (<4.5 
METs, 4.5-6 METs and >6 METs), post-diagnosis time (<6 months, 7-12 months, 13-24 months, 
25-60 months and >60 months) and V̇O2peak among age ranges (30-39, 40-49, 50-59, 60-69, 
>70). Bonferroni post-hoc test was applied to define the groups with statistical differences. 
Data are presented as mean ± SD. Statistical significance was set at p <0.05. Statistical analyses 
were performed using SPSS statistical software (version 20.0, IBM SPSS Statistics, Chicago, IL). 
 
Results 
 
The flow diagram in Figure 11 shows how the CS participants were recruited and the final 
numbers of individuals. Participant characteristics are displayed in Table 4. Physiologic values 
of CS obtained in the CPET and estimated by equations, are listed in Table 5. CS showed a 
mean V̇O2 significantly (p <0.001) lower than the estimated V̇O2. The relationship between 
estimated V̇O2max and the obtained V̇O2peak was significant and high (r = 0.82, p <0.001) (Figure 
2). 
 
 
Figure 11. Recruitment of CS participants. 
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The HRpeak obtained in the CPET was 25bpm less than the estimated HR (p <0.001). The 
relationship between the estimated HRmax and the obtained HRpeak was statistically significant 
(r = 0.56, p <0.001) (Figure 12). The VT was located at 48.0 ± 11.6% of the V̇O2peak, whereas the 
RCP corresponded to 75.3 ± 9.7% of the V̇O2peak. The moderate intensity range (VT-RCP) in 
METs was between 2.5 ± 0.6 and 4.0 ± 1.1. The perceived effort (Borg 6-20 scale) for moderate 
intensity was between 8.0 ± 1.3 and 14.4 ± 1.5 points. The mean HR in the VT was 93.9 ± 14.0 
bpm, while the mean HR for the RCP was 118.5 ± 16.5 bpm. These values corresponded to 65.1 
± 8.8% and 81.9 ± 7.6% of the HRpeak, respectively. The HRres was 74.2 ± 18 bpm and the 
ventilatory thresholds were located at 31.3 ± 12.9% (VT) and 64.3 ± 13.7% (RCP) of the HRres.  
 
Table 4. Participant´s characteristics.  
Age (years) 55.1 ± 12.3 
Sex  
Male 34 (22.4) 
Female 118 (77.6) 
BMI (kg·m-2) 26.5 ± 4.1 
Cancer type  
Colon 16 (10.5) 
Uteri cervix 3 (2.0) 
Endometrium 4 (2.6) 
Gastric  5 (3.3) 
Breast 87 (57.2) 
Melanoma 2 (1.3) 
Ovarian 5 (3.3) 
Pancreatic 4 (2.6) 
Prostate 7 (4.6) 
Lung 3 (2.0) 
Thyroid 2 (1.3) 
Bladder 4 (2.6) 
Others 10 (6.6) 
Total 152 (100) 
Treatment type  
S 22 (14.5) 
S+Q 59 (38.8) 
S+R 12 (7.9) 
S+Q+R 42 (27.6) 
Other 17 (11.2) 
Post-Diagnosis time (months) 32.7 ± 42.7 
Data are presented as mean ± DS for continuous variables and as 
frequency (%) for categorical variables. 
DS, standard deviation; BMI, body mass index; S, surgery; Chemotherapy; 
R, radiotherapy. 
 
Comparisons to published age and sex-matched CRF 35 are presented in Figure 13. 
Participants of this study presented a significantly lower CRF than healthy population in all age 
ranges. CS ages 30-39 years showed a mean V̇O2peak of 17.1 ± 5.5 mL·kg-1·min-1, representing a 
difference of greater than 50% (i.e., lower values) compared to the V̇O2peak of the healthy 
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population (36.8 mL·kg-1·min-1). CS ages 40-49 years showed the highest CRF (20.0 ± 4.5 mL·kg-
1·min-1), but the difference with the ACSM healthy population continued to be high (-43%). 
Among the individuals ages 50-59 years, the V̇O2peak showed greater similarity than that of the 
group ages 0-49 years (19.5 ± 5.0 mL·kg-1·min-1). CS of this study showed a decreasing trend 
in the CRF without large differences among age groups. 
Table 6 shows the intensity ranges defined after obtaining submaximal (VT and RCP) 
and peak parameters in the CPET. The peak values obtained during the CPET placed the 
moderate intensity zone (VT-RCP) at 48-75% of V̇O2peak, 65-82% of the HRpeak, 31-64% of HRres, 
2.5-4 METs and 8-14 points in the RPE scale. There were differences when CS were classified 
into CRF groups. Less than 6 METs group showed the VT in a lower % of V̇O2peak than the others 
(p <0.001). Less than 4.5 METs group showed the %HRpeak at VT higher than the others, 
exhibiting a reduced moderate intensity zone compared with the other two groups. There were 
statistically significant differences among all groups in moderate intensity zone thresholds for 
absolute values in METs. While for the moderate intensity zone was 2-3 METs for the most 
deconditioned group, the same intensity zone corresponded to 2.9-5.3 METs for the fittest 
group. There were no differences when using HR reserve as the exercise prescription method. 
Table 7 shows an exercise intensity classification guide for CS based on the absolute 
and relative submaximal values obtained in the CPET, for the purpose of creating intensity 
ranges relative to the estimated maximal values. The intensity zone values obtained relative to 
the estimated HRmax and V̇O2max were lower than those obtained through the peak values. In 
this case, moderate intensity zone corresponded to 41-64% of V̇O2max, 55-70% of HRmax or 23-
48% of the HRres. 
No association was found between post-diagnosis time (from diagnosis to CPET) and 
cardiorespiratory variables (V̇O2peak, V̇O2 at VT and RCP, HRpeak, HR at VT and RCP, HRres, HRrest), 
without following a physical exercise program. No significant differences were either found in 
any variable when the patients were separated by post-diagnosis time (<6 months, 7-12 
months, 13-24 months, 25-60 months and >60 months). 
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Table 5. Absolute and relative physiologic values of the participants determined in CPET and Estimated. 
CPET Estimated 
V̇O2peak (mL·kg-1·min-1) 18.7 ± 4.6 V̇O2maxT (mL·kg-1·min-1) 22.0 ± 4.9 
V̇O2 VT (mL·kg-1·min-1)   8.7 ± 2.2   
V̇O2 RCP (mL·kg-1·min-1) 14.0 ± 3.7   
%V̇O2peak VT   48.0 ± 11.6 %V̇O2maxT VT   40.7 ± 10.7 
%V̇O2peak RCP 75.3 ± 9.7 %V̇O2maxT RCP   64.0 ± 11.4 
METpeak   5.3 ± 1.3 METmaxT   6.3 ± 1.4 
MET VT   2.5 ± 0.6   
MET RCP   4.0 ± 1.1   
RPE VT   8.0 ± 1.3   
RPE RCP 14.4 ± 1.5   
Wpeak   94.0 ± 33.7   
RERpeak   1.19 ± 0.11   
HRpeak (bpm) 145.1 ± 17.9 HRmaxT (bpm) 170.0 ± 8.2 
HR VT (bpm)   93.9 ± 14.0   
HR RCP (lpm) 118.5 ± 16.5   
% HRpeak VT 65.1 ± 8.8 % HRmaxT VT 55.2 ± 7.7 
% HRpeak RCP 81.9 ± 7.6 % HRmaxT RCP 69.7 ± 8.6 
HRrest (bpm)   70.8 ± 11.0   
HRres (bpm)   74.2 ± 18.0 HRresT (bpm)   99.1 ± 12.5 
% HRres VT   31.3 ± 12.9 % HRresT VT   23.2 ± 10.3 
% HRres RCP   64.3 ± 13.7 % HRresT RCP   48.0 ± 13.8 
Data are presented as mean ± DS. DS, standard deviation; HR, heart rate; MET, metabolic equivalent (1 MET = 3,5 
mlO2·kg-1·min-1 or 1 kcal·kg-1·h-1); RCP, respiratory compensation point; RER, respiratory exchange ratio; RPE, rating 
of perceived effort (Borg, 6-20); V̇O2, oxygen uptake; VT, ventilatory threshold; W,watt; HRmaxT, estimated maximum 
heart rate by ACSM (2013) equation (206.9 – (0.67 * age); HRres, (HRmaxT– HRrest); RCP, respiratory compensation point; 
V̇O2maxT, estimated maximum oxygen uptake by ACSM (2013) equation (V̇O2= 1.8 (W·6.1183) / body mass + 7). 
 
 
Discussion 
 
The main purpose of this study, was to assess the cardiorespiratory parameters of CS (peak 
and submaximal thresholds), for the purpose of creating an adapted exercise intensity 
prescription guideline for this population, which facilitates comparison with current standard 
guidelines. The mean V̇O2peak of the 152 CS of this study was 18.7 ± 4.6 mL·kg-1·min-1. This value 
is within the normal range of CRF of CS 127, and is lower than that of the healthy population 35. 
It is also worth mentioning that in the present study CS did not meet the threshold of 8 METs 
that indicates an increased risk for mortality and cardiac events 1. This deconditioning could 
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be attributed to several factors, such as the low PA level (<90 min/week) adopted following 
cancer diagnosis, the disease itself, treatment and side effects such as chronic fatigue, pain or 
cardiopulmonary dysfunction and the high BMI level (65.1% of participants presented 
overweight or obesity) 120,132  
In fact, a recent study in another Spanish cohort also showed that the prevalence in 
obesity in CS leads to a low cardiometabolic profile 130. Relative intensity (%V̇O2peak) at VT and 
RCP (48.0 ± 11.6% and 75.3 ± 9.7%, respectively) was similar to that of the sedentary adults. It 
seems that for CS any increase of PA could lead to a disproportionately rapid rise of VCO2 and 
minute ventilation as related to V̇O2 131. The %V̇O2peak at RCP was similar to that found by others 
141 in CS (75%V̇O2peak).  
The difference between the estimated and peak HR was 25 bpm. Other studies have 
reported a wide range of HRpeak in CS, varying from 124 to 169 bpm 132,142-144. For this reason, 
it is recommended that heart rate be measured in an incremental exercise test whenever 
possible 35. The ventilatory thresholds corresponded to 65.1 ± 8.8% (VT) and 81.9 ± 7.6% (RCP) 
of HRpeak or 31.3 ± 12.9% (VT) and 64.3 ± 13.7% (RCP) of HRreserve. In a recent study with breast 
CS, higher values of HRpeak (169 ± 12 bpm) were obtained, and the RCP was placed at a higher 
percentage of HRpeak (87.6%) 145. Another study placed the VT at 73 ± 10% of HRpeak and the 
RCP at 88 ± 5% of HRpeak in breast cancer survivors with a V̇O2peak of 24.6 ± 5.8 mL·kg-1·min-1 
132.  
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Figure 12. Association between HRpeak-HRmaxT and V̇O2peak- V̇O2maxT 
V̇O2maxT 
ACSM suggests determining the HRpeak of the individual in an incremental exercise test 
in order to prescribe an exercise program. When it is not feasible, the estimation is accepted. 
In our study, the equation of Gellish 140 (206.9 – (0.67 * age) was used as it is the formula that 
is best adapted to this population 35,146. The correlation obtained between the estimated HR 
and the HRpeak was only moderate (r = 0.56, p <0.001). Whereas the estimated maximum HR 
was 170 ± 8.2 bpm, the peak HR obtained in the CPET was 25 bpm lower (145 ± 17.9 bpm). 
The type of test (cycle-ergometer), the physical deconditioning (caused by the illness itself, 
treatments and inactivity) and the lack of familiarization with these type of tests, could 
contribute to the low HRpeak. However, all CS satisfied 3 of 4 criteria of maximal effort. It may 
be necessary to create a new equation for this population in the future. These differences 
between the estimated and the real values could cause large differences in determining the 
intensity in CS if the equations to estimate the peak values were used. What the international 
PA guidelines classify as moderate intensity (40-59%HRres or 64-76%HRmax) could cause varied 
responses when the prescription is based on the peak HR (145 bpm in CS of the study) or the 
estimated maximum HR (170 bpm in CS of the study). Basing exercise intensity on the 
estimated maximum values, i.e., 64-76%HRmax of 170 bpm (109-129 bpm), would actually result 
in a vigorous intensity (75-89%HRpeak) for a CS with 145 bpm of HRpeak. The correlation between 
the V̇O2peak and the estimated V̇O2max was higher than that obtained for the HR (r = 0.82, p 
<0.001, Figure 12). 
CS showed considerably lower CRF than that of the healthy population 35 in every age 
group, with V̇O2peak decreasing with age (Figure 13). The greatest differences were found in 
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the youngest groups (~53.5% of V̇O2peak lower in CS of 30-39 years and ~43% of V̇O2peak lower 
in CS of 40-49 years). Starting with these age groups, the difference appears to decrease 
(~38.5% of V̇O2peak lower in CS of 50-59 years and ~37% of V̇O2peak lower in CS >60 years). The 
scientific literature has reported differences between ~38-50% of V̇O2peak in favour of the 
healthy population 124,147. In contrast to the healthy population, which exhibits clearly 
decreasing V̇O2peak with age, CS does not present such differences among age groups, and the 
CRF is very low and similar in all age groups (Figure 13). A systematic review about 
cardiorespiratory exercise in the rehabilitation of CS, shows that most patients present a V̇O2peak 
of 16-25 mL·kg-1·min-1 127. CS of our study had low V̇O2peak values in all age groups (lower than 
a mean of 20.0 ± 4.5 mL·kg-1·min-1). These results thus emphasize the need for monitoring CRF 
and creating adapted exercise programs to improve those V̇O2peak values as early as possible. 
 
 
 
Figure 13. Comparison of V̇O2peak between ACSM (2013) age-matched 50th percentile of 
healthy population and cancer survivors of the study.  
VO2, oxygen uptake; ACSM, American College of Sport Medicine. 
** p <0.01 vs ≥ 70 
*  p <0.05 vs ≥ 70 
 
Despite V̇O2peak decreasing with age, the absolute V̇O2 values of VT and RCP were not 
affected. Thus, the relative values (%V̇O2peak) of VT and RCP relative to V̇O2peak increased. Older 
people have tend to have ventilatory thresholds relatively closer to the nearest to V̇O2peak than 
younger people 131. Previous studies conducted among CS pointed to the importance of 
improving the V̇O2peak and even more the VT and RCP, because the increases are positively 
associated with QoL and they imply intensities near those of daily activities 144.  
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As a result of V̇O2peak decreasing with age and the lower CRF of individuals with chronic 
diseases, the general PA guidelines for healthy individuals may not be the most appropriate 
for CS. Furthermore, this population has cardiorespiratory limitations and low cardiorespiratory 
values when exercise intensity is based on absolute intensity, i.e., the MET method 35,131. The 
relative intensity approach tries to eliminate the differences in the absolute values in people 
of different CRF levels 135. Nevertheless, relative intensity approach has been criticized by some 
authors because, at the same relative intensity, the metabolic response of two people could 
be different (i.e., moderate intensity for one but high intensity for the other). It is expected that 
a prescription based on the individual ventilatory thresholds (VT and RCP) produces less 
variability in the metabolic response of patients and offers more homogenous training 
stimulus than the use of other relative prescription methods such as %V̇O2peak, %HRpeak or 
%HRreserve. Additionally, ventilatory thresholds better reflect progress or training adaptations 
123,137. 
 
Table 6. Exercise intensity classification of the participants. Data are presented as relative to the peak values obtained in the CPET. 
V̇O2peak, peak oxygen uptake; HRpeak, peak heart rate; HRres, reserve heart rate (HRmax– HRrest); MET, metabolic equivalent; RPE, rating of 
perceived effort (Borg, 6-20). 
*p <0.001 vs <4.5 METs & 4.5-6 METs 
†p <0.001 vs 4.5-6 METs & >6 METs  
‡p <0.001 vs 4.5-6 METs & >6 METs 
‡p <0.01 vs 6 METs 
†p <0.001 vs 4.5-6 METs & >6 METs 
ǁp <0.001 vs >6 METs 
 
There is a wide range of exercise intensity classifications which define intensity 
categories according to relative intensities (%V̇O2peak, %HRpeak or %HRreserve) or absolute 
intensities (MET´s, RPE) 35. The determination of these intensity categories is based on 
      Intensity relative to maximal exercise capacity in 
METs 
 
Intensity %V̇O2peak %HRpeak %HRres METs RPE  <4.5 METs  
n = 39 
4.5-6 METs  
n = 79 
>6 METs  
n = 34 
Light <48 <65 <31 <2.5 <8 
%V̇O2peak 
%HRpeak 
%HRres 
METs 
<51 
<70 
<34 
<2 
<50 
<64 
<31 
<2.5 
<41 
<62 
<29 
<2.9 
Moderate 48-75 65-82 31-64 2.5-4 8-14 
%V̇O2peak 
%HRpeak 
%HRres 
METs 
51-76 
†70-84 
34-64 
‡2-3† 
50-76 
64-81 
31-63 
‡2.5-3.9ǁ 
*41-72 
62-82 
29-67 
2.9-5.3 
Vigorous >75 >82 >64 >4 >14 
%V̇O2peak 
%HRpeak 
%HRres 
METs 
>76 
>84 
>64 
>3 
>76 
>81 
>63 
>3.9 
>72 
>82 
>67 
>5.3 
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regressions of V̇O2max or % V̇O2max for conversion into %HRmax or %HRres and modifications of 
previous exercise intensity classifications 35,135, since V̇O2res and HRres have been closely 
associated 148 . In the ACSM´s position stand moderate intensity corresponds to 46-63% of 
V̇O2max (52-67% for individuals with a CRF lower than 5 METs), 64-76% of HRmax or 40-59% of 
HRres. The results of our study for moderate intensity (VT-RCP) corresponded to 41-64% of 
V̇O2max, 55-70% of HRmax or 23-48% of HRres (Table 7). The consequence of that it could be to 
overstress the patients when exercise design is performed using the intensity classification of 
international guidelines recommended for healthy population and for CS 19; e.g., from 70% of 
HRmax or 48% of HRres CS would be training at high intensity and not in moderate intensity as 
the international guidelines establish. The position statement of the Exercise and Sport Science 
Australia 46 also places moderate intensity at 50-75% of V̇O2max/HRres and 60-80% of HRmax. 
Once again, these intensities are overestimating what CS can perform at moderate intensity. 
Previous study classified moderate intensity at 40-60% of V̇O2max/HRres or 55-70 of HRmax 149. In 
that case, the relative intensity of V̇O2max and HRmax is similar to the ones found in the present 
study, but prescribing with HRres individuals could be overstressed. 
The perceived effort of moderate intensity was between 8 and 14 points in RPE 20 
points scale, signalling that CS overtake VT early after starting the exercise and in low 
subjective appreciation of the effort. If exercise is designed based on this method, activities 
which are considered as light in international guidelines, such as 9-11 points in RPE, actually 
are moderate intensities for CS. On the other hand, when exercise intensity is based on 
absolute MET values following the typical classification of moderate intensity (3-6 METs) 
established by current guidelines 19,35,46, actually CS would be exercising at maximal intensities 
and some of them would not be able to perform at 6 METs, since the mean peak CRF of CS of 
this study in METs is 5.3 ± 1.3. In this study, moderate intensity corresponded to 2.5-4 METs. 
The classification of 3.1-4 METs for individuals with a CRF lower than 6 METs as suggested by 
ACSM 35, appears to be better adapted to the characteristics of CS. Daily activities such as 
moving light loads and boxes from one place to another, or climbing stairs, which are 
considered to induce 4-6 METs, actually represents high-intensity physical activity for CS. The 
present study categorized CS into different groups based on their CRF to further specify 
exercise prescription (Table 6). Relative exercise intensity should be modified according to the 
CRF of CS. For the most fit CS group (>6 METs) the moderate-intensity zone relative to %V̇O2peak 
was more intense (41-72%V̇O2peak) due to the lower relative value of VT, showing significant 
differences with the other two groups (p <0.001). The most deconditioned group (<4.5 METs) 
showed the moderate-intensity zone relative to %HRpeak (70-84%HRpeak) to be significantly 
higher than the other two groups due to the higher level of VT at relative intensities (p <0.001). 
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Due to low cardiorespiratory values of patients of certain diseases, the %V̇O2 corresponding 
to the ventilatory thresholds is quite high and it could increase with the severity of the disease 
131. This paradoxical phenomenon could be due to the attenuated increase of V̇O2 over the VT 
and/or the low exercise tolerance. In this population, any increase over the resting values (~3.5 
mL∙kg-1∙min-1 of V̇O2) represents a high proportion of V̇O2peak. In this study, the more 
deconditioned the CS was, the higher relative his or her values at VT without any difference in 
RCP.  
 
Table 7. Exercise intensity classification guidelines for cancer survivors. Data are presented as relative to estimated HRmax and 
V̇O2max. 
HRmax, estimated maximum heart rate by ACSM (2013) equation (206.9 – (0.67 * age); HRres, reserve heart rate (HRmax– HRrest); V̇O2max, 
estimated maximum oxygen uptake by ACSM (2013) equation ((V̇O2= 1.8 (W·6.1183) / body mass + 7)); MET, metabolic equivalent; RPE, rating 
of perceived effort (Borg, 6-20). 
 
While the perceived effort does not vary with respect to the CRF, the absolute V̇O2 
values in METs showed statistically significant differences among groups, suggesting that the 
prescription should be modified according to the V̇O2peak of the CS. Moderate PA for <4.5 METs 
group was 2-3 METs, showing significant differences with the other two groups. For the 4.5-6 
METs group the same intensity was 2.5-3.9 METs, whereas for the >6 METs group moderate 
intensity was defined as 2.5-5.3 METs, closer to those of the healthy population 19,35. 
 Finally, the outcomes of this study suggest that without following an exercise program, 
the post-diagnosis time does not have any effect on cardiorespiratory variables and the V̇O2peak 
does not change. Furthermore, when CS were divided into post-diagnosis time groups (<6 
months, 6-12 months, 13-24 months, 25-60 months and >60 months) there were no significant 
differences. 
      Intensity relative to maximal exercise capacity in 
METs 
 
Intensity %V̇O2max %HRmax %HRres METs RPE  <4.5 METs  
n = 39 
4.5-6 METs  
n = 79 
>6 METs  
n = 34 
Light <41 <55 <23 <2.5 <8 
%V̇O2peak 
%HRpeak 
%HRres 
METs 
<40 
<56 
<22 
<2 
<42 
<55 
<23 
<2.5 
<38 
<55 
<24 
<2.9 
Moderate 41-64 55-70 23-48 2.5-4 8-14 
%V̇O2peak 
%HRpeak 
%HRres 
METs 
40-60 
56-68 
22-43 
2-3 
42-65 
55-70 
23-47 
2.5-3.9 
38-67 
55-73 
24-56 
2.9-5.3 
Vigorous >64 >70 >48 >4 >14 
%V̇O2peak 
%HRpeak 
%HRres 
METs 
>60 
>68 
>43 
>3 
>65 
>70 
>47 
>3.9 
>67 
>73 
>56 
>5.3 
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Given the strong association between V̇O2peak and mortality in populations with low CRF 
124, CS must start exercise programs as early as possible. Following exercise programs, the 
improvement of V̇O2peak has been reported to be 2.90 mL·kg-1·min-1 and there have been 
decreases of 1.02 mL·kg-1·min-1 of V̇O2peak in CS who did not participate in exercise programs 
124. An oncologist should advise his or her patient as early as possible to increase their PA levels 
doing light activities such as walking, cycling or swimming. This would improve the adherence 
148. 
Compared to CS of low CRF (<13 mL·kg-1·min-1), those of a moderate CRF (13.1-16.9 
mL·kg-1·min-1) and high CRF (≥17 mL·kg-1·min-1) exhibit a 21% and 24% decrease in mortality 
of any cause. In contrast, a decrease of 1 mL·kg-1·min-1 (the decrease of inactive CS) has been 
associated with a 4% increase in mortality of any cause 146. 
The limitations of the study should be mentioned. There is a risk of population 
stratification due to the diagnosis data (i.e., differences of cancer categories and comorbid 
conditions). On the other hand, the sample is very homogeneous with regard to types of CS, 
most being breast CS, and very little data being present for the remaining cancer types. Despite 
this, the investigation poses the question, “Are we heading in the right direction?”. 
In summary, the intensities defined by current international PA guidelines 
recommended for healthy population and additionally suggested for CS are not adjusted to 
the physiological characteristics of CS, and those individuals could be overstressed following 
the prescription of the exercise intensity of those guidelines. Furthermore, absolute and 
relative intensities should be modified taking into consideration the CRF of the CS. When the 
individualization of exercise intensity in CS is not possible, an exercise intensity design 
guideline specific for CS must be employed to provide adapted stimulation and achieve the 
required outcomes. For this reason, a more adapted set of exercise intensity prescription 
guidelines is presented.  
Exercise programs should be considered as an important part of cancer recovery 
therapies as early as possible after diagnosis, because CS do not improve their CRF 
independently of the post-diagnosis time unless they follow an exercise program.   
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Abstract 
 
Purpose: The aim of this study was to compare the widely used accelerometer activity cut-
points derived from the absolute moderate intensity recommendation (3‒6 METs), with relative 
intensity cut-points according to maximum CRF (46‒63%V̇O2max) and to individual lactate 
thresholds (LT1 and LT2) in postmenopausal women. Method: Thirty postmenopausal women 
performed several exercise tests with measures of heart rate, blood lactate, accelerometer 
activity counts and oxygen consumption. Individual regressions were developed to derive the 
accelerometer activity counts at absolute and relative moderate intensity recommendations 
and at individual LTs. Results: The activity counts calculated at the lower moderate intensity 
boundary were lower for the absolute 3 METs threshold (2026 ± 808 ct·min-1) compared to 
relative 46%V̇O2max intensity threshold (p <0.01, ES: 1.95) and LT1 (p <0.01, ES: 2.27), which 
corresponded to 4.6 ± 0.7 METs. The activity counts at the upper moderate intensity boundary 
were higher for LT2 (7249 ± 2499 ct·min-1) compared to the absolute 6-METs threshold (p 
<0.01, ES: 0.72) and relative 63%V̇O2max  intensity threshold (p < 0.01, ES: 0.55). The 
interindividual variability in activity counts at relative intensity thresholds was high (CV = 30-
34%), and was largely explained by CRF level (R2 = ~50%). Conclusion: Individually-tailored 
(relative to V̇O2max or submaximal LTs), rather than fixed accelerometer intensity cut-points 
derived from the classic absolute moderate PA intensity (3-6 METs) would result in a more 
accurate measurement of an individual´s activity levels and reduce the risk of overestimating 
or underestimating PA. 
 
Keywords: Activity counts; cardiorespiratory fitness; lactate thresholds; exercise intensity 
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Introduction 
 
Compelling scientific evidence indicates that both, PA and CRF provide important health 
benefits 12,150. Physical activity intensity and CRF are often expressed in METs. Each 1-MET 
increment in CRF is associated with 13 and 15% decrements in all-cause mortality and 
cardiovascular disease, respectively 1. Epidemiologic studies suggest that a minimal CRF of 8 
METs may be important for significant prevention of all-cause and cardiovascular disease 
mortality 1. It is well documented that increases in the amounts and intensities of PA typically 
produce increases in CRF, particularly in those who are less physically active or present poor 
CRF 12. Epidemiological studies using self-reported questionnaires suggest that meeting 
current PA recommendations of a minimum of 150 min·wk-1 of MVPA reduces all-cause 
mortality risk by 26-31% 11,12.  
Since the early works of Montoye and colleagues validating uniaxial accelerometers 
against movement counters to measure daily EE 95, its use spread rapidly in behavioural and 
epidemiologic studies replacing PA questionnaires to objectively measure PA behaviour and 
adherence to recommended PA targets 96. Contrary to self-reported estimates, results of 
accelerometer-based objective assessments of PA report much lower volumes of MVPA 11,113, 
indicating that only a small proportion of adults (7-15%) meet current PA recommendations 
113,114,116. Reported objective weekly volumes of MVPA are significantly lower in women and 
vary from as low as seven min·day-1 to 57 min·day-1 113,114,116. The inactivity, along with the lower 
CRF observed in women 6 and the increased risk of cardiovascular disease 117 and osteoporosis 
118 after menopause and with advancing age underline the necessity of a well-designed and 
adequately powered PA program (i.e., intensity). 
Both, the traditional count-based Actigraph approach 98,102,103and other newer methods 
processing accelerometer data in “R” software 104 use raw accelerations (either vertical axis 
only, or a combination of three axes, also known as Vector Magnitude or VM3) accelerations to 
quantify the time spent in different PA intensity levels applying accelerometer cut-points 
derived from the traditional absolute intensity recommendations for moderate intensity (3-6 
METs) activities 19. These studies have generated widely divergent regression models for 
converting counts to EE, yielding different cut-points for PA intensity categories 105. As such, 
with increasing age or decreasing CRF, an activity at a given absolute intensity (MET) requires 
a greater percentage of the V̇O2max (i.e., relative intensity) 19,111. Therefore, using the absolute 
intensity approach may not be the most accurate option for assessing PA outcomes in samples 
varying in age or CRF 109,110. Alternatively, when activity counts cut-points representing 
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moderate intensity activities have been calculated relative to V̇O2max (i.e., 46-63%) 19, the results 
show substantial differences between less fit and most fit groups, even if no differences are 
evident when activity counts are determined according to the absolute intensity criteria 109,110. 
The validity of this “relative intensity” approach has also been substantially criticized 
because exercising at the same relative intensity could elicit a wide range of metabolic stress 
across individuals 63. In contrast, exercise intensity designed relative to lactate thresholds (LT) 
would be expected to produce less individual variation in metabolic responses and in time to 
exhaustion at a constant exercise intensity, providing a more homogenous training stimulus 
64,74. Although more than 20 lactate-related thresholds have been defined until now leading to 
considerable confusion and misinterpretation 75, there are two of these thresolds that have 
emerged as the preferred endurance perfomance markers among the vast majority of sport 
and exercise physiologists: 1) The more frequently called “Lactate Threshold” (LT1) defined as 
the critical exercise intensity level above which BLC first begin to increase above resting values 
during a graded incremental submaximal exercise 151. LT1 has been suggested as the minimum 
exercise intensity required by inactive individuals to improve CRF 70, and is a valid indicator of 
CRF in athletes and inactive people due to its high association with V̇O2max, sport performance 
74,75 and functional capacity in patients 69, and 2) the so-called “Maximal Lactate Steady State” 
(MLSS or LT2), defined as the highest intensity that can be sustained over time without 
continual blood lactate accumulation during a constant intensity exercise 74. Lactate thresholds 
are more sensitive than V̇O2max to predict endurance performance and to evaluate training 
adaptations 83, allowing the definition of three individual intensity domains to guide exercise 
training: light (<LT1), moderate (LT1-LT2) and vigorous (>LT2) 75. 
As far as we know, there are no studies addressing individually-tailored activity counts 
cut-points through LT, that would allow a more accurate design of exercise intensity and a 
proper quantification of the time spent in different PA intensity levels. We hypothesized that 
accelerometer intensity cut-points derived from 3 METs as a representative of the lower 
boundary of moderate intensity were below LT1, and could lead to an overestimation of MVPA 
and the number of postmenopausal women meeting current PA targets. Thus, the aim of this 
study was to compare the widely used accelerometer activity cut-points derived from the 
absolute moderate intensity recommendation (3-6 METs), with relative intensity cut-points 
according to maximal CRF (46-63% V̇O2max) and to individual lactate thresholds (LT1 and LT2) 
in postmenopausal women. 
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Methods 
  
Study design 
Participants performed on different days (with a minimum of one week in between) a 
submaximal incremental exercise test with gas exchange measurement wearing an 
accelerometer to determine the first LT (LT1), several constant velocity tests (CVT) to determine 
the second LT (LT2), and a maximal cardiopulmonary exercise test to determine the CRF level 
(V̇O2max). 
Study participants 
Thirty post-menopausal women (57.6 ± 5.3 yr) from Pamplona (Spain) participated in several 
exercise tests from March to June 2017. Inclusion criteria were: (1) surgical or natural 
menopause (no menstrual periods during previous 12 months); (2) age <75 years old. 
Participants were excluded from the study if they had any of the following conditions that 
might interfere with exercise testing: (1) presence of spine or low-trauma fractures or severe 
arthrosis at the hip, knees or feet; (2) functional limitation to walk for 20 minutes; (3) presence 
of any chronic disease that would impair the cardiorespiratory system during testing. The local 
hospital´s ethical committee approved the study (Pyto2011/71) and written informed consent 
was obtained from all participants before any study procedures were undertaken. The 
procedure of the study was in accordance with the Declaration of Helsinki and was registered 
in ClinicalTrials.gov PRS (NCT02984553). 
Exercise tests protocols 
Submaximal incremental cardiopulmonary test 
Prior to the first visit, participants were instructed to abstain from caffeine and stimulants for 
at least four hours and strenuous activity for ≥24 h before testing. During the first visit, and 
prior to the first testing session, participants were familiarized with the exercise testing 
protocol and the treadmill ergometer. The metabolimeter was warmed up for at least 2 h prior 
to every exercise test to minimize any possible electrical drift. Calibration of the oxygen (O2) 
and carbon dioxide (CO2) analysers was performed immediately prior to every test using two-
point calibration with two precision-analysed gas mixtures. Turbine flow calibration was 
determined using a high-precision 3-L calibration syringe (Vacu-Med, Calibringe 1092, 
Ventura, CA, USA). Participants’ height was measured using a wall stadiometer (Seca, Germany) 
and body mass was measured using a scale to the nearest 0.1kg (Seca, Germany). Each 
participant wore a triaxial accelerometer (Actigraph wGT3X-BT Pensacola, FL, USA) over the 
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right iliac crest in the mid-axillary line throughout the test. Testing was performed in a 
laboratory setting in controlled conditions (temperature: ~20º, humidity: ~27%, barometric 
pressure: ~960mmHg) over a treadmill ergometer (Kuntaväline, Hyper Treadmill 2040, Finland).  
The exercise protocol started with three minutes rest in a standing position. Capillary 
blood samples (0.3 µL) were taken from a hyperemic earlobe for the measurement of BLC 
(Lactate Pro2, Arkray, Japan). Heart rate (Polar V800, Polar Electro Oy, Kempele, Finland) and 
metabolic data were continuously collected using a Vista Mini-CPX computer-integrated 
metabolic system (Vacu-Med, Silver Edition 17670, Ventura, CA, USA). Gas exchange and 
ventilatory variables were measured continuously while participants breathed into a two-way 
breathing mask (Series 7930, Hans Rudolph, Kansas City, MO, USA) and were reported as 30-s 
averages. Participants then started to walk at 2.4 km·h-1. The intensity was progressively 
increased by 0.61 km·h-1 152 at each 2-min stage with 1-min rest in between. At the end of each 
stage a capillary blood sample was taken for BLC analysis. Each participant was free to start 
running from the 7th stage onwards (6.1 km·h-1), or the operator suggested to do so when the 
participant was not able to match the required speed. The test was stopped when: (1) BLC was 
≥3.0 mmol·l-1 to avoid excessive fatigue; and/or (2) participant was exhausted. First LT was 
defined as the highest velocity above which BLC increased by an amount of ≥0.1 mmol·l-1 in 
the following stage and ≥0.2 mmol·l-1 in the subsequent stage. 
Constant velocity tests (CVT) 
On the following visits, participants completed two to seven 20 min CVT. Testing was 
performed in a laboratory setting in a controlled temperature environment (~20º) over a 20 m 
indoor track. Five cones were positioned at 0.5–5–10–15 and 19.5 m and participants had to 
walk in a straight line until the last cone, then turn around and return to the start. The speed 
at which the participant walked was dictated by an audio signal pre-recorded in MP3 audio 
format. Each participant performed the corresponding tests on separate testing days (one week 
in between). Each CVT consisted of two stages of 10 min at a constant pace with a 2-min break 
for blood sampling. Heart rate was continuously recorded, and capillary blood samples were 
obtained at rest, at the 10th min and the end of the test (22nd min). Walking or running velocity 
of the first CVT was programmed as the velocity at which BLC increased by 1 mmol·l-1 above 
the blood lactate value at LT1 during the incremental exercise test. In the following tests, the 
velocity was increased or decreased by ~0.30 km·h-1 until the maximum lactate steady state 
velocity (i.e., LT2) could be determined 153. An increase in BLC ≤0.4 mmol·l-1 during the final 10 
min of exercise was defined as steady state 74.  
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Maximum cardiopulmonary exercise test 
On the last visit, a maximum CPET was performed over a treadmill ergometer (Kuntaväline, 
Hyper Treadmill 2040, Finland) using a graded protocol. Gas exchange and ventilatory variables 
were measured continuously while the participants breathed into a two-way breathing mask 
(Series 7930, Hans Rudolph, Kansas City, MO, USA). After 3-min rest, participants walked at 4.9 
km·h-1 for a minute. Then, the speed was increased and maintained in 5.5 km·h-1 and the 
inclination of the treadmill was increased by 0.5% and by 1.3% in the first and next 1-min 
stages, respectively, to induce a ~0.6METs increment per stage until volitional fatigue. The 
perceived exertion was rated by Borg´s scale 154. A capillary blood sample was taken for lactate 
analysis at the termination of exercise, and at 1, 3 and 5 minutes of recovery if the BLC 
continued increasing (Lactate Pro; KDK Corporation or ABL 800; Radiometer Medical AS). All 
metabolic data were averaged over 30-second periods with the highest 1-min V̇O2 recorded 
as V̇O2max. Achievement of V̇O2max was assumed in the presence of a minimum of three of the 
following criteria: (1) failure of V̇O2 and/or heart rate to increase with further increases in 
workload, (2) individual´s volitional fatigue, rating a perceived effort of a minimum of 8 points 
out of 10 154, (3) elicited an exercise maximum heart rate (HRmax) that exceeded 85% of the 
individuals age-predicted maximum based on the HRmax estimated by 208-0.66·age 155, (4) RER 
≥1.10, and (5) BLCmax >8 mmol·L-1 24. 
Determination of accelerometer activity cut-points and Data Analyses 
Accelerometer activity counts during the submaximal incremental test were calculated by 
averaging the VM3 activity counts in 1-sec epochs during the central 90-sec of each stage to 
avoid the accelerations/decelerations produced during the start or the end of each stage (first 
or last 15 sec). These activity counts were then averaged in 1-min epochs (ct·min-1). We used 
individual centered third order polynomial regression equations between rates of energy 
expenditure (METs) and VM3 activity counts measured at each speed (R2 = 0.98) to derive the 
activity counts at selected moderate intensity thresholds (i.e., at lower and upper boundaries 
of absolute 3-6 METs, relative 46-63%V̇O2max and at individual LTs) 102. Data were analyzed 
using parametric statistics following confirmation of normality (Shapiro-Wilk test), 
homoscedasticity (Levene´s test), and when appropriate sphericity (Mauchly’s test). Repeated 
measures ANOVA with Bonferroni adjusted post hoc test was used to compare the activity 
counts of the three moderate intensity cut-points. The Greenhouse-Geisser correction factor 
to reduce the risk of type I error was applied where sphericity assumptions were violated. Data 
are presented as mean ± standard deviation and 95% confidence interval (CI). Statistical 
significance was set at p <0.05. Statistical analyses were performed using SPSS statistical 
76 
 
software (version 22.0, IBM SPSS Statistics, Chicago, IL) and GraphPad Prism 7 was used for 
figures.  
Results 
 
One of the study participants was excluded from data analysis due to not-meeting maximum 
exercise criteria. Study participants had a V̇O2max of 10.0 ± 4.2 METs (Table 8). Figure 14 shows 
measured METs and activity counts during the submaximal incremental exercise test. The 
average velocity at the classic lower moderate intensity boundary in absolute rates of energy 
expenditure (3 METs) was 3.2 km·h-1, corresponding to a 30%V̇O2max and a 49%HRmax. Average 
velocities at LT1 and LT2 were 5.5 ± 0.6 km·h-1 and 7.3 ± 1.1 km·h-1, respectively, which 
corresponded to 4.6 ± 0.7 METs (47 ± 8%V̇O2max and 59 ± 6%HRmax) and 7.3 ± 1.9 METs (73 ± 
11%V̇O2max and 85 ± 10%HRmax) during the incremental exercise test. 
 
Table 8. Descriptive characteristics of study participants (n = 29). 
Characteristics    
Age (years) 57.2  ± 5.0 
Height (cm)   158.3  ± 5.5 
Body mass (kg)    65.4  ± 12.2 
BMI (kg/m2)  26.0  ± 4.2 
V̇O2max (METs) 10.0  
 
± 4.2 
BLCmax   7.8  
 
± 3.2 
RERmax   1.22  
 
± 0.07 
RPEmax   8.8  ± 1.9 
HRmax 172.7  ± 11.3 
LT1 (km·h-1)   5.5  ± 0.6 
LT1 (METs)   4.6  ± 0.7 
LT2 (km·h-1) 
 
  7.3  ± 1.1 
LT2 (METs)   7.3  ± 1.9 
BMI = body mass index, V̇O2max = oxygen consumption, MET = rates of 
energy expenditure (1 MET is equivalent to 3.5 ml·kg-1·min-1), BLC = blood 
lactate concentration, RER = respiratory exchange ratio RER = V̇CO2/V̇O2), 
RPE = rating of perceived effort, HRmax = maximum heart rate, LT1 =first 
lactate threshold, LT2 = second lactate threshold. 
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The activity counts calculated at the lower boundary of moderate intensity were 2026 
± 808 ct·min-1 (95%CI; 1719-2334) at 3 METs, 4306 ± 1447 ct·min-1 (95%CI; 3756-4857) at 
46%V̇O2max and 4247 ± 1122 ct·min-1 (95%CI; 3820-4674) at LT1. There was a significant 
difference between the three intensity indicators (F2,56 = 79,2, p <0.01) with Bonferroni 
adjusted post hoc tests revealing that the activity counts at 3 METs threshold were 
significantly lower (p <0.01) than activity counts at 46% V̇O2max (p <0.01; 95%CI: -2774 to -
1786; ES: 1.95) or at LT1 (p <0.01; 95%CI: -2559 to -1882; ES: 2.27). No differences were 
observed in the average activity counts between the lower threshold of 46%V̇O2max assigned 
to relative moderate intensities and LT1 (p = 0.72; 95%CI: -363 to 482; ES: 0.05) (Figure 15). 
The data revealed large interindividual variability in activity counts at the three lower 
boundaries of moderate intensity (coefficient of variation, CV = 40, 34, 26%, respectively). 
Figure 14. Measured rates of energy expenditure (METs) and activity counts across the 
velocities of the submaximal incremental test (n = 29). Dashed arrows indicate the lower and 
upper boundaries of moderate absolute (green), relative (blue), and individual (red) intensity. 
   
The activity counts measured at the upper boundary of moderate intensity were 5820 
± 1297 ct·min-1 (95% CI; 5326-6313) at 6 METs, 6068 ± 1765 ct·min-1 (95% CI; 5397-6740) at 
63%V̇O2max and 7249 ± 2499 ct·min-1 (95% CI; 6298-8199) at LT2. The activity counts at LT2 
were significantly higher than those at 63%V̇O2max (p <0.01; 95%CI: 637 to 2221; ES: 0.55) and 
at 6 METs thresholds (p <0.01; 95%CI: 569 to 1792; ES: 0.72) which did not differ between 
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them (p = 0.38; 95%CI: -327 to 824; ES: 0.16) (Figure 15). The data revealed large 
interindividual variability at the three upper boundaries of moderate intensity (CV = 22, 29, 
34%, respectively). The large variation in activity counts at the lower and upper relative 
moderate intensity boundaries was largely explained by V̇O2max (R2 = 54% and 48%, 
respectively), whereas less than 2% of the variability was explained by individuals age and 
BMI. 
 
Figure 15. Measured-activity counts at the lower and upper boundaries of moderate absolute (3-6 
METs), relative (46-63% V̇O2max) and individual (LT1-LT2) intensity. The data are derived from individual 
regressions between rates of energy expenditure (METs) and VM3 activity counts measured at each speed 
during the submaximal incremental test in 29 participants. VM = vector magnitude activity counts per 
minute, MET = metabolic equivalent of energy expenditure, LT1 = first lactate threshold, LT2 = second 
lactate threshold. Dashed line separates lower and upper boundaries of moderate intensity.  
Dashed line separates lower and upper boundaries of moderate intensity.  
a significantly different from 46% V̇O2max and LT1 (p <0.01). 
b significantly different from LT2 (p <0.01). 
 
Discussion 
 
The selection of appropriate accelerometer cut-points to demarcate PA intensity levels is the 
cornerstone to obtain reliable PA outcomes and their association with health markers and 
mortality 111. If the cut-points are too high when evaluating accelerometry data, then 
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participants will not be credited for engaging in MVPA even when being adherent to their 
prescriptions. Conversely, using cut-points that are too low would falsely elevate levels of 
MVPA 111. A possible solution to this problem could be to individualize the activity cut-points 
according to relative intensities, rather than using fixed cut-points for all individuals 109,110.  
An important finding of this study was that the energy cost at the lower moderate 
intensity boundary expressed either, relative to V̇O2max (46%V̇O2max , corresponding to 4.6 ± 
0.9 METs) or to LT1 (5.5 ± 0.6 km·h-1, corresponding to 4.6 ± 0.7 METs) was higher than the 
classic 3 METs threshold assigned to the lower boundary of moderate intensity activities, 
which has been widely utilized by expert panels to create PA guidelines 12,19,150 as well as to 
establish the health benefits of engaging in MVPA 11. A possible explanation could be the 
higher CRF of our study participants (10.0 ± 2.0 METs) compared to the 8-8.5 METs reported 
for women of the same age in other studies 155. Interestingly, the energy cost of the LT1 
agrees with the relative intensity value assigned to the lower moderate intensity boundary of 
individuals with a CRF of 10 METs 6,19.  
Consequently, measured activity counts at 3 METs fell well below the relative intensity 
and individual cut-points derived from LT (p <0.01). This finding is in agreement with the 
results of Miller and colleagues 109 who showed that the activity counts at 3 METs were much 
lower than those obtained at relative intensity cut-points, even in the oldest individuals, and 
this difference increased in individuals with higher CRF 110. Epidemiological studies measuring 
PA with accelerometers 113,114 have commonly used activity counts cut-points derived at 3 
METs intensity as the lower boundary of moderate intensity 98,102,103. Hence, the finding of the 
present study has important consequences, as it could falsely elevate the time spent at MVPA 
and the percentage of people meeting current PA guidelines. In this investigation, measured 
activity counts at 3 METs intensity were 25-37% lower compared to previous actigraph triaxial 
accelerometer validation studies 102,103. However, these two studies obtained 4000 ct·min-1 
at 4.8 km·h-1, which is close to the value of 3616 ct·min-1 found in our study when participants 
walked at the same speed. These two studies used an incremental treadmill protocol with 
activity counts obtained at only 2-4 velocity stages to derive the activity counts at 3 and 6 
METs using linear regression analysis 102 and artificial neural networks 103. In contrast, our 
incremental exercise test provided a minimum of seven data points from all participants, with 
smaller velocity increments between stages (0.6 km·h-1). Besides, we used individual, rather 
than whole-group regression equations to determine the activity counts at moderate 
intensity thresholds. Another possible explanation to the low activity counts observed at 3 
METs intensity could be related to the slightly higher METs measured in our study participants 
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(i.e., 3.9 METs at 4.9 km·h-1) compared to the estimated values of 3.6 METs from the equation 
of Weyand et al. 156 or the 3.5 METs assigned in the compendium of physical activities 26 to 
walking at 4.8 km·h-1. Both, Miller and colleagues 109 and Santos-Lozano et al. 103 reported a 
large variation in measured METs for that speed (from 3 to 4 METs) between young and older 
adults. In our study, age was not a significant predictor of measured METs at a certain velocity, 
but resting METs (standing) contributed in a range of 15-42% of its variance, mainly at slow 
velocities (p <0.001). 
On the other hand, the activity counts measured at the upper boundary of moderate 
intensity were similar between absolute and relative intensities (p = 0.384) and go hand in 
hand with the cut-point derived at 6 METs by Sasaki and colleagues 102. However, LT2 
corresponded to a higher intensity (7.3 ± 1.9 METs or 73%V̇O2max) than either, absolute (6 
METs) or relative (63%V̇O2max) upper boundaries of moderate intensity established by exercise 
intensity guidelines 12,19,150. Consequently, the activity counts measured at LT2 were higher (p 
<0.01) than absolute and relative cut-points. The second LT (i.e., the so-called maximum 
lactate steady-state or MLSS) represents the highest constant-rate velocity or power output 
that can be sustained over time without a continual blood lactate accumulation 74 and is the 
upper limit of exercise beyond which there is an abrupt rise in plasma catecholamine levels 
and fatigue 80. There is a lack of normative values of LTs in adults, but our results demonstrate 
that both moderate and vigorous intensities defined by current PA guidelines 12,19,24,150 are 
included in the relative intensity range between LT1 and LT2 (46-73%V̇O2max or 58-85%HRmax). 
These exercise intensity categories were initially defined according to %V̇O2 reserve as a 
standard for conversion to other expressions of exercise intensity (e.g., METs, %V̇O2max or 
%HRmax) based on a 10 MET fitness group 6,19. In less fit individuals, health/fitness benefits 
have been reported with a minimum exercise intensity of ~40-50%V̇O2 reserve or 55-
65%HRmax. Owing to the high proportion of physically inactive and unfit adults, and people 
with increased risk of cardiovascular disease, PA authorities reduced the recommended 
amount and intensity of PA from the original recommendations, which were based on athletic 
population 25. It is acknowledged that individuals with higher fitness levels require higher 
training stimulus to improve health/fitness 25. Therefore, and in line with the 1998 ACSM´s 
position stand, vigorous exercise or exercise intensities close to LT2 (i.e., 70-90%HRmax) should 
be recommended for larger health/fitness benefits in postmenopausal women with maximum 
CRF values ~10 METs. 
The large interindividual variability in activity counts at absolute, relative and individual 
LT intensities is evidence that individually-tailored rather than fixed acelerometer intensity cut-
points might better represent meaningful volumes of light, moderate and vigorous intensities 
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during daily activities. Our results go hand-in-hand with the findings of Ozemek and 
colleagues 110 showing that CRF, rather than age or BMI influenced individual´s activity count 
cut-points at relative intensities, explaining half of their variance. As we showed in a previous 
study, it was easier for high-fit individuals engaging in higher levels of PA when using the same 
fixed accelerometer intensity cut-points for everyone, but it does not necessarily mean that 
they are having higher relative intensities. In fact, there was no difference in the time spent at 
MVPA when the accelerometer activity cut-points were individualized according to their lactate 
thresholds 157. Therefore, epidemiology studies should at least consider adjusting the 
association between PA and mortality risk by CRF. Besides, a meta-analysis conducted by 
Williams 23 reported higher potential to reduce the risk of developing CVD in favour of CRF 
compared to the amount of PA. Although PA increases CRF and may be an appropriate therapy 
mostly for the unfit, only 35% of the variance in CRF is explained by PA, probably because of 
the low correlation of CRF with the amounts of light or moderate intensity activity. Thus, the 
aforementioned association might have been inflated by the higher CRF in those reporting 
higher physical activity dose. 
This study used a novel approach to set individualized accelerometer activity cut-
points through LTs. Despite the methodological shortcomings of accelerometers-based 
measures in PA surveillance 158, the proposed method in this study avoids the 
misinterpretation of intensity-specific PA levels when using fixed activity cut-points in 
individuals or groups varying in CRF. The current study is not without limitations. First, the 
applicability of this individualized approach is not feasible for large epidemiological studies, 
although they could benefit from population-specific relative intensity cut-points to obtain 
more reliable PA outcomes. Second, the generalizability of these findings are limited to 
postmenopausal women with such V̇O2max values (range: 6-14 METs), who are worthy of 
distinct attention due to the increased risk of cardiovascular disease 117 and osteoporosis 118. 
Third, our study was a cross-sectional study. Although higher relative intensity of daily 
activities has been associated with reduced CHD mortality 32, randomized controlled trials are 
needed to confirm whether PA recommended by guidelines applying relative intensity 
thresholds brings greater long-term health benefits compared to absolute intensity. Finally, 
we did not directly measure the V̇O2 during the CVTs for the determination of the LT2. The 
gold standard method for the determination of LT2 requires at least two or three CVT; 
consequently, increasing the time and cost related to cardiopulmonary exercise testing. 
Instead, we accurately determined LT2 velocity from CVTs to derive the activity counts from 
individual regression equations with measured V̇O2 values from the incremental test. 
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Conclusions 
 
In conclusion, the widely utilized 3 METs threshold to derive accelerometer activity counts 
cut-points that represent the lower boundary of moderate intensity physical activities was 
well below from both, the relative intensity threshold (46%V̇O2max) and LT1. Further, the large 
interindividual variability in activity counts at relative moderate intensities is evidence that 
individually-tailored activity counts cut-points expressed either, relative to CRF level or to LT 
velocities may better represent meaningful PA intensity levels compared to fixed cut-points 
derived from the recommended absolute intensities of 3 and 6 METs in postmenopausal 
women. 
What does this article add? 
The article provides valuable information regarding the use and interpretation of objectively 
measured PA levels using accelerometers. The study highlights the important role of CRF in 
the selection of appropriate accelerometer intensity cut-points. Besides, it provides the 
procedures for the individualization of accelerometer intensity cut-points through an easy-
to-administer submaximal walking test that could overcome the under- or overestimation of 
PA levels using fixed cut-points derived from the absolute moderate intensity 
recommendations. 
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Abstract 
 
Purpose. To investigate how objectively measured PA levels differ according to absolute 
moderate intensity recommendation (3-6 METs) and relative to individual lactate thresholds 
(LT1 and LT2), and to verify if high-fit women record higher PA levels compared to women with 
lower aerobic fitness. Methods. Seventy-five postmenopausal women performed an 
incremental exercise test and several constant-velocity tests wearing an accelerometer to 
identify the activity counts (ct·min-1) corresponding to LT1 and LT2. Individual linear regression 
determined activity counts cut-points for each intensity: 1) sedentary (<200 ct·min-1), 2) light 
(from 200 ct·min-1 to ct·min-1at LT1), 3) moderate (ct·min-1 between LT1 and LT2) and 4) 
vigorous (ct·min-1 >LT2). Participants then wore an accelerometer during a week to measure 
the time spent at each PA intensity level. Results. According to absolute intensity 
categorization, high-fit postmenopausal women recorded twice as much time at MVPA (p 
<0.01) than low-fit women. However, when PA intensity was calculated relative to individual 
lactate thresholds, MVPA was significantly reduced by half (p <0.01) and the data revealed no 
differences (p =0.62) between groups (~20 min·day-1 at MVPA). Conclusions. Accelerometer 
cut-points derived from absolute moderate-intensity recommendations overestimated MVPA. 
Similar time at MVPA was recorded by high- and low-fit postmenopausal women when the 
cut-points were tailored to individual lactate thresholds. A more accurate estimation of PA 
behavior could be provided with the use of individually tailored accelerometer cut-points. 
 
Keywords: Accelerometry; cardiorespiratory fitness; individually tailored cut-points; 
moderate-to-vigorous physical activity.  
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Introduction 
 
Physical activity level and CRF are two of the most powerful predictive factors of premature 
death and chronic disease 1,11. Observational prospective cohort studies using self-reported 
questionnaires suggest that meeting current PA guidelines 12,19,35 of 150 min·wk-1 of MVPA 
reduces all-cause mortality risk by 26-31% 9-11. Several studies have reported that MVPA, rather 
than total EE or light intensity PA is determinant to reduce the levels of cardiometabolic risk 
factors 11,15,20 and osteoporosis 159. 
Large epidemiology studies using self-reported PA questionnaires 10,11 have commonly 
grouped recreational PA into three intensity categories according to their energy 
requirements, supported by evidence-informed guideline recommendations 12,19,26,27,35: light 
(<3 METs), moderate (3-6 METs) and vigorous (>6 METs). Interestingly, Lee and colleagues 32 
showed that it is the relative intensity of exercise, rather than total EE or absolute intensity of 
activities what causes greater reduction in CHD mortality risk. During the last years, 
accelerometers have replaced PA questionnaires to objectively capture human activity, 
applying activity cut-points derived from the traditional absolute 3-6 MET intensities to obtain 
representative volumes of MVPA 98,102,103. These studies have generated widely divergent 
regression models for converting activity counts to EE, yielding different cut-points for PA 
intensity categories 105. Contrary to self-reported estimates, results of accelerometer-based 
objective assessments of PA report much lower volumes of MVPA 11,113 indicating that only a 
small proportion of adults (7-15%) meet current PA recommendations 113-116. Reported 
objective weekly volumes of MVPA are significantly lower in women and vary from as low as 
seven min·day-1 to 57 min·day-1 113-116. Previous studies have demonstrated that the use of fixed 
cut-points may under or overestimate MVPA due to the lack of consideration of an individual´s 
CRF 109-111. When moderate intensity activity counts cut-points have been calculated based on 
relative intensities (i.e., 45-60%V̇O2max) the results show substantial differences in measured 
activity counts between less fit and most fit individuals 109,110. Furthermore, Kujala and 
colleagues 116 using heart-rate based PA assessment reported that although the time spent at 
MVPA applying fixed absolute intensity cut-points was higher in men compared to women, 
and decreased with age, when intensity levels were calculated relative to individual´s CRF, these 
differences disappeared.  
The validity of this “relative intensity” approach has also been substantially criticized 
because exercising at the same relative intensity could elicit a wide range of metabolic stress 
across individuals 63. The determination of individual physiological break points of energy 
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supply, as the lactate thresholds (LT), is the gold standard method for accurate exercise 
intensity prescription 72,74,78. Besides, the achieved workload at LT is an accurate indicator of 
CRF 75. In this study, we were interested in accurately quantifying PA volumes in 
postmenopausal women because they usually report lower MVPA compared to men 113,116, and 
because they have an increased risk of osteoporosis and cardio-metabolic diseases related to 
menopause, lower fitness and inactivity 117,118. It is unknown how well individually-tailored 
accelerometer cut-points derived from LT reflect PA levels during routine activities of daily 
living, and whether differences exist between less fit and most fit women.  
This study aimed to investigate how objectively measured PA levels differ according to 
absolute moderate intensity recommendation (3-6 METs) and relative to individual lactate 
thresholds (LT1 and LT2), and to verify if high-fit women record higher PA levels, especially 
MVPA, compared to women with lower fitness level.  
Methods 
 
Study design 
This cross-sectional study investigated the volumes of absolutely and relatively (i.e., relative to 
participant´s LT) determined PA at different intensity levels (sedentary, light, moderate, 
vigorous, and moderate-to-vigorous combined) during one week in postmenopausal women. 
Participant´s aerobic fitness and PA data were collected from November 2015 to June 2017. 
Participants performed on different days an incremental submaximal shuttle test (IST) and 
several CVT wearing an accelerometer to identify the activity counts corresponding to LT1 and 
LT2 velocities. Participants then wore an accelerometer for seven complete days to assess their 
PA patterns.  
Study participants 
Participants were recruited through advertisements placed on healthcare centers. One hundred 
and four participants were screened by telephone, 88 were deemed eligible and were invited 
to participate in the study. Inclusion criteria were: 1) surgical or natural menopause (no 
menstrual periods during previous 12 months), 2) age <75 years. Participants were excluded 
from the study if they had any of the following conditions that might interfere with exercise 
testing: 1) presence of spine or low-trauma fractures or severe arthrosis at the hip, knees or 
feet, 2) functional limitation to walk for 20 minutes, 3) presence of any chronic disease that 
would impair the cardiorespiratory system during testing. The local hospital´s ethical 
committee approved the study (Pyto2011/71) and written informed consent was obtained from 
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all participants before any study procedures were undertaken. The procedure of the study was 
in accordance with the Declaration of Helsinki and was registered in ClinicalTrials.gov PRS 
(NCT02984553). 
Exercise tests  
Incremental shuttle test (IST)  
Prior to the first visit, participants were instructed to abstain from caffeine and stimulants for 
at least four hours and strenuous activity for ≥24 h before testing. Height was measured using 
a wall stadiometer (Seca, Germany) and body mass was measured using a scale to the nearest 
0.1kg (Seca, Germany). Before starting the test each participant´s resting HR (Polar V800, Polar 
Electro Oy, Kempele, Finland) and BLC (Lactate Pro2, Arkray, Japan) were measured on a 
standing position. Capillary blood samples (0.3 µL) were taken from a hyperemic earlobe. 
Testing was performed in a laboratory setting in a controlled temperature environment (~20º) 
over a 20 m indoor track. The distance of the course was extended to 20 m from the original 
test 152 to keep the pace constant avoiding excessive turns that might increase the energy cost 
and musculoskeletal demand, potentially leading to premature fatigue, discomfort or even 
injury. Five cones were positioned at 0.5–5–10–15 and 19.5 m and participants had to walk in 
a straight line until the last cone, then turn around and return to the start (Figure 16a). The 
speed was dictated by an audio signal. A double beep indicated the start of each stage. After 
that, participants were instructed to be at the next cone with each beep while keeping the pace 
as constant as possible. The IST started at 2.4 km·h-1 (~2.1 METs). The intensity was 
progressively increased by 0.61 km·h-1 152 at each 2-min stage with 1-min rest in between. At 
the end of each stage, HR and BLC were recorded. Each participant wore a triaxial 
accelerometer (Actigraph wGT3X-BT Pensacola, FL, USA) over the right iliac crest in the mid-
axillary line throughout the test. 
Each participant was free to start running from the 7th stage onwards (6.1 km·h-1), or the 
operator suggested to do so when the participant was not able to match the required speed. 
The test was stopped when: 1) BLC values were ≥3.0 mmol·l-1 to avoid excessive fatigue, and/or 
2) participant repeatedly failed to match the pace programmed, and/or 3) participant was 
exhausted. LT1 was defined as the highest velocity above which BLC increased by an amount 
of ≥0.1 mmol·l-1 in the following stage and ≥0.2 mmol·l-1 in the subsequent stage (Figure 16b).  
Constant-velocity tests (CVT)  
Participants completed two to seven 20 min CVT on the same 20 m track used for the IST. Each 
participant performed the corresponding tests on separate testing days (one week in between). 
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Each CVT consisted of two stages of 10 min at a constant pace with a two minutes interruption 
for blood sampling. Heart rate was continuously recorded, and capillary blood samples were 
obtained before at rest, at the 10th min and the end of exercise (22nd min). Walking or running 
velocity of the first CVT was programmed as the velocity at which blood lactate increased by 1 
mmol·l-1 above the blood lactate value at LT1 during the IST. In the following tests, the velocity 
was increased or decreased by ~0.30 km·h-1 until the maximal lactate steady state velocity (i.e., 
LT2) could be determined 153. An increase in BLC ≤0.4 mmol·l-1 during the final 10 min of 
exercise was defined as steady state 74 (Figure 16c). 
 
Figure 16. a) Schematic representation of the 20 m track used in the IST and CVT. b) Blood lactate 
and heart rate response during the IST for the individual determination of the LT1 in a representative 
participant. The participant started running at 6.7 km·h-1 c) Lactate response during several CVT for 
the determination of the LT2 in the same representative participant. Three metabolic intensity zones: 
light (<4.25 km·h-1), moderate (4.25-7.45 km·h-1) and vigorous (>7.45 km·h-1) are indicated by 
different background colours (green, yellow and red, respectively). LT1 = first or aerobic threshold, 
LT2 = second or anaerobic threshold, W: walk, R: run. 
 
Physical activity assessment  
Each participant was instructed to wear an Actigraph wGT3X-BT accelerometer over the right 
iliac crest at the mid-axillary line on an elasticized belt for eight consecutive days (24h) 
alongside a daily log. 
Each monitor was previously initialized at a 50Hz frequency and downloaded after the 
8-day period in VM3 activity counts in 1-min epochs (ct·min-1). Data were analyzed with Actilife 
6® full software (Actigraph, Pensacola, FL, USA). The first recording day was not used for the 
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analysis. Sleep periods were selected from participant’s daily logs. For the present analysis, 
only data over the day were used. Participants were included in the analysis if they had a 
minimum of five days of monitoring, including two weekend days and daily wear time was ≥12 
hours 105. Periods of continuous zeros lasting more than 60 min with allowance for 2 min 
interruptions of activity counts between 0 and 200 96 were checked in participant´s daily logs 
and assigned as non-wear time if corresponded 105. High activity levels (>10.000 ct·min-1) or 
high step counts (>20.000 steps·day-1) were verified against participant’s daily logs.  
Accelerometer activity counts measured during the IST at the velocities corresponding 
to each participant´s LT1 and LT2 were used to determine three individual intensity zones: light 
(<LT1 ct·min-1), moderate (LT1 ct·min-1 - LT2 ct·min-1) and vigorous (>LT2 ct·min-1). Both, the 
light-intensity and the moderate-intensity zones were subdivided into other identical two 
zones (low and high) (Figure 17). The time (min·day-1) spent in each of these intensity zones for 
every valid day and the number of daily steps were averaged. Both, sedentary time and MVPA 
were reported in one (+1) and ten (+10) minute bouts (the minimum time required to be 
between the specified intensity cut-points). The time spent at each relative intensity category 
was compared to absolute accelerometer activity counts cut-points, which have been 
previously validated against direct measurement of oxygen uptake during treadmill walking 
and running activities designated as movements that represent moderate intensity 
recommendations (3-6 METs) (i.e., light = 200-2689 ct·min-1, moderate = 2690-6166 ct·min-1, 
vigorous ≥6167 ct·min-1 102. 
Statistical analysis 
Accelerometer activity counts during IST were calculated by averaging the VM3 activity counts 
in one-second epochs during the central 90sec of each stage. These activity counts were then 
averaged in 1-min epochs (ct·min-1). The corresponding ct·min-1 at LT2 were selected from the 
individual regression equations obtained in the IST. For women who walked at the LT2 during 
the CVT, the data of running stages were removed. For women who ran at LT2 during the CVT 
and for whom this velocity was between the last walking stage and the first running stage of 
the IST, linear interpolation was performed.  
For the whole sample, repeated measures ANOVA was used to determine differences 
in both, [La-] and activity counts throughout the IST. Bonferroni Post Hoc analysis was applied 
when significant effects were observed for velocity stages. 
Participants were categorized into two groups according to their LT2 velocity (Low-
fitness group; as ≤6.8 km·h-1 [n = 37], and high-fitness group; as >6.8 km·h-1 [n = 38]), which 
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represented the median speed of LT2 and corresponded to the minimum level of CRF (6-7 
METs) associated with lower event rates in 40 to 60 years old women 1. The differences in the 
activity count cut-points at LT1 and LT2 between groups were presented using Tukey Box Plots 
and Mann Whitney U-test was used for comparison between groups. 
The primary outcome of the study was the volume of objectively measured PA 
(particularly MVPA+10) expressed as mean ± SD, using both, relative and absolute cut-points. 
Intra-group PA levels (min·day-1) were compared using a paired t-test or Wilcoxon test (for 
non-parametric data), and Independent samples test or Mann Whitney U test were used for 
inter-group analysis.  
We conducted a post hoc power analysis using the G*Power software 160. The level of 
statistical power reached in this study was 0.99 for the following variables; alpha level (α = 
0.05), sample size (n = 75), and effect size (ES = 0.80 relative vs. absolute MVPA+10). Statistical 
significance was set at p <0.05. Statistical analyses were performed using SPSS statistical 
software (version 22.0, IBM SPSS Statistics, Chicago, IL). 
Results 
 
Population selection and characteristics 
Among 104 interested participants who were screened for eligibility, 14 were excluded. 
Reasons for exclusion were; 1) not meeting eligibility criteria (n = 12), and 2) declined to 
participate (n = 2). Among 88 participants who were invited to participate, 75 completed all 
the assessments and were included in the study for data analysis. Reasons for exclusion in data 
analysis were inability, musculoskeletal pain or discomfort when running (n = 6), failure to get 
the LT2 with accuracy (n = 3), invalid 7-day accelerometry recording (n = 1), cardiovascular or 
pulmonary disease (n = 2), and failure to keep testing appointment (n = 1). All participants had 
a minimum of 5-valid days (2 weekend days included), and 78% had 7-valid days. 
Determination of PA intensity levels through lactate thresholds 
The average velocity vs. BLC curve during the IST in the whole group of participants is 
presented in Figure 17. During the first five stages BLC did not change noticeably. From the 
fifth stage onwards, BLC significantly increased (F8,568 = 137.5, p <0.001) in each subsequent 
exercise stage. Accelerometer activity counts increased linearly and significantly (F7,497 = 892, P 
<0.001) over the duration of the IST. Average LT1 was 5.1 ± 0.7 km·h-1, and the corresponding 
activity counts, BLC, and HR values were 4133 ± 1152 ct·min-1, 0.8 ± 0.2 mmol·l-1 and 98 ± 12 
beats·min-1 (bpm), respectively. Mean LT2 was 7.1 ± 1.0 km·h-1, and the corresponding activity 
91 
 
counts, BLC, and HR values in the IST were 6783 ± 2077 ct·min-1, 2.4 ± 0.7 mmol·l-1, and 141 ± 
17 bpm. Respectively 
Figure 17. Blood lactate concentration and accelerometer activity counts during the IST. Data are mean 
values for the whole sample (n = 75). Five metabolic intensity zones: low-light and high light (<LT1), 
mod-low and high-low (between LT1 and LT2) and vigorous (>LT2) are indicated by different 
background colours (blue-green, yellow-orange and red, respectively). [La-] = blood lactate, ct·min-1 = 
activity counts per minute, LT1 = first or aerobic threshold, LT2 = second or anaerobic threshold, Vmax = 
maximal velocity obtained during the test, VM3 = vector magnitude activity counts, MET = estimated 
metabolic equivalents 156, W, W&R, R = number of subjects walking, a combination of walking and 
running or running, respectively, at each stage. * Significantly (p <0.01) different from the previous stage.  
 
Individually tailored activity counts cut-points by fitness group 
High-fit women were five years younger (p <0.01) and their body mass was eight kg lower (p 
<0.01) compared to the low-fit group. LT1 and LT2 were 17% and 24% higher in high-fit 
compared to low-fit women (p <0.01), respectively. Accordingly, measured activity counts 
were greater in the high fit group (p <0.01) at both, LT1 (4659 ± 1250 vs. 3592 ± 729 ct·min-
1) and LT2 (7989 ± 2035 vs. 5543 ± 1223 ct·min-1) (Figure 18).  
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Figure 18. Tukey Box Plot showing the median and the 25-75 percentiles of the VM3 activity counts at 
LT1 and LT2 velocities in Low-fit (red coloured) and High-fit (blue coloured) groups. The grey coloured 
area shows the VM3 activity counts cut-points derived from walking and running activities that represent 
an intensity of 3 and 6 METs 102. VM3 = vector magnitude, MET = metabolic equivalent, LT1 = first or 
aerobic threshold, LT2 = second or anaerobic threshold, Low-fit = low aerobic fitness group (≤6.8 km·h-
1), High-fit = High aerobic fitness group (>6.8 km·h-1). * Significantly different between groups (p <0.01). 
 
Physical activity levels 
Table 9 shows the results of the minutes spent per day at each intensity level for each group, 
using both, absolute intensity cut-points 102 and individually-tailored LT cut-points. The two 
groups exceeded the target of 10.000 daily steps recommended by PA guidelines 19. Recorded 
MVPA+10 using the absolute intensity cut-points (31.1 ± 24.2 min·day-1 or ~218 min·week-1 in 
low-fit and 51.8 ± 31.4 min·day-1 or ~363 min·week-1 in high-fit) approached the recommended 
target of 150 min·week-1 19. High-fit women were ~1 h·day-1 less sedentary (p <0.01), they 
recorded on average 3156 more daily steps (p <0.01), and they engaged in twice as much time 
(p <0.01) at absolute MVPA compared to low-fit women. However, when PA intensity 
boundaries were individually tailored, daily time spent at MVPA+10 was significantly reduced (p 
<0.01) by ~40% in low-fit and by ~60% in high-fit groups. These data revealed no differences 
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(p = 0.62) between groups (~20 min·day-1 in 10-min). Accordingly, the number of participants 
meeting PA guidelines dropped from 62% to 32% in low-fit and from 82% to 40% in high-fit 
(p <0.01). The only difference between groups using relative intensity cut-points was in low-
light PA. The high-fit group spent ~1 h·day-1 more at the lowest intensity activities (p <0.01). 
 
Table 9. Comparison of daily physical activity levels (min·day-1) according to relative or absolute intensity activity cut-points in high 
and low cardiorespiratory fitness groups. 
Data presented as mean ± standard deviation or percentages. Low-fit = Low LT2 velocity group, High-fit = High LT2 velocity group, relative = 
relative intensity method based on lactate thresholds, Absolute = absolute intensity method based on measured activity counts at 3-6 METs 102, 
MVPA = Moderate-to-vigorous physical activity. Physical activity (PA) guidelines = ≥150 min·wk-1 of MVPA in 10-min bouts 19. Sedentary time and 
MVPA are reported in 1 and 10 minute bouts (+1, +10, respectively).  
†Significant intra-group differences between relative and absolute cut-points (p <0.05). 
††Significant intra-group differences between relative and absolute cut-points (p <0.01). 
* Significant inter-group differences at absolute cut-points (p <0.05). 
** Significant inter-group differences at absolute cut-points (p <0.01). 
≠ Significant inter-group differences at relative cut-points (p <0.05). 
 
Discussion 
 
In this study, we tested whether individually-tailored cut-points based on lactate thresholds 
differed in the time spent at different PA intensity levels to fixed cut-points obtained at 
absolute moderate intensity (i.e., 3-6 METs) 102 in postmenopausal women differing in CRF. Our 
findings demonstrated that high-fit women were 1h less sedentary, recorded ~3000 more daily 
steps and twice as much time at MVPA compared to low-fit individuals using absolute intensity 
cut-points. However, when PA intensity cut-points were individually tailored according to LT, 
        Low-fit (n=37) High-fit (n=38) 
Age (years)            61.4 ± 5.8             56.6 ± 4.0**  
Height (cm)          157.8 ± 5.0           159.3 ± 5.8  
Body mass (kg)  69.7 ± 12.7             61.4 ± 6.0**  
BMI (kg/m2)            27.9 ± 4.3             24.2 ± 2.5**  
LT1 (km·h-1)  4.7 ± 0.5      5.5 ± 0.6**  
LT2 (km·h-1)  6.3 ± 0.4      7.8 ± 0.9**  
Steps      10682.1 ± 3402.0    13837.7 ± 4074.3**  
Sedentary +1 (min·day-1)     503.2  ± 103.7        449.9 ± 96.7*   
Sedentary +10 (min·day-1)    426.0 ± 121.7       363.4 ± 104.7*   
Activity intensity level (min·day-1)          Relative Absolute Relative Absolute 
Low-light 342.6 ± 86.2 297.6 ± 69.5†† 402.9 ± 78.8≠ 311.5 ± 65.9†† 
High-light 75.8  ± 34.0 99.1 ± 39.5†† 73.9 ± 27.6 112.7 ± 32.5†† 
Low-mod 20.6  ± 16.5 41.8 ± 19.5†† 25.2 ± 26.7 47.9 ± 18.9†† 
High-mod 7.5  ± 11.4 13.2 ± 18.5† 6.2 ± 8.3 31.1 ± 24.2*†† 
Vigorous 3.3  ± 7.8 0.7 ± 1.5†† 2.3 ± 5.2 6.0 ± 8.9*†† 
MVPA+1 31.4  ± 24.7 55.6 ± 28.0†† 33.7 ± 28.5 85.0 ± 32.9*†† 
MVPA+10 18.8  ± 21.2 31.1 ± 24.2†† 21.6 ± 25.9 51.8 ± 31.4*†† 
Meeting PA guidelines (%)       32.4   62.2†† 39.5  81.6† 
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the time spent at MVPA was significantly reduced by 60% in high-fit and by 40% in low-fit 
groups, showing no difference in the time spent at MVPA between groups.  
Fixed or individually tailored cut-points. The role of cardiorespiratory fitness 
The selection of appropriate accelerometer cut-points to demarcate PA intensity levels is the 
cornerstone to obtain reliable PA outcomes and their association with health markers and 
mortality 111. LT represent individual physiologic adaptations in the use of energy pathways, 
and they are accurate indicators of relative exercise intensity 78. The average activity counts at 
LT1 were 4133 ± 1152 ct·min-1, showing a substantial interindividual variability (~2000‒10000 
ct·min-1) due to the large range in LT1 (3.6-7.3 km·h-1). This value is 54% and 29% higher than 
previously reported values of 2690 102 and 3208 ct·min-1 103for the lower boundary of moderate 
intensity (3 METs), respectively. These differences could be related to the higher energy 
expenditure value estimated at LT1 (3.7 ± 0.7 METs) 156 compared to the classic 3 METs 
threshold. Besides, the above mentioned studies 102,103 obtained 4000 ct·min-1 at 4.8 km·h-1, 
which is closer to the value of 3869 ct·min-1 found in our study at the same speed, suggesting 
that the 3 METs classic boundary falls below the LT1, and thus is not representative of the lower 
relative moderate intensity boundary in our group of postmenopausal women.  
The activity counts measured at LT2 (6783 ± 2077 ct·min-1) were 9% higher and 21% 
lower than those reported by Sasaki et al. (2011) and by Santos Lozano et al. (2013), 
respectively, at the upper classic boundary of moderate intensity (6 METs). These two studies 
used an incremental treadmill protocol with only 2-4 stages to derive activity counts cut-points 
at 3 and 6 METs. In contrast, our IST provided a minimum of seven data points from all 
participants, with small speed increments (0.6 km·h-1). Besides, we directly determined the 
activity counts at LT1 and we used individual, rather than whole-group regression equations 
to determine the activity counts at LT2. Our results go hand-in-hand with the findings of 
Ozemek and colleagues (2013) showing that CRF (i.e., LT2 velocity) (R2 = 0.35‒0.56), rather than 
age or body mass index (R2 <0.03) influenced individual´s activity count cut-points at relative 
intensities (Figure 18). These findings are evidence that individually tailored cut-points may 
better represent intensity-specific PA levels. 
Implications in the measurement of physical activity 
Large variations exist in the volume of objectively monitored MVPA across different countries 
and studies, and, therefore, in the percentage of adults meeting current PA recommendations 
113-116. These differences could be explained in part by the non-harmonized data collection, and 
the use of different activity monitors and intensity cut-points between studies 105. In our study, 
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using the absolute intensity approach, daily time spent at MVPA+10 was 42 min·day-1 or 294 
min·week-1, and 72% of the study participants met the MVPA target. These values are higher 
than the 8 min·day-1 113 or the 21 min·day-1 115 reported by US and Canadian women, 
corresponding to 7% and 15% of American and Canadian women meeting PA guidelines, 
respectively. The high number of daily steps (~12300) also confirms that our sample was more 
active than the vast majority of women in previous studies 113,113,115. This finding is supported 
by the results of the IPEN study 114, where, among the 17 city-regions, the participants from 
Pamplona (Spain) recorded the highest levels of MVPA (51 min·day-1 in 1-min bouts). Our 
findings strongly suggest that CRF, rather that BMI has a stronger relationship with both, MVPA 
and daily steps (p <0.01, r = 0.49 and 0.53 vs. r = -0.24 and -0.28, respectively), without being 
affected after adjusting for BMI or age. An important finding of our study was that MVPA was 
significantly reduced (p <0.01) by half (40% in low-fit and 60% in high-fit) when the cut-points 
were individually-tailored. Thus, the data confirmed that the use of fixed absolute intensity 
cut-points derived from 3 and 6 MET intensities overestimated MVPA. 
Another important finding of this study was that although the high-fit group was ~1h 
less sedentary, recorded ~3000 more daily steps and twice as much time at absolute MVPA 
compared to the low-fit group, these differences disappeared when PA levels were analysed 
according to their relative intensity cut-points, and both groups recorded similar time at MVPA 
(~20 min·day-1 in 10-min bouts). Our results are in line with a large-scale Finish study 116 who 
found that using HR-based absolute intensity thresholds men recorded twice as much MVPA 
than women (~45 vs ~22 min·day-1 in 1-min bouts). However, using relative intensity 
thresholds, MVPA was reduced by half (~17 min·day-1) without differences between them. 
Overall, this information is evidence that using fixed accelerometer activity cut-points derived 
from the recommended 3-6 METs moderate PA intensity approach may not be the most 
accurate option when examining PA behavior in samples varying in CRF. 
Strengths and limitations of the study 
This is the first study measuring accelerometer-based PA using individually tailored cut-points 
corresponding to LT. Despite the methodological shortcomings of accelerometers-based 
measures in PA surveillance 158, the proposed method in this study avoids the misinterpretation 
of intensity-specific PA levels when using fixed activity cut-points in individuals or groups 
varying in CRF. However, the current study is not without limitations. First, the applicability of 
this individualized approach is not feasible for large epidemiological studies, although they 
could benefit from population-specific relative intensity cut-points to obtain more reliable PA 
outcomes. Second, the generalizability of these findings is limited to postmenopausal women, 
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who are worthy of distinct attention due to the increased risk of cardiovascular disease 117 and 
osteoporosis 159. Third, our study was a cross-sectional study. Although higher relative intensity 
of daily activities has been associated with reduced CHD mortality 32, randomized controlled 
trials are needed to confirm whether PA recommended by guidelines applying relative 
intensity thresholds brings greater long-term health benefits compared to absolute intensity. 
Fourth, accelerometers do not capture accurate energy expenditure of certain activities (e.g., 
cycling, swimming, weight training, and some complex low-intensity activities) 106. Besides, 
habitual PA could be much more variable than constant velocity exercise tests used to 
demarcate PA intensity categories, in a way that makes the same ct·min-1 more intense (e.g., 
uphill, involving arm movement or resistance). Nonetheless, LT are the gold standard markers 
of relative exercise intensity, and the present focus on walking exercise tests is appropriate, 
because it is the most common type of activity among adults 11. 
Conclusions 
 
This study demonstrated that applying recommended absolute moderate intensity criteria of 
3-6 METs to accelerometer activity counts cut-points overestimated the time spent at MVPA. 
Compared to low-fit individuals, it was easier for high-fit individuals to reach MVPA target 
according to absolute criteria. However, no differences were observed in the time spent at 
MVPA between high- and low-fit postmenopausal women when the intensity cut-points were 
individually tailored to their lactate thresholds velocities. Our findings suggest that 
individually-tailored accelerometer cut-points may provide a more representative PA profile 
of individuals differing in CRF, compared to the widely used absolute intensity cut-points. 
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Abstract 
 
Purpose: This study aimed to estimate the maximal lactate steady-state velocity (vMLSS) from 
non-invasive bloodless variables and/or BLRTs measured during an IST, and to determine 
whether the addition of a CVT could improve the estimation. Methods: Seventy-five 
postmenopausal women conducted the IST to determine several BLRTs and bloodless variables, 
and two to seven CVTs to determine vMLSS. Determined BLRTs were conventionally used LT 
measured either visually (vLT+0.1mM) or mathematically (vLEmin), and 0.5, 1 and 1.5 mmol·L-1 above 
LT, along with fixed BLRTs. Results: The best single predictor of vMLSS (7.1 ± 1.0 km·h-1) was 
vLEmin+1.5mM (R2 = 0.80, p <0.001; SEE = 0.46 km·h-1). The combination of BLRTs and bloodless 
variables improved the estimation of vMLSS (R2 = 0.85, p <0.001; SEE = 0.38 km·h-1). The 
addition of a CVT still improved the prediction of vMLSS up to 89.2%, with lower SEE (0.32 km·h-
1). Conclusion: This study suggests that vLEmin-related thresholds obtained from a single 
submaximal IST are accurate estimates of vMLSS in postmenopausal women, and thus the time-
consuming procedure of vMLSS testing could be avoided. Performing an additional CVT is 
encouraged because it improves the prediction of vMLSS.  
 
Keywords: Cardiorespiratory fitness, blood lactate-related thresholds; exercise testing; 
intensity prescription. 
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Introduction 
 
Epidemiological studies have shown an inverse association between CRF and the incidence of 
CHD or all-cause mortality in healthy or asymptomatic men and women 1. The most widely 
accepted index of CRF is V̇O2max expressed in mL O2·kg-1·min-1or in METs 2. It is acknowledged 
that the minimum level associated with significantly lower event rates for men and women is 
approximately 8 and 6 METs (at 50 years), and 7 and 5 METs (at 60 years), respectively 1,2. 
However, the measurement of V̇O2max requires maximal exercise testing, which is very often not 
accesible nor possible in middle-aged people due to motivational or financial reasons 22. An 
easier, non-dependent on motivation and widely accepted approach to evaluate CRF is the 
analysis of BLC plotted against exercise intensity or duration during submaximal exercise. 
More than 20 BLRTs have been defined so far, leading to considerable confusion and 
misinterpretation 75. However, two of these thresholds have emerged as the preferred 
endurance performance markers among the vast majority of sport and exercise physiologists: 
1) The so-called “Lactate Threshold” (LT) defined as the critical exercise intensity level above 
which BLC first begin to increase above resting values during incremental exercise 151. The LT 
has been suggested as the minimum exercise intensity required by inactive individuals to 
improve CRF 70-72 and is a valid indicator of CRF in athletes and inactive people due to its high 
association with V̇O2max, sports performance 72,74,75,153 and functional capacity in patients 69, and 
2) the so-called “Maximal Lactate Steady State” (MLSS), defined as the highest constant 
workload that can be sustained over time without continual blood lactate accumulation 74. 
Both LT and MLSS are more sensitive than V̇O2max to predict endurance performance and to 
evaluate training adaptations 83, allowing the definition of three individual intensity categories 
to guide exercise training: light (<LT), moderate (LT-MLSS) and vigorous (>MLSS) 75. While LT 
can be determined in a single graded submaximal test, the assessment of MLSS is, however, 
cumbersome, since it requires several (3-6) constant workload tests on separate days, 
lengthening the aerobic conditioning evaluation to a minimum of 1-3 weeks 74. For this reason, 
simpler methods have been proposed to estimate MLSS intensity from a single incremental 
test, involving the use of either blood lactate 74,75,85-87, respiratory 67,89, or the maximum 
workload achieved during an exercise test to exhaustion 72,90, resulting in a wide range of 
correlations (r = 0.63-0.95) with MLSS. However, all existing single session MLSS-estimating 
tests are variably handicapped by compromised validity, accuracy, resolution, and reliability 
due to methodological differences and a suboptimal statistical approach (i.e., correlation 
analysis) leading to incomparable and inconclusive results 75,85,91. Most of these studies have 
been conducted in small groups of athletes using exercise tests to volitional fatigue, but little 
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is known about the prediction of MLSS from BLRTs using submaximal tests in adults. The 
inactivity, along with the lower CRF observed in women 155, and the increased risk of 
cardiovascular disease 117 and osteoporosis 16 after menopause and with advancing age, 
underline the necessity of well-designed and adequately powered (i.e., intensity) PA programs 
for postmenopausal women. 
To avoid the extensive procedure needed to assess MLSS velocity (vMLSS), we aimed to 
elucidate whether vMLSS could be accurately predicted from lactate-related and/or bloodless 
variables measured during an IST in 50-75 years old postmenopausal women. A secondary 
purpose of the study was to determine the extent to which a single CVT, performed several 
days after the IST, could improve the prediction of vMLSS. Based on a previous study performed 
with endurance-trained athletes 161, we hypothesized that BLRTs that rely on the individual 
lactate curve would be accurate predictors of vMLSS, showing stronger agreement compared 
to bloodless variables. We expected that an additional CVT performed on subsequent days 
would improve the estimation of vMLSS. 
Methods 
 
Study participants 
Participants were recruited through advertisements placed on healthcare centres. One hundred 
and four participants were screened by telephone, 88 were deemed eligible and were invited 
to participate in the study. Inclusion criteria were: 1) surgical or natural menopause (no 
menstrual periods during the previous 12 months), 2) age <75 years. Participants were 
excluded from the study if they had any of the following conditions that might interfere with 
exercise testing: 1) presence of spine or low-trauma fractures or severe arthrosis at the hip, 
knees or feet, 2) functional limitation to walk for 20 minutes, 3) presence of any known chronic 
disease that would impair the cardiorespiratory system during testing. The local hospital´s 
ethical committee for human studies approved the study (Pyto2011/71) and written informed 
consent was obtained from all participants before any study procedures were undertaken. The 
procedure of the study was in accordance with the Declaration of Helsinki and was registered 
in ClinicalTrials.gov PRS (NCT02984553). 
Incremental shuttle test (IST) 
Prior to the first visit, participants were instructed to abstain from caffeine and stimulants for 
at least four hours and strenuous activity for ≥24 h before testing. Height was measured using 
a wall stadiometer (Seca, Germany) and body mass was measured using a scale to the nearest 
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0.1kg (Seca, Germany). Testing was performed in a laboratory setting in a controlled 
temperature environment (~20º) over a 20 m indoor track 152. The distance of the course was 
extended to 20 m from the original test to keep the pace constant avoiding excessive turns 
that might increase the energy cost and musculoskeletal demand, potentially leading to 
premature fatigue, pain, discomfort or even injury. Five cones were positioned at 0.5–5–10–15 
and 19.5 m and participants had to walk in a straight line until the last cone, then turn around 
and return to the start. The speed at which the participant walked was dictated by an audio 
signal pre-recorded in MP3 audio format. The IST started at 2.4 km·h-1. The velocity was 
increased by 0.61 km·h-1 every 2-min 152, with 1-min intervals between stages. Each participant 
was free to start running from the 7th stage onwards (6.1 km·h-1), or the operator suggested to 
do so when the participant was not able to match the required speed. Immediately after each 
stage, heart rate (HR) (Polar V800, Polar Electro Oy, Kempele, Finland), a rating of perceived 
effort in Borg´s 0-10 scale 154 and capillary blood samples for blood lactate measurements were 
obtained from a hyperemic earlobe. The test was stopped when: 1) BLC values were ≥3.0 
mmol·L-1 to avoid excessive fatigue, and/or 2) participant repeatedly failed to match the pace 
programmed, and/or 3) participant was exhausted. 
Constant-velocity tests (CVT) 
On subsequent laboratory visits, participants completed two to seven 20 min CVTs on the same 
20 m track used for the IST. Each participant performed the corresponding tests on separate 
testing days (one week in between). Each CVT consisted of two stages of 10 min at a constant 
pace with 2 min interruption for blood sampling (i.e., 22 min duration). Heart rate was 
continuously recorded, and capillary blood samples were obtained at rest, at the 10th min and 
the end of exercise (22nd min). Walking or running velocity of the first CVT was programmed as 
the velocity at which blood lactate increased by one mmol·L-1 above LT during the IST. 
Depending on the BLC stability of the first CVT, the velocity was increased or decreased by 
~0.30 km·h-1 in the following CVTs. If during the first CVT a steady state or a decrease in BLC 
was found, the velocity for the next CVT was increased by 0.3 km·h-1. Conversely, if an increase 
in BLC superior to the stability criterion was observed, the speed of the following CVT was 
decreased by 0.3 km·h-1 until the vMLSS was determined. The highest constant velocity with an 
increase in BLC ≤0.4 mmol·L-1 during the final 10 min of exercise was defined as the vMLSS 
74,153,153 (Figure 20).  
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Blood Sampling and Blood Lactate Concentration (BLC) determination 
A hyperaemic earlobe was cleaned and dried before puncturing by a lancet device to aspirate 
a 0,3 μL whole blood sample into an enzyme-coated electrode test strip. Blood lactate 
concentration was determined via amperometric measurement using a portable analyzer 
(Arkray KDK Corporation, Lactate Pro2 LT-1710, Shiga, Japan) calibrated before each test. The 
instrument has shown a good accuracy (R2 = 0.97; standard error of the estimates, SEE = 0.69 
mmol·L-1) and intra-assay reliability (coefficient of variation, CV = 2.9%; intraclass correlation 
coefficient, ICC = 0.999) at a wide range of BLC 162. 
Determination of Blood Lactate-related Thresholds (BLRT) 
Nine different BLRTs were determined (Figure 19A). The velocity at the LT (vLT+0.1mM) was 
defined as the highest stage-velocity above which BLC increased by ≥0.1 mmol·L-1 in the 
following stage and ≥0.2 mmol·L-1 in the subsequent stage. The velocities at 0.5 mmol·L-1, 1 
mmol·L-1, or 1.5 mmol·L-1 above vLT+0.1mM, were called vLT+0,5mM, vLT+1mM, and vLT+1.5mM, 
respectively. The velocity corresponding to the Minimum Lactate Equivalent (vLEmin) 34was 
considered the minimum value of the quotient BLC/velocity in the individual BLC/velocity vs. 
velocity second-order polynomial curves (Figure 19B). The velocities at 1.0 and 1.5 mmol·L-1 
above the vLEmin in the individual BLC vs. velocity second-order polynomial curves where called 
vLEmin+1mM and vLEmin+1.5mM, respectively. The velocity at a fixed blood lactate concentration of 
2.5 mmol·L-1 163 (vFBLC2.5mM) was determined from the individual BLC vs. velocity second-order 
polynomial curves. The lowest velocity at which BLC was ≥3 mmol·L-1 was defined as V≥3mM. 
Besides, the average magnitude of the differences in BLC between successive velocities [[(BLC 
4.9-4.3) + (BLC 5.5-4.9) + (BLC 6.1-5.5) + (BLC 6.7-6.1)] / 4] during the IST was tested as an 
independent predictor (∆BLC). 
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Figure 19. Mean velocity vs. blood lactate/heart rate curve during the submaximal 
Incremental Shuttle Test (IST) in the whole group of participants and selected BLRTs (n 
= 75). Schematic representation of A) average BLRTs values and B) determination of 
vLEmin by modeling the quotient BLC/velocity in the individual BLC/velocity vs. velocity 
second-order polynomial curve. vLEmin = velocity at the minimum lactate equivalent 
(km·h-1), vLT+0.1mM = highest stage-velocity above which BLC increased by ≥0.1 mmol·L-
1 in the following stage and ≥0.2 mmol·L-1 in the subsequent stage, vLT+0.5mM, vLT+1mM, 
vLEmin+1.5mM = velocity at the lactate threshold + 0.5, 1 and 1.5 mmol·L-1  (km·h-1), 
vLEmin+1mM, vLEmin+1.5mM = velocity at the minimum lactate equivalent + 1 and 1.5 mmol·L-
1 (km·h-1), vFBLC2.5mM = velocity at the fixed blood lactate concentration at 2.5 mmol·L-1 
(km·h-1), vMLSS = velocity at the maximal lactate steady-state (km·h-1), V≥3mM  = the 
lowest velocity of the IST where the blood lactate value was ≥ 3 mmol·L-1, ∆BLC = mean 
differences in blood lactate between successive stages (from 4.3 to 6.7 km·h-1), ∆HR = 
mean differences in heart rate between successive stages (from 4.3 to 6.7 km·h-1). * 
significantly different (p <0.01) from the previous stage. 
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Velocities at BLRTs were determined using MATLAB R2015a (The MathWorks Inc., Natick, MA, 
USA). Coefficients of determination (R2) of the individual second-order BLC vs. velocity, and 
second-order quotient BLC/velocity vs. velocity polynomial curves were all >0.90. Velocities at 
BLRTs 72, as well as vMLSS 64 frequently show test-retest intra-class correlation coefficients >0.94, 
and coefficients of variation ≤3%. Heart rate values at BLRTs were computed from the individual 
HR vs. velocity second order polynomial equations (r >0.98; p <0.001) obtained during the IST. 
Bloodless variables 
Participant´s age, anthropometric characteristics [body mass, height, and body mass index, 
(BMI)] and the following HR and perceived exertion 154 related variables were obtained from 
the IST: minimum resting HR (HRrest) in a supine position for 10min, average magnitude of the 
differences in HR (∆HR) between successive velocities during the IST [[(HR 4.9-4.3) + (HR 5.5-
4.9) + (HR 6.1-5.5) + (HR 6.7-6.1)], the velocity associated with the minimum value of the 
quotient HR/velocity obtained from the HR/velocity vs. velocity second-order polynomial curve 
(HRmin), and the velocity corresponding to a value of 4 (i.e., “something hard”) on Borg´s scale 
of perceived exertion (0-10) 154 obtained from the second-order polynomial curve between 
perceived exertion values and velocity (RPE4).  
Statistical analysis 
Standard statistical methods were used for the calculation of means, SD, SEE and CI. Data 
were analyzed using parametric statistics following confirmation of normality (Shapiro-Wilk 
test), homoscedasticity (Levene´s test), and when appropriate sphericity (Mauchly’s test). 
Repeated ANOVA measures with Bonferroni post-hoc test was used to compare BLC and HR 
at different velocities during the IST and at different time-points during the CVT.  
Student´s paired t-test was used to evaluate differences between each BLRT with 
vMLSS. The magnitudes of the differences were assessed with 95% CI and Cohen´s effect sizes 
(ES). Two-factorial ANOVA with Tukey´s post-hoc test was used to identify differences in BLC 
between CVTs. We studied the strength of the individual relationships between independent 
variables and vMLSS before fitting the models using Pearson product-moment correlation 
coefficients (r). Using vMLSS determination as the reference method, three different multiple 
regression models were assessed against it. After checking normality and homoscedasticity 
by paired plots, all significant variables were entered in a block to each model with the main 
independent variables of each model defined as: 1) Bloodless variables from a single IST, 2) 
BLRTs along with bloodless variables from a single IST and 3) Change in BLC from the 20th to 
the 10th minute (∆BLC20-10) during an additional CVT at vLT+1mM, in addition to BLRTs and 
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bloodless variables from the IST. Non-significant variables and those producing collinearity 
were excluded from the final model. Adjusted R2 was used to assess the proportion of the 
variance explained by the model. The validity of each predictive equation was investigated 
with the SEE and the 95% limits of agreement method (LoA, mean difference ± 1.96 SD) 164. 
A regression analysis between mean vMLSS and the difference in vMLSS between the 
estimated and the measured value was applied to explore whether the degree of systematic 
error is uniform over the range of values. The level of significance was set at p <0.05. 
Statistical analyses were performed using SPSS statistical software (version 22.0, IBM SPSS 
Statistics, Chicago, IL) and GraphPad Prism 7 was used for figures. 
Results 
 
Population selection and characteristics 
Among 104 interested participants who were screened for eligibility, 14 were excluded. 
Reasons for exclusion were; 1) not meeting eligibility criteria (n = 12), and 2) declined to 
participate (n = 2). Among the 88 participants who were invited to participate, 75 completed 
all assessments and had valid data for analysis (age = 59.0 ± 5.5 years old, BMI = 26.0 ± 3.9 
kg/m2). 
Submaximal Incremental Shuttle test  
Mean velocity vs. BLC curve during the IST in the whole group of participants (n = 75) is 
presented in Figure 19A. Blood lactate concentration started to increase from the fifth stage 
onwards (F8,568 = 137.5, p <0.001). Velocity at LEmin (4.8 ± 0.6 km·h-1) was 5.9% lower than 
vLT+0.1mM (p <0.001; 95%CI: 0.14 to 0.32; ES: 0.38) and both of them were 32% (p <0.001) and 
28% (p >0.001) lower than vMLSS, respectively (Table 10). Average vFBLC2.5mM (p = 0.984; 95%CI: 
-0.10 to 0.11; ES: 0.00) and vLT+1.5mM (p = 0.742; 95%CI: -0.13 to 0.09; ES: 0.02) did not differ 
from vMLSS whereas vLEmin+1.5mM was only 2.8% lower (p <0.01; 95%CI: -0.26 to -0.05; ES: 0.16) 
than vMLSS. Heart rate increased significantly (F9,639 = 1095.5, p <0.001) throughout the test. 
The HR values at vLEmin and vLT+0.1mM were 95 ± 11 bpm and 98 ± 12 bpm, respectively. When 
vMLSS determined from the CVT was set in the velocity vs. BLC or the velocity vs. HR curves 
obtained during the IST, the corresponding BLC and HR values were 2.4 ± 0.7 mmol·L-1 and 
141 ± 17 bpm, respectively. 
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Table 10. Descriptive features of BLRTs and their association with vMLSS (n = 75). 
BLRTs = blood lactate-related thresholds,  vLEmin = velocity at minimum lactate equivalent (km·h-1), vLT+0.1mM 
= highest stage-velocity above which blood lactate concentration increased by ≥ 0.1 mmol·L-1 in the 
following stage and ≥ 0.2 mmol·L-1 in the subsequent stage, vLT+0.5mM, vLT+1mM, vLT+1.5mM = velocity at lactate 
threshold + 0.5, 1 and 1.5 mmol·L-1 above vLT+0.1mM (km·h-1), vLEmin+1mM, vLEmin+1.5mM = velocity at the minimum 
lactate equivalent + 1 and 1.5 mmol·L-1 (km·h-1), vFBLC2.5mM = velocity at the fixed blood lactate at 2.5 mmol·L-
1 (km·h-1), vMLSS = velocity at maximal lactate steady-state (km·h-1). V≥3mM = the lowest velocity of the IST 
where the blood lactate value was ≥ 3 mmol·L-1, N/A = not applicable. 
a p <0.01 vs vMLSS. 
b p <0.001 vs vMLSS. 
 
Constant Velocity Tests (CVTs) 
Figure 20 shows the BLC during 3 CVTs at vLT+1mM, at vMLSS, and at 0.3 km·h-1 faster velocity 
than vMLSS (vMLSS+≤0.3). At vLT+1mM (6.7 ± 0.8 km·h-1), BLC increased from rest (1.2 ± 0.3 mmol·L-
1) to the 10th minute of exercise (2.8 ± 1.1 mmol·L-1) and remained constant (2.7 ± 1.1 mmol·l-
1) throughout exercise (p = 0.17; 95% CI: -0.3 to 0.0; ES: 0.10). However, at this velocity, 25% of 
the participants showed a blood lactate accumulation during exercise (increase in BLC ≥0.4 
km·h-1 during the last 10 min of exercise). Slightly higher (p <0.01; 95% CI: 0.3 to 1.0; ES: 0.58) 
BLC values were obtained at vMLSS (7.1 ± 1.0 km·h-1; range: 5.4-10.0 km·h-1), increasing from 
 
 
km·h-1 
 
%vMLSS 
Association 
with vMLSS 
Variables  Mean ± SD Range  Mean ± SD Range r 
vLEmin  4.8 ± 0.6 b 3.8 – 7.0  68.8 ± 5.5 57.3 –  80.7  0.833 b 
vLT+0.1mM  5.1 ± 0.7 b 3.6 – 7.3  72.1 ± 7.2 56.1 – 91.2 0.722 b 
vLT+0.5mM  6.2 ± 0.7 b 4.6 – 9.2  88.2 ± 8.0 68.6 – 101.7 0.746 b 
vLEmin+1mM  6.5 ± 0.8 b 5.0 – 9.5  91.7 ± 6.0 79.2 – 104.5 0.895 b 
vLT+1mM  6.7 ± 0.8 b 5.2 – 9.5  95.5 ± 7.3 77.4 – 110.8 0.839 b 
vLEmin+1.5mM  6.9 ± 0.9 a 5.3 – 10.4  98.2 ± 6.4 85.1 – 112.4 0.897 b 
vLT+1.5mM     7.0 ± 0.9 5.4 – 9.9  100.1 ± 6.5 83.4 – 114.6 0.890 b 
vFBLC2.5mM     7.1 ± 0.9 5.3 – 9.8    100.4 ± 6.5 87.6 – 114.5 0.896 b 
vMLSS     7.1 ± 1.0 5.4 – 10.0  100.0 ± N/A N/A N/A 
V≥3mM     7.6 ± 1.0 b 6.1 – 10.4    108.5 ± 6.5 89.9 – 125.2 0.869 b 
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1.2 ± 0.3 mmol·L-1 at rest to 3.3 ± 1.1 mmol·L-1 at the 10th minute of exercise, and remained 
constant throughout exercise. Average HR values during the CVT at vMLSS slightly increased 
from the 10th min (146 ± 13 bpm) to the end of exercise (151 ± 13 bpm) (p <0.01; 95% CI: 3.9 
to 5.6; ES: 0.03). At vMLSS+≤0.3, nine participants failed to finish the CVT, and in the remaining 
participants BLC increased as a function of time from 4.5 ± 1.8 mmol·L-1 at the 10th minute of 
exercise to 5.5 ± 2.0 mmol·L-1 at the end of exercise (p <0.01; 95% CI: 1.0 to 1.4; ES: 0.65). 
 
Figure 20. Evolution of blood lactate concentration during the constant velocity tests for the 
determination of vMLSS at vLT+1mM, vMLSS, and at 0.3 km·h-1 faster velocity than vMLSS (vMLSS+≤0.3). vMLSS 
= velocity at the maximal lactate steady-state (km·h-1), vLT+1mM = velocity at the lactate threshold + 1 
mmol·L-1 (km·h-1), vMLSS+≤0.3 = constant velocity test performed ≤0.3 km·h-1 faster velocity than vMLSS. * 
significantly different (p <0.01) from vMLSS and vLT+1mM., # significantly different from vMLSS, † significant 
effect for time on BLC (min 10 vs min 22). 
 
Prediction of vMLSS  
Every BLRT correlated significantly with vMLSS (p <0.001, r = 0.72-0.90) (Table 10). Velocity at 
LEmin+1.5mM was the best single predictor of vMLSS (R2 = 0.801, p <0.001; SEE = 0.456; 95% LoA 
= -0.90 to 0.89) (Figure 21), closely followed by vFBLC2.5mM and vLEmin+1mM (R2 = 0.799, p <0.001; 
SEE = 0.461; 95% LoA = -0.90 to 0.90), and vLT+1.5mM (R2 = 0.789, p <0.001; SEE = 0.467; 95% 
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LoA = -0.91 to 0.92), indicating that the prediction of vMLSS from these four single BLRTs could 
be biased up to ~13% above or below the actual vMLSS. 
 
Figure 21. Linear regression between the best single predictor of vMLSS (vLEmin+1.5mM) and 
vMLSS. vLEmin+1.5mM = minimum lactate equivalent + 1.5 mmol·l-1 (km·h-1), vMLSS = velocity at 
the maximal lactate steady-state (km·h-1). Solid line: linear regression. Dashed lines: 95% 
confidence intervals. 
 
After checking individual associations between BLRTs, bloodless and anthropometric 
variables, we created three multiple regression models to predict vMLSS. In the first model, we 
tested the accuracy of bloodless variables obtained during the IST for predicting vMLSS (Table 
11, model 1). The key determinants identified for the prediction of vMLSS were; ∆FC, age, 
resting HR in supine position (HRrest), and body mass (kg), accounting for 59% of the the 
variance, with a large SEE (0.64 km·h-1; 9% of the mean vMLSS). The regression equation for the 
sample (n = 70) was:  
vMLSS´ = 16.574 – (0.078 · ∆FC) – (0.075 · age) – (0.036 · HRrest) – (0.027 · Body mass) 
(eq. 1) 
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Table 11. Prediction of vMLSS from BLRTs and bloodless models from a single IST and an additional CVT (n = 75) 
Model Predictors B SE(B) β t Adjusted R2 Sig. (p) 
1 
Bloodless 
∆HR 
Age 
HRrest 
Body mass 
-0.078 
-0.075 
-0.036 
-0.027 
0.016 
0.015 
0.009 
0.008 
-0.374 
-0.398 
-0.318 
-0.285 
-4.723 
-4.959 
-3.963 
-3.563 
0.588 <0.001 
2 
BLRT & 
Bloodless 
vLEmin+1mM  
Age 
HRLEmin+1mM 
Body mass 
1.085 
-0.040 
-0.012 
-0.012 
0.072 
0.009 
0.004 
0.005 
0.837 
-0.211 
-0.137 
-0.125 
15.001 
-4.338 
-2.703 
-2.593 
0.853 <0.001 
3 
BLRT & 
Blodless + 
CVT  
vLEmin+1mM 
∆BLC20-10 
Age 
Body mass 
HRLT+1mM 16-20 
1.120 
-0.304 
-0.021 
-0.012 
-0.010 
0.063 
0.083 
0.009 
0.004 
0.003 
0.864 
-0.162 
-0.114 
-0.120 
-0.154 
17.757 
-3.652 
-2.460 
-2.775 
-3.555 
0.892 <0.001 
vMLSS = velocity at maximal lactate steady-state, BLRT = Blood lactate-related thresholds, IST = incremental submaximal 
shuttle test, CVT = constant velocity test, ∆HR = average magnitude of the differences heart rate between successive velocities 
during IST, HRrest = resting HR supine position, vLEmin+1mM = velocity at the minimum lactate equivalent + 1 mmol·L-1 (km·h-1), 
HRLEmin+1mM = HR at vLEmin+1mM, ∆BLC20-10 = Change in blood lactate from the 20th to the 10th of the CVT at Lactate Threshold+1mM  
velocity, HRLT+1.5mM 16-20 = average HR of the last 5min (min16-20) of the CVT at LT+1mM  velocity. 
 
The Bland-Altman method between predicted and the actual vMLSS against their mean 
for eq.1 showed small bias but wide LoA [-0.00 (1.24) km·h-1] (Figure 22A). The gradient of the 
regression line was significantly different from zero (p <0.01) indicating a higher bias in fitter 
individuals. 
In the second model, a combination of single BLRTs and bloodless variables from the 
IST were entered to a multiple regression (Table 11, model 2). The best model revealed that 
the velocity and HR at LEmin+1mM, age, and body mass accounted for 85.3% of the variation in 
vMLSS, with a lower SEE (0.38 km·h-1; 5.4% of mean vMLSS). The regression equation for the 
sample (n = 75) was as follows: 
vMLSS´ = 4.630 + (1.085 · vLEmin+1mM) – (0.04 · age) – (0.012 · Body mass) – (0.012 · 
HRLEmin+1mM) (eq. 2) 
The Bland-Altman method between the predicted and the actual vMLSS against their 
mean for eq. 2 showed strong agreement and narrow individual LoA [Bias (95% CI)] [0.08 (0.76) 
km·h-1] (Figure 22B). The deviation of the regression line was not significantly different from 
zero (p = 0.087). 
The prediction of vMLSS still improved with an additional CVT performed one week after 
the IST at a velocity corresponding to 1 mmol·L-1 above the vLT+0.1mM, accounting for 89.2% of 
the variation in vMLSS (p <0.001), with a low SEE (0.32 km·h-1; 4.5% of mean vMLSS). The 
determinants identified for the prediction of vMLSS were vLEmin+1mM, the difference in BLC 
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measured between the 20th and 10th minute of exercise during the CVT at vLT+1mM (∆BLC20-10), 
age, body mass (kg), and the average absolute HR during the last 5 min of the CVT at vLT+1mM 
(HRLT+1.5mM 16-20) (Table 11, model 3). The regression equation for the sample (n = 69) was: 
vMLSS´ = 3.262 + (1.120 · vLEmin+1mM) – (0.304 ·∆BLC 20-10) – (0.021 · age) – (0.012· body 
mass) – (0.010· HRLT+1mM 16-20) (eq. 3) 
The Bland-Altman method between the predicted and the actual vMLSS against their 
mean for eq. 3 showed a small bias, and the narrower LoA [0.06 (0.63) km·h-1] (Figure 22C). 
The gradient of the regression line did not deviate from zero (p = 0.30). 
Discussion 
 
The main finding of this study was that vLEmin+1.5mM determined from a single IST was the 
strongest single predictor of vMLSS, closely followed by vFBLC2.5mM, vLEmin+1mM, and vLT+1.5mM and 
the rest of the predictor variables (Table 10) in a large sample of postmenopausal women. The 
prediction of vMLSS was improved when the velocity and HR at vLEmin+1mM along with age and 
body mass were entered in a multiple regression model. The addition of a CVT performed one 
week after the initial IST still improved the explained variance of vMLSS.  
  The first exponential increase in BLC during incremental exercise (i.e., vLT) and the highest 
constant workload where the participant is still able to maintain steady blood lactate 
concentrations (i.e., vMLSS) during prolonged exercise are particularly relevant BLRTs, due to its 
practicability to transfer these lower and upper limits of effective but still safe exercise 
intensities into guidelines for individualized training 78. On average, vLT (vLT+0.1mM) and vMLSS 
of our study participants were 5.1 km·h-1 and 7.1 km·h-1, respectively. This vLT value is 11% 
higher than that reported in diabetic 50-years old women 165 and 21% lower than untrained 
younger women (~32 years old) using a similar protocol 72. These two physiologic breakpoints 
may serve as a basis for exercise intensity prescription as well as to evaluate the effects of 
exercise training without the need to expose individuals to volitional fatigue 75. However, it is 
not feasible, because of the number of trials necessary to directly determine the vMLSS. 
Consequently, numerous authors have sought easier and less time-consuming exercise tests 
to identify lactate-related or ventilatory thresholds as a surrogate of vMLSS 75,90,166-168. 
Nevertheless, most of these studies have focused on athletic population, and little is known 
about the prediction of vMLSS in adults, and even less in postmenopausal women. 
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Figure 22. Bland-Altman plots of agreement between measured 
and predicted vMLSS from A) bloodless variables obtained in the 
IST, B) Bloodless and BLRTs obtained in the IST, C) the addition of 
variables obtained in the CVT at vLT+1mM. vMLSS = velocity at the 
maximal lactate steady-state (km·h-1), IST = Incremental Shuttle 
test, BLRT = Blood Lactate-related thresholds, CVT = Constant 
Velocity Test. Dotted bold line represent mean Bias and upper and 
lower dotted lines represent the 95% limits of agreement. The thick 
black line represents the slope of the association.  
 
The magnitudes of the association between vLT (measured either visually as vLT+0.1mM or 
using a polynomic equation as vLEmin) and vMLSS in our sample (r = 0.72 and r = 0.83, 
respectively) are similar to those reported between LT and MLSS in cyclists (r = 0.71-0.76) 166,167, 
and lower to those reported in college students (r = 0.95) 71 and in a previous study conducted 
in our laboratory with endurance runners (r = 0.86) 161. Exercise intensities above vLT that rely 
on the individual lactate curve presented higher associations with vMLSS. The vLEmin+1.5mM was 
the best single predictor of vMLSS accounting for 80% of its variance (SEE = 6.5% and LoA = 
12.6% of mean vMLSS), closely followed by vFBLC2.5mM, vLEmin+1mM, and vLT+1.5mM. These findings 
agree with previous research performed in young recreational or endurance-trained athletes 
showing that BLRTs, such as vLEmin and vLEmin+1.5mM 161, OBLA 84,169, IAT 84, Dmax 169,  LT 83, or other 
BLRTs 170 obtained during a single incremental exercise test are significant determinants of 
vMLSS. 
Non-invasive low cost and easy-to-administer exercise test protocols have traditionally 
been of general interest to the sport and fitness community. However, our results suggest that 
the prediction of vMLSS by submaximal bloodless variables in postmenopausal women lacks 
of accuracy and is, therefore, not recommended because the explained variance was low (R2 = 
59%) (Table 11), and it could be biased up to 17% above or below actual vMLSS in some 
individual cases (Figure 22A). In the absence of blood lactate, García-Tabar and colleagues 163 
found that the velocity corresponding to the 90% of HRmax (V90) is a more accurate bloodless 
predictor of vMLSS (R2 = 64%; 90% LoA: 9.5% of vMLSS). However, the maximal effort required 
to assess V90 is not practical for non-clinicians in sedentary and diseased people. 
The prediction of vMLSS improved when several bloodless variables (age and body 
mass) along with the velocity and HR at LEmin+1mM were entered into the same model, explaining 
up to 85.3% of its variance (Table 11). This value is among the highest reported in the literature 
(55-88%) 75,90,161,166-168. Differences such as homogeneity of the sample, number of participants 
involved, test protocol characteristics and specificity, precision and stability criterion in the 
vMLSS determination, determination of BLRTs and other variables, as well as age and training 
113 
 
status of the participants of each study might explain these discrepancies. For instance, the 
sample size of this study was larger and showed similar heterogeneity in vMLSS (CV = 15%) 
compared to the studies mentioned above (CV = 7-17%). Probably, the higher accuracy in 
vMLSS determination (± 0.3 km·h-1; ± 4.5% of mean vMLSS) compared to most of previous 
research in the field (3-10% of the mean), and the low-velocity increments of the IST for blood 
sampling (0.61 km·h-1 or 8.5% of vMLSS) could have positively contributed to the estimation of 
vMLSS. The prediction of vMLSS resulted in a low SEE (0.38 km·h-1), which corresponds to 5.4 % 
of the mean vMLSS. (Equation 2). The 95% LoA (± 0.76 km·h-1; i.e., ± 10.7 % mean vMLSS) are 
similar or lower to the values reported in the literature from maximal exercise trials (≈6% of 
the mean vMLSS) 86,86,90, BLRTs (5.9-23.5% of the mean vMLSS) 75,161,167,170, or ventilatory 
thresholds (9-22 % of the mean) 89,168 in cyclists 75,167,170, runners 75,86,89, and soccer players 90. 
The reason why LEmin-related variables would offer significant prediction advantages 
over other BLRTs to estimate vMLSS can be related to: 1) the resolution of vLEmin determination 
that is finer than other BLRTs (e.g., vLT+0.1mM) because all the data points before and after the 
transition are used to project the LEmin value (Figure 19B); 2) the vLEmin could essentially take 
on an infinite number of values, whereas vLT+0.1mM and vLT+0,5mM  determination, for example, 
could only be based on the discrete values of the specific velocity-rate stages; 3) the 
troublesome identification of the first BLC elevation above baseline values due to initial BLC 
fluctuations associated with the error of the analyzer 72; and 4) as opposed to FBLC, vLEmin-
related variables (e.g., vLEmin+1.5mM) do not seem to be influenced by pre-test intramuscular 
glycogen stores and BLC values 85 or by exercise patterns 171. This fluctuation is solved by the 
“U”-shape BLC curve, for the identification of vLEmin.  
The second purpose of this study was to investigate whether the prediction accuracy 
of vMLSS could still improve by the addition of a CVT at vLT+1mM, one week after the IST. The 
results showed that BLC and HR values observed between the 10th and 20th min of the CVT, 
along with age, body mass and vLEmin+1mM obtained during the IST, improved the explained 
variance up to 89.2%, with narrower SEE (0.32 km·h-1 or 4.5% of the mean vMLSS) and 95% LoA 
(0.63 km·h-1; 8.9% of the mean vMLSS). These results are in agreement with previous studies 
performed with soccer players 90 and endurance-trained runners 172 in our laboratory. It is, 
therefore, suggested to perform an additional CVT whenever possible. 
This study presents some important strengths such as the large sample size, the 
accurate estimation of vMLSS, and the utilization of a single test of submaximal nature, or the 
addition of a CVT to improve the accuracy of the estimation. However, the present 
investigation is not without limitations. First, the generalizability of the results is limited to 50-
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75 years old women with vMLSS values ranging from 5.4 to 10 km·h-1. Second, the reported 
prediction equations are only recommended to be used with the specific testing procedures 
described in this study. Third, a test-retest analysis of vLEmin was beyond the scope of this study, 
and therefore, whether vLEmin is reliable was not verified. Dickhuth et al. 173, however, found a 
good test-retest reproducibility (r = 0.90) of vLEmin in young males. Finally, this study is a cross-
sectional study. Further longitudinal studies are required to examine whether longitudinal 
training-induced changes in vMLSS could be predicted and monitored by vLEmin-related 
variables.  
Conclusions 
 
The results of the present study indicate that when BLC assessment is available but only one 
testing session is feasible, vLEmin-related variables obtained from an incremental submaximal 
test are accurate estimates of vMLSS. The use of only bloodless variables to estimate vMLSS is 
not recommended, due to its low accuracy. Performing an additional CVT one week after the 
incremental test is encouraged because it improves the prediction of vMLSS. We, therefore, 
recommended the IST as a simple non-exhaustive and time-efficient alternative to the classical 
determination of vMLSS or maximal exercise tests for non-athletic population.  
  
115 
 
8 
Conclusions & 
Perspectives 
 
Measuring CRF and reliable PA levels is the cornerstone; 1) to evaluate whether an individual 
is within the evidence-based minimum scores associated with health benefits and reductions 
in the risk of chronic disease and all-cause mortality, and 2) to design an individualized PA or 
exercise intervention. 
In this doctoral thesis we showed that when exercise testing is not feasible and intensity 
prescription is based on estimated V̇O2max or HRmax values, applying currently recommended 
absolute and relative exercise intensity targets for adults by the ACSM could overstress CS, 
who present a much lower CRF and maximum cardiac response compared to healthy adults. 
This drawback can be solved by prescribing exercise intensity or designing/delivering exercise 
interventions according to submaximal physiologic breakpoints such as, ventilatory or lactate 
thresholds from submaximal exercise tests. This procedure guarantees the safety and the 
adequacy of the exercise dose administered to each patient and might maximize the 
therapeutic benefits. In the absence of exercise testing equipment, we offer an adapted 
exercise intensity guideline for CS that can guide clinicians, exercise physiologists and the 
patients themselves during exercise training. 
The determination of the first increase in blood lactate during an incremental exercise 
(i.e., the lactate threshold) and the highest sustainable intensity with steady-state BLC during 
prolonged exercise at constant work-rate (the so-called MLSS) is the gold standard method for 
exercise intensity prescription and for the assessment of CRF/endurance, without the need to 
expose individuals to volitional fatigue. However, the determination of MLSS is time consuming 
since it requires several (3-6) constant workload tests performed on separate days. The results 
of this study indicate that this extensive procedure can be avoided with a single, easy-to-
administer, submaximal incremental exercise test with measurement of blood lactate. The 
prediction equations reported in this study can be used for the assessment of CRF and for 
exercise intensity prescription in postmenopausal women, and very likely, by other adults 
showing similar fitness levels. When it is feasible, performing an additional constant workload 
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test several days after, is highly encouraged because it improves MLSS estimation and adds 
information about the metabolic, cardiac and perceived effort responses during a more real 
exercise-training environment, where exercise is performed during prolonged time, instead of 
been gradually incremented like in standard testing conditions. 
Interestingly, both, the VT1 in CS during an incremental cycling test, and the LT1 in 
postmenopausal women during an incremental walking test agreed in average with the lower 
boundary of relative moderate intensity activities recommended by PA guidelines and position 
stands for adults (i.e., ~45%V̇O2max or ~60%HRmax), which can be considered the minimum 
exercise intensity that can provide health and fitness benefits in sedentary adults, supported 
by evidence-based studies. However, the large variability observed in the absolute (e.g., METs, 
speed or Watts) and relative exercise intensities associated with this first physiological 
threshold (from as low as 1 MET in CS to 7 METs in healthy postmenopausal women or from 
~30% to ~70%V̇O2peak) is evidence that a threshold-based approach is preferred to provide a 
tailored cardiopulmonary and metabolic stress to each individual. Further, our results show 
that both, moderate and vigorous intensities defined by current PA guidelines are included in 
the relative intensity range between thresholds (~45-75%V̇O2max or 60-85%HRmax) both in CS,  
and in postmenopausal women. 
Finally, while most of research studies using accelerometer-based objective 
measurement of PA levels have simply chosen previously validated accelerometer cut-points 
estimated from walking or running at 3 and 6 MET absolute intensities (current target of 
moderate intensity activities, which has been extensively used in epidemiology studies to 
establish the relationship between the time spent in questionnaire-based MVPA and mortality), 
our data support the use of individually tailored cut-points for a meaningful and a more 
accurate quantification of PA levels. Hence, these findings have important implications for the 
use and interpretations of accelerometer data and for the design/delivery of PA interventions 
for adults. Epidemiology studies should at least consider adjusting the association between PA 
and mortality risk by CRF, because as we demonstrated, it is easier for high-fit individuals 
engaging in higher levels of PA, but it does not necessarily mean that they are having higher 
relative intensities. Thus, the aforementioned association might have been inflated by the 
higher CRF in those reporting higher PA dose. Another, more accurate way of quantifying PA 
levels that suits better to small clinical trials or to one-on-one consultations, that overcomes 
with the risk of under-or overestimating PA when using fixed absolute intensity cut-points to 
define the PA intensity categories, is, to individualize this intensity cut-points according to 
relative intensities. Setting individualized relative intensity categories from submaximal 
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ventilatory or lactate thresholds accounts for differences in CRF between individuals, and thus, 
reduces the risk of underestimating or overestimating individual PA levels, and provides the 
appropriate exercise intensity stimulus for an individual. Measuring LTs through an incremental 
and submaximal walking exercise test is a feasible way of; 1) evaluating aerobic fitness and 
assessing the efficacy of an exercise intervention, 2) individualizing exercise intensity 
categories to design a tailored exercise intervention, and 3) measuring reliable PA levels with 
accelerometers to provide behaviour change feedback and evaluate its efficacy, without the 
need to expose the individual to exhaustion. 
 
Take home messages 
 Recommended exercise intensity guidelines for the general population can 
overstress CS who have a lower CRF and cardiac response. Accordingly, using the 
proposed exercise intensity guideline adapted to CS´s cardiopulmonary responses is 
highly recommended. 
 
 The individualization of accelerometer intensity cut-points through LTs may better 
represent the time spent in different PA intensity levels during daily activities, and 
reduce the risk of underestimating or overestimating PA levels, compared to the 
classic absolute moderate intensity (3-6 METs) fixed cut-points approach. 
 
 Even that high-fit postmenopausal women recorded more daily steps and reached 
the MVPA target more easily than less fit individuals according to absolute intensity 
criteria, when accelerometer intensity cut-points were individually-tailored according 
to relative intensity criteria, these differences disappeared.  
 
 Maximal lactate steady-state can be accurately estimated from BLRTs obtained during 
a single, non-exhaustive exercise test in postmenopausal women. 
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10 
10.1 
Supplementary 
Material 
 
 
Practical Applications 
 
Bridging the gap between research and practice 
 
Exercise programming in a cancer patient from 
physical activity and fitness measurements 
Medical history 
Age: 55 
Body mass, height and BMI: 48kg · 1.54m · 20.3 BMI 
BP: 130/75 Resting HR: 53 
Sociodemographic status: married, retired, lives in Bilbao, no economic problems 
Primary reason for attendance 
GP´s referral. Cancer rehabilitation and reduction of side-effects  
Cancer specific  
05-02-2018 Metastatic Lung cancer Stage IV (metastasised to the liver) 
Thoracoscopic surgery (pain and stiffness on the area) 
Undergoing chemotherapy (3 out of 6 cycles every 3 weeks) 
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Cancer related fatigue (7 out of 10 average) 
Neutropenia 
Decreased pulmonary function 
Gastro-intestinal discomfort (nausea) 
Impaired immune function 
Cardiac/metabolic 
Early menopause 
Shortness of breath walking 
Slightly high sugar levels (not taking medication) 
Reflux 
Diarrea  
Musculoskeletal 
Osteopenia 
Peripheral neuropathy 
Low back pain 
Other 
Depression 
Former smoker (1 pack of cigarettes a day) 
Medications 
Platinol + taxotere (chemo) 
Erlotinib (targeted therapy) 
Calcium+Vit D 
Omeoprazol 
Family history 
Father with prostate cancer 
Reported past and current Physical activity levels: enjoyment barriers, facilitators 
Past: Walking, hiking (enjoys nature sports) 
Sedentary work (administrative) 
Current: walking 3-4 times per week 15-30min 
CV risk (SCORE) 
3-4% (low) 
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Physical fitness 
Cardiopulmonary exercise test with gas exchange measures 
To obtain reliable cardiorespiratory fitness values, a maximal incremental exercise test can 
be performed. An initial workload of 20W and 8-10W increment per minute until volitional 
exhaustion is suitable for cancer survivors. 
V̇O2peak: 5.3 METs 
HRpeak: 155 
Wpeak: 94 
VT1: 2.5 METs (45W, 94bpm) 
VT2: 4.0 METs (70W, 120bpm) 
* The VT2 obtained during an incremental test does not guarantee that during prolonged 
exercise at 70W the energy expenditure is going to be 4 METs (It will probably be higher) 
nor that training at 120bpm is the highest sustainable intensity over time without continual 
blood lactate accumulation. 
Measurement of lactate thresholds  
This is the preferred method since it does not require a maximal effort and provides valuable 
information to design an exercise program according to lactate thresholds, guarantying the 
safety and the adequacy of the prescribed exercise.  
1) Incremental walking exercise test with blood lactate measurement wearing an 
accelerometer 
Estadio Duración V (km/h) MET FC [L] RPE Counts 
Reposo 0 - 3 0 1 61 0,8 0 0 
1 3 - 5 2,4 2,2 62 0,8 0 1994 
2 6 - 8 3,0 2,4 67 0,8 0,3 2570 
3 9 - 11 3,6 2,8 67 0,6 0,5 3115 
4 12 - 14 4,3 3,1 73 0,7 1 3919 
5 15 - 17 4,9 3,6 77 0,7 2,5 4780 
6 18 - 20 5,5 4,1 81 0,8 4 5568 
7 21 - 23 6,1 4,6 93 1,1 4,5 6246 
8 24 - 26 6,7 7,2 111 1,7 5 6130 
9 27 - 29 7,3 7,6 138 3,9 7 7088 
Post 1' rec   116       
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From this data, LT1 can be visually determined at 4.9 km·h-1 and corresponding activity 
counts are 4780 ct·min-1. As shown in the 7th chapter, LT1 can be mathematically determined 
(LEmin) for a higher resolution as shown in the next graph, resulting in 4.6 km·h-1. 
Using the Equation 2 of the 7th chapter we could estimate the maximal lactate steady-state 
(LT2). This estimation results in 5.5 km·h-1. However, it is highly encouraged to confirm this 
estimation by a constant velocity test. We have two choices to select the speed for the next 
test: 1) As shown in Chapter 7, we can choose the speed associated with 1 mmol·L-1 above 
LT1, which is usually a tolerable exercise with steady-state lactate values. Then, we only need 
to use the equation 3 provided in this text to estimate the MLSS with a higher accuracy. 2) 
We could directly try with the estimated speed from the equation 2. In this specific case, we 
suspect that the MLSS is at higher velocity than 5.5 km·h-1 due to the low HR and BLC at this 
speed during the incremental exercise test. Therefore, we chose the first alternative.  
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2) Constant velocity test for the confirmation of MLSS. 
 
Estadío Duración V (km/h) FC [L] RPE 
Rep 0 - 3 - 70 1,2 - 
1 3 - 13 6,7 122 3,9 3 
Rec. 13 - 15 -   - - 
2 15 - 25 6,7 135 4,8 5 
Rec 1´ 25 - 26 - 122 - - 
Rec 3´ 25 - 28 - 111 - - 
 
Min by 
min FC 
1 67 
2 70 
3 70 
4 101 
5 117 
6 121 
7 125 
8 127 
9 129 
10 129 
11 131 
12 130 
13 132 
14 111 
15 104 
16 118 
17 131 
18 135 
19 137 
20 139 
21 138 
22 142 
23 143 
24 145 
25 142 
26 122 
27 117 
28 111 
 
There is a 0.9 mmol·L-1 increment in BLC between the 10th and the 20th minute of exercise, 
so we can conclude that this speed is above LT2. In order to avoid more constant velocity 
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tests for the determination of the MLSS, we can apply the equation 3 of the Chapter 7. This 
results in 6.4 km·h-1, which is just 0.1 km·h-1 above the actual vMLSS. Performing this 
additional exercise test gives us important information about the cardiac response and the 
perceived effort during prolonged exercise, which is very useful to design an exercise 
program because it reflects the effort in real conditions. We might expect that exercising 
above ~140 bpm would elevate the lactate levels over time, accelerating fatigue and 
compromising the immune system in patients suffering from anaemia or neutropenia as a 
consequence of chemotherapy treatments.  
 
Exercise testing without cardiopulmonary or metabolic equipment 
If cardiopulmonary or metabolic exercise testing is not feasible other simpler exercise tests 
are available to estimate V̇O2peak. In this doctoral dissertation we used the ACSM´s (2013) 
equation with peak power output obtained during an incremental (8-10W per minute with 
an initial load of 20W) maximal cycling exercise protocol (1.8 (W·6.1183)/BM + 7). 
 
As we showed in the 4th study, MLSS can be estimated through basic information such as 
heart rate and anthropometric data, using the 1st equation provided in that study. 
Continuing with the previous example, MLSS would be as follows:  
vMLSS´ = 16.574 – (0.078 · ∆FC 9.5) – (0.075 · age 55) – (0.036 · HRrest 53) – 
(0.027 · Body mass 48) = 8.5 km·h-1 
 
This estimation is far from the actual MLSS value (6.3 km·h-1). Taking into account that 40% 
of the variation of vMLSS is not explained by these variables, it does not seem reasonable to 
use it. 
Another easier exercise test to evaluate cardiorespiratory fitness is the 400m walk test 
174,175,175,176,176, widely used with cancer patients by one of the top exercise oncology institutes 
in the world (Exercise Medicine Research Institute, Edith Cowan University. Western 
Australia). Maximum HR can be estimated using the equation of Gellish (2007) (206.9 – 
(0.67*age)). 
Estimated VO2max: 6.3 METs 
Estimated HRmax: 170 bpm 
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Physical activity assessment 
7-day accelerometry recording on the right-hip. 
First, we have to individualize the activity counts cut-points according to the patient’s lactate 
thresholds (LT1 = 4.9 km·h-1 and 4780 ct·min-1, and LT2 = 6.4 km·h-1 and 6318 obtained from 
the regression equation between speed and activity counts. 
The results of the weekly physical activity analysis show that the patient meets the 10.000 
daily steps target. Using the absolute intensity cut-points criteria she engages in ~50 
min·day-1 at moderate intensity activities (in 10-min bouts), exceeding current recommended 
minimum target of 150 min·wk-1 of MVPA. However, as her LT1 (4.1 METs) is at a higher 
intensity than the 3 MET-s threshold, we can see that when individually-tailored cut-points 
are selected, the patient only spend ~10 min·day-1 at moderate intensity activities (over LT1), 
which is more meaningful for her health/fitness. Finally, we can observe that she spends too 
much time in sedentary activities (~10 h·day-1). Therefore, a possible realistic goal for this 
patient could be to engage in a structured exercise program at moderate intensities two 
days per week and to reduce the sedentary time, mostly on Sundays and Mondays. 
 
 
Promedio actividad física diaria (min/día) 
  Relative  Absolute  
Zona de  intensidad (min/día)   
Sedentaria 559 559 
Muy Suave 262,1 196,4 
Suave 70,1 73,3 
MVPA (mod + vig) 11,6 52,6 
Vigorosa 0 0 
Pasos diarios   12020 
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¿Suficiente AF MVPA?   No 
¿Tiempo sedentario <8h? 9,8h (no) 
  
 
 
Individualized exercise programming 
From the results of the incremental and the constant velocity tests, individualized exercise 
intensity zones can be designed. In the absence of exercise testing, we can use the Table 4 
provided in the Chapter 4 as a start point. 
These exercise intensity zones are used to guide the exercise training as seen in the next 
figure, starting with 8min bouts at M2 intensities during the first month, and progressing to 
5min intervals at M3 intensities during the third month. 
Zone V HR RPE Training type 
HIT >6,4 >140 >4,5 
High-intensity training where blood 
lactate rises exponentially, and is no 
longer sustained at steady-state 
M3 5,8-6,4 119-140 4,0-4,5 
Intensive moderate-intensity training 
with steady-state lactate values. The 
patient has difficulties to talk and 
sweating increases 
M2 5,1-5,7 98-118 3,0-3,5 Moderate-intensity training. The patient feels an increased breathing frequency 
M1 4,6-5,0 76-97 2,0-3,0 Low-moderate intensity training. There is almost no elevation of blood lactate 
LIT <4,6 <76 <2,0 
Low intensity. Daily activities requiring 
low levels of effort. No elevation of 
lactate 
The intensity zones are based on the values obtained during incremental and constant velocity tests. The 
lower end of M1 and the upper end of M3 zones (“moderate intensity” are anchored on LT1 and LT2 
(MLSS), respectively. V = velocity, HR = heart rate, RPE = rating of perceived effort. 
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Interpretation of exercise sessions 
This is an important and often forgotten part of the exercise interventions. The exercise 
benefits are associated with the cardiovascular and metabolic responses during the sessions, 
and not with the exercise program designed on the paper. Therefore, exercise intensity 
monitoring during the sessions is crucial. Below, we can see an example of the quantification 
of the training “dose” and the adherence to the prescribed exercise. This is very useful to 
adapt the training session to the patient´s current physical and emotional state, due to 
common side effects of the treatments. 
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Follow-ups: continuous feedback and re-programing 
It is well known that continuous feedback is an important for the long-term adherence to 
the exercise program. Here, we show an example of the evaluation of the aerobic fitness 
through the incremental submaximal exercise test at three different time-points. The next 
figure shows how both LT1 and LT2 (MLSS) have been displaced rightwards to higher 
velocities. As the aerobic fitness improves, the patient would need to work at higher loads 
to have the same cardiovascular response.  
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